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Abstract
Bowel cancer (BC) is a major type of cancer in the UK. Population based bowel cancer 
screening (BCS) was introduced to the UK in 2006. Bowel screening, via a faecal occult 
blood test (FOBt), has been speculated to reduce BC mortality by approximately sixteen 
percent. However, the effectiveness of the screening programme to reduce mortality is 
reliant upon substantial participation. Prior to the national roll-out of the BCS programme, a 
UK pilot reported that approximately forty percent of the population declined the invitation 
to be screened for bowel cancer. Literature to date has identified psychosocial factors and 
barriers which may result in an individual declining BCS. However, only a limited amount 
of research was found to be specific to screening via FOBt, and to participation in the new 
BCS programme. Furthermore, relatively little research was dedicated to the reasons why 
individuals chose to decline screening.
Therefore, within this thesis, three qualitative studies were conducted initially to explore the 
factors affecting screening participation via FOBt. These studies revealed that there were a 
number of emotions, beliefs and issues with a FOBt affecting screening participation. To 
ascertain if any of these factors were more predominant than others, a wider-based 
quantitative study was conducted. This study indicated that males and older individuals may 
be more likely to decline routine BCS, and that overall the practical elements of carrying out 
a FOBt may reduce screening participation. To address this issue, a systematic review 
identifying the effect of a FOBt on participation was carried out. This revealed that the type 
of FOBt affected participation rates. Hence, the final study conducted was an intervention to 
address attitudes towards the practical elements of completing a FOBt, and whether these 
were altered by seeing a FOBt, or by the type of FOBt. The findings indicated that these 
factors affected attitudes about BC and BCS. Consequently, implications for further research 
and future directions for the BCS programme were discussed.
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Chapter One 
Introduction
The purpose of this chapter is to provide a brief background for the research presented within 
this thesis. Firstly, screening in general will be discussed, outlining the pros and cons of 
screening. This will be followed by an overview of bowel cancer, bowel cancer screening 
and screening participation. The chapter will conclude with the initial direction for the 
research conducted, and a summary of the thesis content.
Background of cancer screening
According to Cancer Research UK at least one in three people will develop some type of 
cancer in their lifetime (CRUK, 2009). Cancer screening in the UK commenced in 1988, 
when the first invitations for breast and cervical cancer were sent out (NHS CSP, 2009). 
These were implemented as population based screening programmes, whereby people with 
no symptoms were invited for routine screening, i.e., at three to five year intervals. They aim 
to detect the disease before individuals become symptomatic, which can be an indication that 
the disease has progressed (Utsun and Ceber, 2004). These programmes were devised to 
target particular groups in the population who were considered to be at an increased risk, 
which is governed by age, i.e., only 50-69 year olds are routinely screened for breast cancer 
(NHS CSP, 2009). In this way population based screening differs from cascade screening, 
whereby the relatives of patients with cancer are offered screening (De Wert, 2005).
Both breast and cervical screening programmes are forms of cancer prevention. In breast 
screening, cancer can be detected and then treated, whereas cervical screening does not 
diagnose cancer, but detects early cell changes which can develop into cancer (NHS CSP, 
2009b). It has been estimated that cervical screening saves 4,500 lives per year and breast 
screening reduced cancer mortality by up to thirty five percent (Peto, Gilham, Fletcher and
Matthews, 2004; lARC, 2002). However, the effectiveness of cancer screening to reduce 
mortality is only apparent with substantial participation in screening programmes (Weller, 
Patnik, Macintosh and Dietrick, 2009). Fortunately, the adherence to these programmes is 
generally very good, i.e., breast cancer screening achieves an eighty five percent adherence 
rate in the UK (Weller, Moss, Butler, Campbell, Coleman, Melia and Robertson et al., 2006).
Pros and cons of cancer screening
Psychological
A recent review of literature examining the short-term effects of cancer screening on 
people’s quality of life found that the main psychological benefit of being screened for 
cancer is the reassurance and relief gained on the receipt of a normal result (Cullen, 
Schwartz, Lawrence, Selby and Mandleblatt, 2004). However, there is a downside to this as 
previous research has found that normal results can give individuals false reassurance, i.e., 
that they are cancer free (Marshall, 1996). This can result in lower participation in the future 
screening (Wardle and Pope, 1992). The main psychological disadvantage of screening is 
deemed to be anxiety. Cullen et al. (2004) found substantial evidence that receiving positive 
results, or false positive results, can result in anxiety which can negatively affect many areas 
of an individual’s life including their relationships and psychological well-being.
Ethical
Kitchener (1984) outlined three ethical principles which were deemed relevant to cancer 
screening by Marshall (1996b); namely non-maleficence, beneficence, and autonomy. Non­
maleficence or ‘above all do no harm’ applied to this context means that screening should 
benefit the individual, not harm them (McCleod, 1998). In this respect, it could be said that 
screening programmes do not abide with this principle for three reasons. Firstly, as 
previously stated, the screening process can induce anxiety which can psychologically harm 
the individual. Secondly, there is evidence to suggest that screening can result in physical
harm. For example, biopsies following abnormal mammography results can result in 
infections and abscesses (Marshall, 1996). Furthermore, mammography results can result in 
unnecessary treatment, i.e., removal of benign breast tumours which may not have developed 
into cancer (Irwig, McCaffery, Salkeld and Bosuyt, 2006). Thirdly, screening programmes 
can cause social harm (Marshall, 1996). Here, social harm is considered to be the stigma 
associated with being diagnosed with cancer, i.e., society’s perception of ‘sick’ individuals, 
and the incurred cost of attending a screening appointment during work hours, i.e., loss of 
time and thus salary.
Beneficence or the ‘injunction to promote human welfare’ signifies that the benefits of 
screening should outweigh the risks (McCleod, 1998). Beneficence has been professed to be 
upheld in cancer screening programmes as they consider themselves to be predominantly 
beneficial, i.e., they significantly reduce the likelihood of cancer mortality (CRUK, 2009b). 
However, Irwig et al. (2006) argued that a majority of information available to the public 
about cancer screening overemphasises the benefits of the programmes, and diminishes the 
negative aspects. Finally, autonomy is the concept that individuals possess the ability to 
formulate and execute their own decisions (Boyd, Higgs and Pinching, 1997). In this context, 
autonomy pertains to an individual’s right to choose or refuse participation in screening.
To ensure cancer screening is ethically viable, despite the drawbacks noted, the notion of 
informed consent is imperative (Utsun and Ceber, 2004). Here, informed consent relates to 
the individual giving consent to partake in screening, after they have been given, and 
understood, information concerning the benefits and harms of the screening in the context of 
their life. This relies on the individual possessing the capacity to make a voluntary decision 
on the basis of patient information (Utsun and Ceber, 2004). Austoker (1999) stipulated that 
the autonomy of the individual must be respected at all times, even if consent is not given by 
the individual, and this is detrimental to them.
What is Bowel Cancer?
Cancer Research UK declared bowel cancer (BC) to be one of the main types of cancer in 
the UK after breast and lung cancer (CRUK, 2009). Bowel cancer, also known as colorectal 
or colon cancer most commonly occurs in the large intestine (Adrouny, 2002); see Figure 
1.1.
Figure 1.1; The Human Intestine
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If the cells in the lining of colon develop abnormally, they may form clumps (Adrouny, 
2002). If left, these clumps of pre-cancerous cells or polyps will develop over a period of 
years, until they invade the large colon wall and form a bowel cancer; see Figure 1.2 
(Adrouny, 2002). At this point, the individuals may experience symptoms such as rectal 
bleeding coming from the polyp, and other bowel problems, e.g., diarrhoea as the bowel will 
be effectively obstructed (Adrouny, 2002).
Figure 1.2: Development of bowel cancer
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What are the risk factors for Bowel Cancer?
Similar to other cancers, there are particular risk factors for BC which include age, genetic 
predisposition, family history, history of bowel disorders, diet and lifestyle (ACS, 2009). 
Although younger people are diagnosed with BC, the majority of people tend to be over 60 
years old (CRUK, 2009). Genetic predisposition to BC only occurs in a minority of cases, 
whereby conditions such as familial adenomatous polyposis (FAP) and hereditary non­
polyposis colon cancer (HPNCC) result in a higher generation of polyps, and thus higher risk 
of BC (ACS, 2009). A family histoiy of cancer can also increase the likelihood of a BC 
diagnosis (CRUK, 2009). Here it is deemed that risk is higher if an individual has a first 
degree relative (FDR), i.e., parent or sibling, who was diagnosed at the age of 45 years old or 
under, or two FDR’s who have been diagnosed with cancer at any age. However, in the 
latter, diet and lifestyle factors have been found to have a larger effect (CRUK, 2009).
Individuals with a previous history of polyps or BC are more likely to develop cancer in 
other parts of their bowel (ACS, 2009). Furthermore, a histoiy of other disorders such as 
Crohn’s disease and ulcerative colitis, which are both infiammatory conditions in the bowel, 
can also increase the risk of BC (ACS, 2009). Generally, diets containing a high red meat or 
processed meat content have been associated with increased risk of BC whereas diets which 
contain high fruit and vegetable intake are associated with lower risk (Hislop, 2000). Finally,
lifestyle factors which can lower the risk of BC have been found to be regular exercise and 
not smoking (CRUK, 2009). It was stated here that individuals who did less exercise were at 
a fifty percent higher risk of developing the disease, and that smokers were more likely to 
develop polyps and BC. However, despite the risk factors described here, with a majority of 
BC cases in the UK, the exact causes remain unknown (NHS, 2009).
What is bowel cancer screening?
Population based bowel cancer screening (BCS) was introduced in the UK in 2006 (NHS,
2008). This is the first screening programme for both men and women (NHS, 2009). The 
bowel cancer screening programme (BCS?) invites people between 60-69 years old, every 
two years, for large bowel screening (NHS, 2009). Similar to cervical screening, this 
programme aims to detect abnormal changes, or in this context polyps, which could indicate 
the early onset of BC (NHS, 2009). The programme follows a generic pathway. This process 
is represented diagrammatically in Appendix 1. As shown in Appendix 1, individuals 
initially receive an invitation to take part in BCS (Appendix 2) with a BCS leaflet ‘Bowel 
Cancer Screening- The Facts’ explaining the process, benefits and possible harms of 
screening (Appendix 3). They are then sent the screening test card (Appendix 4) and test kit 
instructions (Appendix 5) a few days later.
The screening test
The screening test is a faecal occult blood test (FOBt). FOBt’s have been found to reduce 
bowel cancer mortality by around sixteen percent (Hewitson, Glasziou, Irwig, Towler and 
Watson, 2006). This is the first screening test which can be carried out by the individuals in 
the privacy of their own home (Weller et al., 2006). The test involves taking samples of 
faecal matter, from three separate bowel motions, and applying them to the test card (NHS,
2009). The individual is then asked to place the completed FOBt in a secure envelope 
provided (Appendix 6) and to return the test to the BCSP laboratory for testing (NHS, 2009).
Once received by the laboratory, the test card is analysed by removing the ‘do not open’ strip 
on the reverse of the test card (NHS BCSP, 2009). A solution of hydrogen peroxide is 
applied to the strip (NHS BCSP, 2009). If blood is detected in any of the samples, the strip 
will noticeably change colour (NHS BCSP, 2009). Depending on how many samples blood 
is detected in, individuals will ether be asked to complete a re-test, to see if the blood is 
persisting, or to attend a nurse clinic appointment at their local hospital (NHS, 2009). This 
appointment is a pre-requisite to a colonoscopy (NHS, 2009). A colonoscopy is an internal 
investigation whereby a small camera scope is introduced into the large bowel via the anus 
(Adrouny, 2002). The camera is designed to travel around the large bowel to detect polyps, 
which if found, can be removed instantaneously and sent for analysis (Adrouny, 2002).
Bowel cancer screening participation
Prior to the implementation of the BCSP, a UK Colorectal Cancer Screening Pilot, using 
FOBt’s, was carried out to test the effectiveness of the screening programme (Weller et al., 
2006). The results found that approximately forty percent of the population declined 
participation in BCS. Until the pilot commenced, much research in this area to date had not 
featured the NHS BCSP specifically, or the FOBt as the predominant modality of screening. 
Past research has often been based in countries other than the UK, and on screening 
modalities such as flexible sigmoidoscopy and colonoscopy, as shall be discussed in 
subsequent chapters. Therefore, although research has been conducted into the reasons why 
individuals choose to accept or decline BCS screening, the only research known to have been 
conducted in conjunction with the programme, were the qualitative studies carried out during 
the UK pilot of the national programme.
Conclusion
This introductory chapter has highlighted not only the necessity of screening, but the 
importance of screening participation in the reduction of cancer. In relation to BC, the level 
of participation was considered low in comparison to breast and cervical screening. 
Therefore, it was deemed necessary to commence the research for this thesis with an 
exploration of the existing literature in this area, pertaining to the factors affecting BCS 
participation; as detailed in chapter two. Subsequently, the purpose of chapter three was to 
outline the theoretical framework which underpins the research regarding factors affecting 
BCS participation, and to consider the theoretical constructs which could be utilised in the 
quantitative studies later in the thesis.
Chapter four outlines three qualitative studies which aimed to identify the factors affecting 
participation in relation to the NHS BCSP. A triangulation was then performed on the 
findings from these studies to ascertain the predominant factors affecting screening. These 
factors were then operationalised, in the form of constructs, in chapter five; a quantitative 
study addressing the intention to be screened in the BCSP. The results from the quantitative 
study revealed the importance of the practical elements of completing a FOBt to the 
intention to take part in BCS. Therefore chapter six consisted of a systematic review 
addressing literature which has considered how the characteristics of a FOBt specifically, 
can affect participation rates. Chapter seven outlines an intervention study which was based 
upon a culmination of the results from studies one to four, and the outcome of the systematic 
review. Therefore this study concentrated upon how the type of FOBt would affect the 
intention to be screened, and if intention was affected by seeing what a FOBt involves.
Finally, chapter eight consists of an overall discussion of the research conducted within this 
thesis. This chapter aimed to discuss the strengths, limitations and implications of the 
research; concluding with the contribution the research has made to this area.
Chapter Two 
Literature Review Part One 
Psychosocial factors and barriers affecting screening participation
Introduction
The purpose of this chapter is to outline literature in the area pertaining to the demographic 
and psychosocial factors, plus the barriers which have been found to affect participation rates 
in BCS. Psychosocial factors in this context have been construed as the psychological 
interaction with the social environment which results in a decision about screening 
participation. In addition to the demographic and psychosocial factors effecting participation 
in the BCSP, declining BCS via a FOBt may also be influenced by individual barriers to 
screening (Broughton, Bailey and Linney, 2004). Barriers are understood to be cognitive 
factors which can impede the decision to take part in BCS.
Demographic factors 
Age
As specified in chapter one, BCS in the UK is currently offered to individuals aged between 
60-69 years of age (NHS, 2009). The age of the individual has been identified as a 
fundamental factor for determining screening participation as suggested in Vernon’s (1997) 
review identifying demographic factors associated with BCS participation. Here, a number 
of studies found that older individuals, especially those over 70 years old, were less likely to 
take part. This was supported in a study seeking the socio-demographic correlates of 
intention to be screened for bowel cancer (BC), whereby older individuals were less likely to 
show interest in screening (Tong, Hughes, Oldenburg, Del Mar and Kennedy, 2000). 
Similarly, Robb, Miles and Wardle (2004) conducted a study investigating the relationship 
between perceived risk of BC and demographic and psychosocial factors. These findings 
illustrated that older participants, 60-64 year olds, perceived themselves to be at a lower risk
of BC compared with the younger age group; 55-59 year olds. Unfortunately, no conclusion 
was drawn in either of the latter studies as to why this was the case.
Contrastingly, the initial NHS BCSP UK pilot focus groups found that most participants 
agreed that they were more at risk of BC because of their age (O’Sullivan and Orbell, 2003). 
The findings fi*om the second pilot found that screening participation increased with age as 
there was a twelve percent increase between those aged up to 55 years old, and 65-69 year 
olds (Weller et al. 2006). loannou, Chapko and Dominitz (2003) also found advancing age to 
be a predictor of participation in BCS. They were able to conclude that this may be a result 
of a higher perceived risk of developing the disease. Additionally, participation may have 
been greater because older individuals may be more health aware due to having had other 
investigations for gastrointestinal problems.
This was also found by Jerant, Franks, Jackson and Doeescher (2004) who sought to identify 
the cause of age-related disparities in cancer screening. This study was based on previous 
research which claimed that ageism was an issue in health care systems whereby older 
individuals were actively disfavoured (Alliance for Aging Research, 2003). In the area of 
bowel screening, it was hypothesised that this disparity may also have been the result of 
ageism, or favouritism towards younger individuals in the health system. However, their 
hypothesis was not supported as ageism was not considered a root cause or disfavour of 
older individuals. In fact, there appeared to be an increase in screening participation with 
age. The reason for this was difficult to attribute. Firstly, there was a possibility that a higher 
percentage of older people took part because they may have had a higher perceived risk of 
developing the disease. However, participation may have been greater because older 
individuals tend to present with symptoms, e.g., rectal bleeding, as they get older resulting in 
a greater need to be screened. This conclusion was deemed interesting because it highlights 
the role of the patient seeking screening from the health practitioner. However, if the older
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patients within this study were displaying no symptoms, would they have been screened as 
readily? This was not clarified by Jerant et al. (2004), and does imply that ageism for an 
asymptomatic population may still exist.
Jepson, Clegg, Forbes, Lewis, Sowden and Kleijen (2000) performed a systematic review of 
the determinants of screening participation. Their findings, similar to those mentioned here, 
found individuals over the age of sixty five were more likely to accept screening. They also 
raised the point that it was difficult to compare studies in terms of age, as many studies 
reported different age ranges for younger and older participants. This highlights a limitation 
of the studies discussed here, that they too are difficult to compare because of their age 
ranges. Despite this, the usefulness of studies cited here comes from their ability to highlight 
that age can be a barrier to screening. However, not many conclusions have been drawn by 
authors as to why this is the case. Perhaps it is because age is a barrier that appears to be 
inter-related with others; which will be discussed as this chapter progresses.
Gender
Vernon (1997) found conclusive evidence in most of the studies reviewed that women were 
more likely to participate in BCS via FOBt than men. This was reflected in the first pilot 
focus groups, whereby men were considered to be more reluctant to take part in screening 
(O’Sullivan and Orbell, 2003). Here, it was stated that men may deny that they are at risk of 
BC or not take part because they have not been invited to take part in screening programmes 
in the past. As the BCSP is the first national BCS programme available to both males and 
females, males have not been invited to take part in any national screening programmes until 
now (NHS, 2009). Unsurprising perhaps then, that males are more likely to decline BCS. 
This was supported in the second pilot whereby male participation was eight percent lower 
than females (Weller et al., 2006).
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Robb et al. (2004) suggested that men were less likely to participate in BCS than women 
because males perceive they are at a lower risk of developing BC. Contrastingly, a female 
based study found that women were less likely to participate in BCS than in any other type 
of screening (Weinberg, Turner, Wang, Myers and Miller, 2004). This was thought to be 
because women perceived that it was a disease mostly found in men. Here, it was found that 
there was a link between women’s cognitive factors and psychosocial factors. Women were 
more likely to accept screening if they felt that it significantly reduced the risk of developing 
BC and that it coincided with their GPs recommendation. However, if there was any element 
of fear about the screening process itself, the women would be more likely to decline.
Evans, Brotherstone, Miles and Wardle (2005) reviewed literature concerning the gender 
differences in cancer screening as a primary detection and therefore prevention of cancer. 
This was speculated by Evans et al. (2005) to be due to the under utilization of primary 
cancer prevention, i.e., screening, by men. For instance, if they develop cancer symptoms, 
men tend to delay visiting their GP for longer than women do (Kerrippainen, Raiha, Rajala 
and Sourander, 1993). This was thought to be because they tend to visit their health services 
for curative rather than preventative reasons. Secondly, with regards to participation in BCS, 
screening does not rely wholly on individuals having knowledge of cancer and its symptoms; 
there is also an emphasis on the asymptomatic nature of cancer (Harris, Treloar and Byles, 
1998). Unfortunately, as men appear to under value the prevention of cancer, there may also 
be a lack of awareness as to the asymptomatic nature of BC.
Lowered levels in participation may also be borne from the lack of publicity concerning 
men’s cancers (Evans et al., 2005). It was stated in one article that the information available 
regarding both prostate and colorectal cancer was one third of that dedicated to breast cancer. 
This too could account for the lowered awareness of cancer in men (Katz, Sheridan, Pignone, 
Lewis, Battle and Gollop et al., 2004). However, the difference between the genders is not
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clear cut. Not only do men delay seeing their GP if they have symptoms, and are less aware 
of cancer itself, but their participation in BCS also tends to depend on the type of screening 
(Jorgensen, Kronborg and Fenger, 2002). For instance men are less likely to participate in a 
FOBt because they tend to have less self-efficacy and less faith in its salience (Myers, Ross, 
Jepson Wolf and Millner, 1994). Furthermore, Myers et al.’s (1994) study, addressing 
adherence to BCS, found that men often require more encouragement and direction than 
women in this area. This was concluded to be due to men being generally less aware of 
symptoms and seeking preventive health behaviours less readily then women.
This was looked at in more detail by Brawarsky, Brooks, and Mucci (2003) who found that 
perceived risk of cancer, confidence that screening could prevent cancer, and a previous 
diagnosis of cancer meant that men were more likely to participate in BCS. Contrastingly, 
women were found to take part more readily if they were older and had participated in other 
screening programmes. However, these predictors of screening behaviour were not found to 
be significant with regards to the modality of screening as previously mentioned.
The final evidence reviewed by Evans et al. (2005) concerns the matter of masculinity and 
its characteristics. We have seen earlier that males have less faith in primary preventions; we 
also know that they tend to visit their GP less. However, what is lacking from this research is 
the component of masculinity and its impact on cancer screening participation. The male 
gender role in society conjures up a picture of physical and emotional strength. Therefore 
research has noted that men may be less likely to visit their GP, as this may be a sign of 
weakness (Addis and Mahalik, 2003). In this way, men may be less likely to take part in 
screening as they are less likely to practise good health behaviours, thus maintaining their 
perceived invulnerability to illness (Courtenay, 2000).
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Socio-economic background
There is evidence to support the fact that individuals with a lower socio-economic status are 
more likely to decline BCS (Vernon, 1997). The reasons for this are varied. Firstly, there is 
evidence to suggest that individuals with a lower socio-economic status tend to live in more 
deprived areas, where there is less education, and thus less awareness of BC. This was found 
in an investigation into socio-economic influence on BCS participation (Wardle, McCaffery, 
Nadel and Atkin, 2004). Findings showed that participants from deprived areas, who had a 
low educational status were less likely to participate in BCS.
Slattery, Kinney and Levin (2004) sought to identify the impact of socio-economic factors 
upon BCS participation. Here, it was found that certain factors such as higher levels of 
education predisposed higher rates of participation. Unfortunately, the limitation with this 
study was that there were no suggestions as to why this would be the case. In contrast to this 
Tong et al. (2000) found that an increased income can result in a lower intention to be 
screened for BC, simply because individuals stated that they were too busy to complete the 
test card. The assumption drawn from this study was that those individuals with a higher 
income may have been employed full-time whereas part-time and unemployed individuals 
were more likely to participate.
Unfortunately, socioeconomic factors are often difficult to identify independently. Theisen 
(2004), in the United States, stated that it is often difficult to differentiate between 
socioeconomic factors and ethnicity factors for example. In this discussion it was outlined 
that these particular factors are difficult to disentangle, e.g., there is often lowered 
participation in immigrant groups; however, it is difficult to discern if this is for cultural, i.e., 
restricted by cultural beliefs, or socioeconomic reasons, i.e., restricted by finances and thus 
insurance. Although this example differs from the UK in that individuals do not have to 
incur financial costs to participate in screening, it has been found that deprived areas do have
14
lowered cancer survival rates, possibly as a result of lower participation in BCS (McCaffery, 
Wardle, Nadel and Atkin, 2002).
McCaffery et al. (2002) noted the socioeconomic differences in participating in BCS via 
flexible sigmoidoscopy (FS). Here, they suggest that the adherence rate to this procedure was 
imperative as it would improve the cancer care offered in the UK. In this study they took a 
population from a deprived area in Glasgow, and found that individuals were less likely to 
participate if they lived in this area. Unfortunately, there was no direct conclusion drawn 
from this study. However, the study did succeed in highlighting that this problem exists in 
the UK, as much as in the United States. It also demonstrates the possibility that socio­
economic factors alone are not responsible for BCS participation.
Wardle et al. (2004) addressed how psychosocial factors, i.e., social support and stress, and 
cognitive factors i.e., fatalism, benefits, and fear interact with socio-economic status to affect 
an individual’s intention to be screened. Here, findings showed that even though participants 
from deprived areas suffered from more stress and had lowered social support, this did not 
reduce their intention to be screened. Interestingly, the cognitive factors were more 
influential upon intention to be screened, whereby individuals of lower socio-economic 
status were fatalistic and fearful about BC, plus they were less convinced about the benefits 
of screening. Participants had been given literature to read during the course of the study 
which was specifically aimed at reducing fatalism and fear whilst showing the benefits of 
BCS. Wardle et al. (2004) concluded that one reason for this may have been lower 
education; i.e., those from a lower socio-economic area, have less education and therefore 
are less likely to read such information, hence lowering participation.
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Ethnicity
An individual’s ethnic origin can also affect participation in screening. The reasons for this 
were outlined in both rounds of the national pilot (UK CRC Evaluation Team, 2003; Weller 
et al., 2006). Here adherence in the Asian community was found to be approximately thirty 
two percent for Muslims and forty four percent for Hindus compared with a sixty two 
percent adherence in the non-Asian community. Apart from the lower level of uptake, there 
were also interesting findings within this cohort. Firstly, no difference was found in 
participation rates between genders, as found in the non-Asian community. Secondly, one of 
the main reasons for lowered adherence was reasoned to be the associated language barrier 
of receiving test kits and their instructions through the post, resulting in some individuals 
being sent up to four test kits for one episode. In conjunction with this were the attributes of 
the participants GPs. This impacted on adherence when GPs did not share the same religious 
background, or speak the same language as participants. Thirdly, it was found during focus 
groups that individuals from the Asian community perceived their risk of developing BC as 
lower even though they also had a lowered awareness of the disease. The lowered awareness 
appeared to be a derivative of lowered experience of BC, particularly in close family.
It was also reported that self-efficacy within this group was lower than the non-Asian 
participants. This was considered to be because individuals were not as confident in carrying 
out the test kit. This, the pilot reasoned, could also have been due to the existing language 
barrier. Furthermore, some individuals questioned the effectiveness of the kit itself, and thus 
their confidence in the screening programme was lessened resulting in non-participation. 
These findings were replicated whilst examining racial and ethnic disparities in screening, 
where there was also a clear awareness of a lower participation in non-white communities 
(Goel, Wee, McCarthy, Davis, Ngo-Metzger, and Phillips, 2003). The rationale here was 
that there is a language barrier, which lowers the awareness of BC, the screening process and 
its benefits. Furthermore, it is felt that there is often a lack of GPs who can cater for
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minority populations of this nature, which often results in lower access to healthcare and thus 
screening in general.
More recently, Robb, Solarin, Power, Atkin and Wardle (2008b) conducted a study to 
identify the attitudes held by ethnic minority groups towards BCS. It was found here that 
there was a distinct lack of knowledge held about BC by these groups, particularly regarding 
the causes of BC. This was considered to be because, in the past, certain ethnic groups have 
been at a lower-risk of developing the disease; hence they may not actively recognise their 
current risk. Apparently, the most frequent response to the contributory factors of BC was 
diet (Robb et al., 2008b). In the past research has shown that diets in some cultures, e.g.. 
South Asian, result in a lower risk of BC, which is why this perception may have been held 
by these groups (McKeigue, Adelstein, Marmot, Henly, Owen, Hill and Thompson, 1989). 
This is considered worrying, as pointed out by Robb et al. (2008b), because there is now 
evidence to support BC rates having increased in these groups. Secondly, it was found that in 
comparison to white groups, the ethnic minority groups reported that their main obstacle to 
screening was embarrassment. Unfortunately no conclusion was drawn as to why this was 
the case.
Psychosocial factors 
Family history
As outlined in chapter one, an individual with a first-degree relative (FDR), diagnosed with 
BC at an early age, has three times more risk of BC than an individual in the general 
population; this risk increases if the individual has more than one FDR diagnosed with this 
condition (Dowling, St John, MaCrae and Hopper, 2000). In such instances, individuals may 
opt for FOBt, depending on their circumstances; i.e., with some patients, colonoscopy is 
deemed more appropriate (Winawer, Fletcher and Miller et al., 1997). Vernon (1997) found 
that individuals with an inherited risk of BC are more likely to participate in BCS. Evidence
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here reveals that individuals who have known an individual with BC, especially a FDR, 
have a higher perceived risk of developing BC and therefore are more likely to accept 
screening. It has been speculated in such instances that this is because the individual’s 
personal experience of BC has made them feel more vulnerable to cancer, because they may 
have a genetically higher risk of developing the disease (Robb et al., 2004).
Conversely, family history has been regarded as a reason to decline screening. There is 
evidence to suggest that in the presence of a family history, an individual’s fear of BC may 
cause them to decline screening, i.e., ‘if I am going to develop the disease, I don’t want to 
know’ (McCaffeiy, Borril, Williamson, Taylor, Sutton, Atkin and Wardle, 2001). Here, 
whilst investigating the decision-making process behind BCS via FS, respondents were said 
to distance themselves from family members who have experienced BC as a defence 
mechanism to the threat of the disease. Research has also shown that a lack of awareness of 
BC can exist, regardless of family history (Glanz, Grove, Le Marchand and Gotay, 1999). 
Glanz et al. (1999) found that although awareness of BC was generally higher amongst 
families with a histoiy of BC, there were sub-groups within these families, e.g., males, who 
were less aware of a FDR, were less knowledgeable about BC and thus had a lower 
perceived risk of the disease. This poses the question of whether such individuals would also 
decline screening. Secondly, as found in a study investigating adherence, there is the 
misconception amongst individuals who do not have a family history of BC that they have a 
lower risk of developing the disease, and therefore decline screening (Hart, Baron and 
Maybeny, 1997).
Symptomotology
During the first pilot focus groups, researchers were content that a high number of 
individuals were aware of, and could confidently state, the symptoms of BC (O’Sullivan and 
Orbell, 2003). It was unsurprising to find research stating that individuals presenting with
18
symptoms of BC are more likely to accept screening (Robb et al., 2004). The reasoning here 
is that by experiencing the symptoms of BC there is a higher risk of developing the disease 
in the future. These findings appear to be synonymous with that seen in individuals with a 
family histoiy of BC. Individuals who display bowel symptoms, like individuals who are 
aware of their family history, appear to be more knowledgeable and thus vigilant about BC, 
compared to those whom do not have any symptoms; as they feel more at risk to developing 
BC (Robb et al., 2004).
Interestingly, akin to the absence of family history, individuals who do not appear to have 
any bowel symptoms and feel well perceive their risk of developing BC as lower (Robb et 
al., 2004). McCaffery et al. (2001) also found that during focus group responses, the test was 
referred to as unnecessary because respondents were currently in good health and they had 
no symptoms. This misunderstanding is considered wonying, especially as the early stages 
of BC have been documented to be asymptomatic (Austoker, 1994). Similarly, lack of 
awareness of symptoms can often lead to a delay in seeking advice (Broughton et al., 2004). 
Here it was stipulated that individuals who did not relate bowel symptoms to BC were less 
likely to approach a health practitioner. It has also been reported that some individuals who 
decline screening do so because they do not think that screening, seemingly well people, 
justifies the financial costs of the screening process (Hart et al., 1997).
However, Power, Van Jaarsveld, McCaffery, Miles, Atkin and Wardle (2008) considered the 
role of symptomology in a study addressing intentions and actions in BCS. Here it was found 
that bowel symptoms were a good predictor of the intention to be screened, but not of the 
action. Furthermore, Lipkus, Rimer, Lyna, Pradhan, Conaway and Woods-Powell (1996) 
looked at BCS patterns in an African-American population. They found that screening 
services were utilised for their diagnostic power rather than as a preventative measure. Each 
of the findings from these studies are deemed to be worrying by the author, as it strongly
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suggests that individuals who are asymptomatic when called for BCS through the NHS may 
decline.
Health behaviours
Health behaviours in this context are understood as behaviours in which individuals engage 
in order to remain healthy (Taylor, 2006). In this respect, it is expected that individuals 
engaging in health related behaviours, e.g., regular exercise, would reduce their risk of 
developing cancer (Lipkus, Rimer and Strigo, 1996b). However, the evidence presented on 
health related behaviours varies. For instance, it has been reported that smokers realise that 
they have a higher risk of developing cancer than non-smokers (Robb et al., 2004). 
Furthermore, those who engage in regular exercise also perceived themselves to be at a 
lower risk (Robb et al., 2004). These findings imply that those who do not engage in as many 
health related behaviours, and thus perceive themselves at a higher risk, may more readily 
accept screening.
This was not thought to be the case in an earlier study whereby a population survey reported 
that those who do not engage in health related behaviours have declined BCS more readily 
than those who do (Shapiro, Seeff and Nadel, 2001). The reasoning behind this is that 
individuals who engage in health related behaviours such as other screening tests, not 
smoking, seat belt use, eating a high amount of fruit and vegetables and exercising regularly 
are more likely to accept screening. The association between BCS tests and other screening 
tests was particularly high in this case, and this was thought to be because individuals with 
more interest in screening tests generally would be more likely to be screened for BC. 
Interestingly, this was also thought to be due to the level of interest shown by the 
individual’s health practitioner in screening tests, which was thought to be associated with 
higher screening attendance.
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Research has also shown a link between obesity and a higher adherence to screening 
(Slattery et ah, 2004). In this study, obese women more readily took part in BCS. The 
reasoning behind this was that because they saw their GP on a more regular basis, there was 
a higher possibility that BCS had been mentioned by the GP. Secondly, the individuals may 
have associated a link between obesity and developing BC, and therefore are more likely to 
accept screening.
Social relationships
When individuals encounter stress, they tend to cope with it better when they have social 
support from others, or the belief that they are loved and have a sense of belonging (Lau, 
2001). Findings have shown that social support is important for how individuals cope with 
life stressors, e.g., social support can increase self-esteem making it easier for the individual 
to cope with the impact of stressors (Sarafino, 2002). In this context, if individuals feel that 
they do not have the social support of friends and family to participate in BCS, they are more 
likely to decline participation (Brouse, Basch, Wolf, Shmukler, Neugut and Shea, 2003).
Findings such as these have been looked at in more depth, with regards to BCS education. In 
2006, a study was carried out to see if increased social support aided the process of an 
education programme designed to raise the awareness of BCS (Larkey, 2006). Here, groups 
of women were encouraged to meet on a regular basis for education, question and answer 
sessions, and to meet others in a similar position. The results indicated that the strengthening 
of such social support networks, could improve participation in screening and thus cancer 
prevention. However, it did stipulate that these factors alone could not improve participation 
drastically; this would require a more rigorous intervention (Larkey, 2006).
Jepson et al.’s (2000) review found that support, from family and friends, was not a good 
predictor of screening behaviour; thus there was no causal relationship drawn between social
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support and increasing participation. This was considered to be a surprising finding as they 
cited a previous study, by Thomas, White, Mah, Geisser, Church and Mandel (1995), which 
demonstrated contrary results. Thomas et al. (1995) found that it was not so much the social 
support of family and friends that was important, it was logistically where this support was 
placed. Here, participation was said to be dramatically increased if the individual resided in 
the same place as that of the individual deciding to take part, and were taking part 
themselves.
Kremers, Mesters, Pladdet, Van de Borne and Stockbrugger (2000) considered social support 
in more depth, by analysing the different types of social support available to individuals, and 
the varying impacts they had on screening participation. Social support from family and 
friends alone did not significantly affect uptake. Emotional support only marginally affected 
uptake, although it was not dictated as to the source of this support. Finally, it was the social 
support from practical and informational sources which had the most significant impact on 
increasing adherence and thus participation in screening. It was found that practical forms of 
support were the most beneficial as they increased individuals’ response efficacy.
Relationships with significant others have also been found to affect preventative health 
behaviours (Helgeson, Novak, Lepore and Eton, 2004). The dynamics of these relationships 
were different compared to those of social support. Here, the concept of social control was 
investigated with regards to its relationship to health behaviours and cancer in men. Social 
control was defined as either indirect, i.e., individuals feel responsible to a social network to 
remain healthy, or direct, i.e., members of an individual’s social network influence the 
individual’s health behaviour. One of the aims of Helgeson et al.’s (2004) study was to 
examine the effect of direct social control on patients, i.e., spousal control on health 
behaviour, e.g., exercise and smoking. The findings revealed that social control resulted in 
worsened health behaviours, i.e., the more spouses promoted good health behaviours, the
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less likely patients were to carry them out. This demonstrated the negative effect social 
relationships can have on health behaviours, and imply that the same may be the case for 
screening. This was highlighted in an historical study predicting BCS (Macrae, Hill, St. 
John, Ambikapathy, Gamer, The Ballarat General Practitioner Research Group, 1984). Here, 
BCS participation was strongly influenced by the individual’s spouse, and whether they 
would want the individual to carry out the test.
Contrary results were found by Van Jaarsveld, Miles, Edwards and Wardle (2006) who 
investigated the effect of cohabiting partners on intention to, and participation in, BCS. 
Married couples, or those living as such, were more intent on being screened for BC which 
resulted in a higher participation rate. This they found was a result of positive social control. 
Men reported that indirect social control was an important motivation to be screened. In 
regards to direct control, women encouraging men to be screened resulted in a higher 
participation rate.
Fatalism
Fatalism in this context relates to how individuals view external events to be the most 
powerful and that we as human beings have no control over these events (Straughan and 
Seow, 1998). In relation to cancer, or cancer screening behaviour, this outlook translates into 
individuals declining screening because they have an elevated external locus of control, i.e., 
they do not feel they have control over their long-term health (Straughan and Seow, 1998). 
Furthermore, Straughan and Seow stated that these beliefs reduce an individual’s self- 
efficacy. Powe and Finnic (2003) stated in their review of literature that when cancer 
fatalism exists, individuals are more likely to believe that cancer inevitably results in death. 
They discussed several studies relating to fatalism and BCS specifically. Each of these 
studies utilized the Powe Fatalism Model which was developed to explain the relationship 
between demographics, knowledge of BC, cancer fatalism, and participation in BCS (Powe
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and Johnson, 1995). The studies revealed that cancer fatalism was significantly related to 
demographics i.e., women, older people, and ethnic minority groups who held more fatalistic 
beliefs. Individuals with a lower income and lower levels of education were also more 
fatalistic. Finally, they found that individuals with lower levels of knowledge about BC and 
BCS also had higher levels of cancer fatalism.
Powe, Daniels and Finnie (2005) looked at perceptions of cancer fatalism held by African 
American patients and their health care providers. In this study, perceptions of cancer 
fatalism related to screening behaviours. Findings here showed that it was the health care 
providers who perceived their patients to be more fatalistic, whereas the patients’ scores of 
fatalism remained quite low. This implied that providers may have been communicating 
differently with patients who they perceive hold these beliefs. This could mean that 
practitioners’ perception of the patient reduces the amount of health information they share 
or discuss with them, as they do not think that they will cany out these behaviours, e.g., a 
patient who does not ask about screening is perceived to be fatalistic, hence is not informed 
about screening. Therefore, negative perceptions held by the GP may result in the level of 
cancer fatalism increasing in patients.
Nierdeppe and Levy (2007) investigated fatalistic beliefs towards cancer prevention, i.e., 
diet, exercise and non-smoking, in relation to fatalistic beliefs in US adults. Firstly, they 
found that fatalistic beliefs were held by a large proportion of their population, particularly in 
those who were less educated. Secondly, they found that these beliefs were significantly 
related to lower engagement in preventative health behaviours. Nierdeppe and Levy (2007) 
concluded that individuals may be more likely to decline screening if they held fatalistic 
beliefs, although they also questioned whether fatalism was a concept which should be 
applied uniformly to prevention and screening, or whether these should be sub-divided.
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However, it was highlighted at the end of the study that fatalistic beliefs may result in a 
higher risk group of adults who do not engage in preventative health behaviours.
This was supported by Miles, Voorwinden, Chapman and Wardle (2008) who sought to 
identify the relationship between fear, fatalism and the avoidance of cancer information in 
older adults. The conclusion drawn from this research was that adults with more fatalistic 
beliefs were more likely to avoid cancer related information, which in turn would allow their 
beliefs to strengthen. This finding was considered to be very important by the author as this 
could imply that fatalistic individuals receiving information from the NHS BCSP, may not 
be engaging with the literature and thus declining screening.
Anxiety
The evidence regarding the emotional state of anxiety in BC appears to fall into the 
categories of intrinsic, i.e., inherent to the individual and extrinsic, i.e., externally influenced. 
Anxiety about the BCS process has been reported as a key psychological factor in perceived 
risk of BC, in two respects. Intrinsically, individuals who are less anxious are more likely to 
regard their risk as lower (Robb et al., 2004). This is because individuals who are less 
anxious tend to be more optimistic in their outlook, and thus feel that their chances of 
developing BC are lower (Robb et al., 2004). It could be determined from this that less 
anxious people may decline screening more readily. However, as found by McCaffery et al. 
(2001), this could also imply that individuals who are more anxious, fear that their risk of 
developing BC is higher and this poses them with a psychological threat, and this may deter 
them from being screened. Extrinsically, anxiety may be brought about by the BCS itself. 
For example, there is evidence to suggest that individuals have become anxious whilst 
considering the BCS pathway. For instance, anxiety is said to arise when individuals receive 
an invitation to be screened, as they may believe the invitation implies they have the disease 
being screened (Marteau, 1993). Similarly, thinking about the screening process, especially
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with regards to uncertain results such as a false-positive may instil anxiety (Hansen and 
Hannon, 2005).
As a nation, it has been regarded by GPs, that there is a general unwillingness to discuss 
bowel habits (Woodrow, Rozmovits, Hewitson, Rose, Austoker and Watson, 2006). It is 
unsurprising therefore that there is evidence of the mere process of discussing BC inducing 
anxiety (Jepson et al., 2001). Furthermore, it has been stated that anxiety can also be caused 
by the unpleasantness of completing a FOBt (Hansen and Hannon, 2005). All of these 
anxiety promoting factors have been noted to deter individuals from taking part. Similarly, 
individuals who have previously declined BCS stated that the predominant reason was 
because they felt BCS was too intrusive and personal; they did not even want to discuss it 
with their partner (Kremers, et al. 2000). This supports McCaffeiy et al. (2001) findings 
which suggest that talking about the possibility of BC induces anxiety.
The documented, so called positive argument for anxiety when it comes to BCS is that it is 
often short-lived (Miles and Wardle, 2006). It was suggested here that anxiety about BC 
itself could be reduced after BCS had taken place. This was supported by Weinberg et al. 
(2004) who conducted a study to assess the factors influencing women to comply with BCS. 
Here, anxiety about the screening process did not affect participation. Any anxiety 
experienced was outweighed by the knowledge that BCS was an effective process in which 
early cancers could be detected and treated.
Denial
Historically, Levanthal (1970) considered denial to be a mechanism of fear control. If an 
individual feels fearful, they will attempt to combat this fear with denying the source of their 
concern. In regards to BC and BCS, fear control may result negatively for the individual, as 
they may only concentrate on reducing their emotional distress rather than concentrating on
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preventing a potentially life-threatening disease (Levanthal, 1970). This has been 
demonstrated in recent years by O’ Sullivan and Orbell (2004). This study found that denial 
occurs as a response to threat. Therefore, if the screening process is not perceived as an 
effective way of detecting and /or preventing BC, it becomes a threat the individual would 
prefer to deny (O’Sullivan and Orbell, 2004).
This has been supported in other research which stipulates that denial is a concomitant 
barrier to fear, as fear can often result in denial (Brouse et al., 2003). Here, a study looking 
at barriers to BCS, found denial to be as strong a barrier to screening as fear. This was 
thought to be because denial is a complex barrier determined by emotions and thus difficult 
to overcome. In the context of BCS, denial can be conceived as detrimental on three levels. 
Firstly, there is the possibility that the fear of the unknown has led to a denial thought 
process, i.e., BC will never happen to me, resulting in lowered screening attendance (Brouse 
et al., 2003). Secondly, the course of denial may be seen when an individual wants to avoid 
the anxiety caused by thought of BC and BCS (McCaffery et al., 2001), again declining 
screening. Thirdly, research here does not allow for individuals who may be presenting with 
symptoms for BC, but declining BCS. This is considered by the author to be a real 
possibility, for example, in males who are more reluctant to visit a GP when they are 
exhibiting symptoms (Jorgensen et al., 2002). Alternatively, in a positive sense, denial can 
protect the individual temporarily until they were prepared to deal with their situation 
(Hymovich and Hagopian, 1992). However, in the negative sense, if the individual does not 
accept what is happening to them, they may not seek medical advice (Hymovich and 
Hagopian, 1992).
Following on from denial, there is also documented evidence to suggest that individuals 
decline BCS as an avoidance mechanism and thus avoidance is described as a potential 
barrier (Kremers et al., 2000). Avoidance has been noted to contradict some of the factors
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previously noted. For instance, it is understood from earlier in the discussion that family 
history of BC promotes the early detection and thus participation in BCS. However, some 
individuals have been noted to state that as they have a family history that they are more at 
risk and therefore would rather not know, and thus decline BCS (Kremers et al., 2000). 
There are also individuals who decline BCS because they want to avoid any emotional or 
psychological discomfort by worrying about the test, its results and possible implications 
(Kremers et al., 2000).
Barriers
Knowledge
Knowledge in this context pertains to the awareness of BC, the risks and symptoms, the need 
for BCS in the absence of family history or symptoms, and the necessity for early detection 
as stipulated by The American Cancer Society (ACS, 2004). The UK Colorectal Cancer 
BCS Pilot found that there was a general awareness of BC, its causes and symptomology 
amongst focus groups (O’Sullivan and Orbell, 2003). However, awareness is closely linked 
to understanding, and this is where current research has highlighted some disparities. An 
individual’s lack of awareness or knowledge about BC, and indeed the BCS pathway, has 
been found to prompt an individual to decline screening (Tessaro, Mangone, Parkar and 
Pawar, 2006). Tessaro et al. (2006) conducted a study in the United States to look at the 
knowledge, predictors and barriers to BCS using surveys and focus groups. It is considered 
necessary at this point to stress that most barriers to BCS seem to be made up of a number of 
different factors. There appears to be a strong link between predictors of screening and the 
barriers to screening. The predictors outlined by Tessaro et al. (2006) are not dissimilar to 
those that have been previously mentioned. Their results show that older individuals, males, 
participation in other types of screening, regular exercise, social support, good health care 
provider information, a higher perceived risk of BC and a family history all predispose 
individuals participating in BCS.
28
The knowledge that individuals were equipped with seemed to depend highly upon their 
health care provider. If their health care provider failed to recommend BCS, then individuals 
were unlikely to have taken part in screening. In the same way, there was an apparent lack of 
awareness and understanding as to the need for screening, especially in the absence of 
symptoms, and the modalities of screening, i.e., which was the best one to choose. Once 
again, Tessaro et al. (2006) reported a strong reliance on individuals to gain this information 
from their health care provider, and thus if this was restricted in any way, e.g., due to 
medical insurance, then awareness, understanding and knowledge would remain low. This 
has been supported by further evidence suggesting that there is a general lack of interest in 
BCS when there is no family history or symptoms present (Kremers et al., 2000).
Recommendation by health practitioner
Endorsement of screening by a health practitioner was considered to be the primary way to 
improve patients’ acceptance of screening (ACS, 2004). It is apparent from Tessaro et al. 
(2006) that effective communication between health practitioners and patients can facilitate 
increased participation in BCS. This has been reflected elsewhere in this discussion whereby 
practitioner involvement can be a confounding factor in the decision to be screened, i.e., in 
relation to the age of the patient (Jerant et al., 2004) and screening tests in general (Shapiro 
et al., 2001). This finding can be generalised to other populations as, according to Hansen 
and Hannon (2005), a lack of GP recommendations to participate in BCS may have an 
impact on an individual’s acceptance of screening. Individuals have noted that as their GP 
specifically had not requested for them to participate in BCS there was in fact no need to do 
so (Hansen and Hannon, 2005). Similarly, if an individual did not think that the letter 
inviting them to BCS was from their GP directly, they were more likely to decline screening, 
as it was deemed unnecessary (Vernon, 1997). This failure to recommend BCS was cited as 
a main barrier to screening as it can result in a lowered awareness about BCS. Research has 
shown that individuals, who feel that there is an inconsistency regarding screening, are more
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likely to decline screening, i.e., if there is seemingly no awareness or support from GPs 
(Schroy, 2002).
This is generally supported by evidence suggesting that individuals who have taken part in 
other BCS programmes are more likely to participate in BCS because there has been a prior 
positive association made between the healthcare provider and the BCS process (Shapiro et 
al., 2001). Furthermore, a recent randomised control trial found that participation in BCS 
was three times higher if individuals were required to return their FOBt to their GP rather 
than their local hospital (Federici, Rossi, Bartolozzi, Farchi, Borgia and Guastcchi, 2006). 
This also supports the theory that participation is higher when the individual perceives that 
they are following their GPs recommendation, i.e., participation has been promoted by a 
credible source (Cole, Young, Byrne, Guy and Morcom, 2002). Cole et al. (2002) looked at 
the relationship between the health care provider and FOBt participation. This study 
recognised that although GP involvement was paramount, it was generally considered time 
consuming and costly to invest time into each individual. Therefore, they considered how GP 
endorsement alone could influence screening, e.g., receiving an invitation from the GP or 
being signed by the GP. It was found that this personalised service actually improved 
adherence to BCS. Contrastingly, Federici et al. (2006) concluded that although the role of 
the GP was important, ultimately participation relied on the willingness of the patient to be 
screened.
Practicality
Practicality barriers here relate to the factors which may affect the completion of a FOBt, 
ultimately influencing individuals to decline screening. These factors include timing and 
convenience, visual or dexterity issues, and the unpleasantness of performing a FOBt (ACS, 
2004).
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In the first round of the UK pilot focus groups, some participants mentioned that the 
collection of faecal samples in relation to personal hygiene was distasteful, whereas more 
were concerned about the storage of the kit and the implications for more general hygiene 
(O’Sullivan and Orbell, 2003). However, researchers did comment that participants’ 
responses may have been less evident overall in this area because they had not been asked to 
actually cany out a FOBt themselves (O’Sullivan and Orbell, 2003). Whilst reviewing 
literature on various barriers to screening Schroy (2002) also reported the practicality of a 
FOBt as problematic. Here, FOBt was considered by some as embarrassing or distasteful, 
resulting in non-participation. Furthermore, this barrier was strengthened by a lack of self- 
efficacy or confidence in being able to carry out the test successfully. Similarly, Weitzman, 
Zapka and Eastabrook (2001) examined individual’s reluctance to take part in BCS. They 
found that focus group participants thought a FOBt was too ‘messy’ to complete.
Janz, Lakhani, Vijan, Hawley, Chung and Katz (2007) examined why individuals choose not 
to use BCS tests including FOBt, FS and colonoscopy. Questionnaire respondents were 
assigned to one of three groups, those who had never completed a BCS test ‘non-users’, 
‘attempters’ who had attempted but never completed a test and ‘users’, those who completed 
a test in the last three years. The perception of BCS as embarrassing was the highest in ‘non­
users’. Factors hindering participation using a FOBt for ‘attempters’ were that the test was 
unpleasant, embarrassing and they were unsure as to how to complete. O’Sullivan and Orbell 
(2004) conducted a study to explore the decision-making process behind FOBt completion. 
The results from four focus groups were very informative with regards to the practicality of a 
FOBt. The resounding view amongst the groups was that a FOBt completed at home was an 
acceptable concept. However, there were other factors to consider. The general concerns 
raised here stemmed from thought of handling faeces, and the storage of the FOBt once 
commenced, and how this was considered to be unhygienic. Finally, the review of twelve 
studies by Vernon (1997) found that seven outlined practical reasons why individuals did not
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participate in BCS. These included lack of convenience, too busy, the test conflicts with 
family or work commitments, no interest, and being away from home. Finally, Kremers et al. 
(2000) found that individuals declined the FOBt if they perceived it as difficult to complete 
and problematic to find the time to take part in the screening.
Information
As a national BCSP, the NHS provides individuals with information regarding the BCS 
process, at the point of invitation (Appendix 3). The information provided is devised in 
order to give individuals adequate information from which to make an informed decision 
about participating in BCS (Appendix 3). There were concerns prior to the launch of the 
national BCSP, that the information could instigate public alarm and anxiety about BC 
(Wardle, Taylor, Sutton and Atkin, 1999). Thankfully, this argument was not supported, and 
it was found that the information actually provided reassurance and support to individuals 
(Wardle et al., 1999). Decision aids, such as the information booklet seen in Appendix 3, 
are considered to play an important role in screening participation (O’Connor, Stacey, 
Entwistle, Llewellyn-Thomas, Rovner, Holmes-Rovner, Tait, Tetro, Fiset Barry and Jones, 
2006). This large systematic review stated that decision aids were developed to outline the 
individual’s options, the costs and benefits of screening. The report summarised, from two 
hundred randomised controlled trials, that decision aids made the decision making process 
easier by increasing people’s knowledge and maintaining realistic expectations about the 
costs and benefits of screening; hence increasing participation.
An individual’s decision-making process also affects their preference for seeking 
information about BCS or embarking on shared decision-making, e.g., consulting their GP 
for advice (Tessaro et al., 2006). Therefore, when addressing the psychosocial determinants 
of individuals’ participation in screening, individual’s beliefs and attitudes to BCS must be 
gauged (Broughton et al, 2004). Millett and Parker (2003) examined the ethical
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considerations with regards to informed decision-making. This editorial found that by 
outlining the individual cost of participating, this may reduce the adherence rate to a 
screening programme. There was also concern that the information being issued would be 
too complex for the people being invited for screening to understand which may also affect 
uptake. Patients also identified that there was limited information about BC, its severity, and 
the BCS tests available. Additionally, they stipulated worries about how the test would 
work, how often it would be required and how accurate it was. They speculated that 
information, education and support from their GP were crucial when considering screening; 
as was tailoring the information specifically to the population, e.g., culture. Therefore the 
source and type of information individuals receive as part of the BCS programme may 
govern participation in screening. Moreover, patients have been found to be motivated by 
BCS information when it comes directly from their GP (ACS, 2004). However, the amount 
of support required to attain sufficient participation in BCS in the population remains 
questionable (UK CRC Evaluation Team, 2003).
Conclusion
From this discussion, it is now possible to identify the many factors and barriers which 
contribute to individual’s rationale to decline screening. It has been outlined how age, 
gender, socio-economic status, ethnicity and even family history can motivate an individual 
to decline screening. These factors are contributed to by the many barriers to screening, i.e., 
symptomology, health-related behaviour, social support, knowledge, anxiety, fear, denial and 
practicality. There is a wealth of research in the area of BCS with regards to these factors 
and barriers. However, what is apparent is a lack of research which is firstly specific to the 
national BCSP, the FOBt and accesses individuals who do not want to take part in screening. 
The current research hopes to bridge these discrepancies. Primarily, it aims to evaluate 
personal experiences of FOBt by addressing individual beliefs and attitudes and investigate 
barriers to FOBt by examining reasons for non-participation. However, before considering
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the empirical work conducted, the theoretical framework underlying BCS participation will 
be discussed in the following chapter.
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Chapter Three 
Literature Review Part Two 
Theoretical Framework
Introduction
The purpose of this chapter is to outline the theoretical framework which underpins research 
exploring BCS participation. Two well established theories, and six theoretical models, 
which have been utilised to predict participation in screening programmes, shall be discussed 
primarily. The constructs from these models, which attempt to explain the reasons why 
individuals choose not to participate, will then be examined. It is important to note that some 
constructs appear in more than one model; however this shall be explained as the discussion 
progresses. Furthermore, only the elements of these models and theories which deal with the 
prediction and adoption of BCS behaviour will be discussed. The maintenance of health 
behaviours has been excluded as the author wishes to focus the research in this thesis upon 
individual experiences and perceptions of BCS, not whether they are maintaining BCS 
behaviour.
Models predicting screening participation 
Health Belief Model (HEM)
Historically, there have been several versions of the HBM, however for the purpose of this 
discussion, the version developed by Becker and Rosenstock (1984) shall be examined here. 
The HBM consists of two primary components, perception of health threat, and belief that 
adopting health behaviour will reduce that threat (Taylor, 2006). The individuals’ perception 
of threat comprises of general concern for their health, perceived severity of, and 
susceptibility to the health threat (Abraham and Sheeran, 2005). The reduction of the health 
threat involves an evaluation by the individuals as to the benefits of the health behaviour, 
and whether these outweigh the costs of carrying out the behaviour (Taylor, 2006). For
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instance, an individual who values their health, feels vulnerable to BC and considers BC to 
be a severe illness would probably participate in BCS. Alternatively, an individual who does 
not think that BCS can reduce their risk and perceives the costs of participating e.g., 
completing a FOBt, outweighing the benefits e.g., early detection of BC, may decline 
participation. Thes.e core constructs are said to ready the individual to carry out health 
behaviours (Taylor, 2006).
To activate this readiness to act, a further construct, cues to action, was added (Glanz, 
Marcus and Rimer, 1997). Cues to action referred to the internal or external cues which may 
result in screening participation, i.e., rectal bleeding could be construed as an internal cue, 
and a BCS leaflet could be interpreted as an external cue. Two further constructs, namely 
health motivation and self-efficacy, were later added to the model (Ogden, 2000). Health 
motivation related to the motivation or drive of the individual to participate in screening, 
whereas self-efficacy pertains to the individual’s confidence, e.g., confidence in carrying out 
a FOBt. Vernon, Myers and Tilley (1997) strove to develop an instrument to measure the 
adherence to BCS. The instrument was predominantly based on constructs from the HBM, 
i.e., susceptibility, benefits, costs, fear and self-efficacy. Vernon et al. (1997) concluded that 
there were elements within the HBM which overlapped, such as self-efficacy and perceived 
costs. They also stated that the benefits and costs constructs coincide with that of social 
influence from the PMT model. The findings supported the constructs of susceptibility and 
fear but not self-efficacy, benefits or costs.
Power et al.’s (2008) study, to investigate intentions and actions in BCS, tested the four core 
HBM constructs. They found that although all of the constructs were significantly related to 
intention, they were not associated with the actual screening behaviour. Power et al. (2008) 
speculated that if they had incorporated a measure for self-efficacy, their findings may not 
have been so restricted. They claimed this was because self-efficacy has been found to
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bridge the gap between intention and action. Whilst investigating the factors which result in 
individuals declining BCS, the core beliefs were deemed to be significant predictors of 
health behaviours as a whole (McCaffery, Borril, Williamson, Taylor, Sutton, Atkin and 
Wardle, 2001). However they questioned the usefulness of the individual constructs on their 
own and whether the constructs would remain the same throughout a decision-making 
process. Wardle, Sutton, Williamson, Taylor, McCaffeiy, Cuzick, Hart and Atkin (2000) 
looked that the psychosocial factors affecting BCS via FS. Here, it was concluded that the 
core components adequately predicted screening behaviour. Individuals who perceived that 
they were more susceptible to BC, that BC is a severe disease, and that the potential benefits 
outweigh the costs were more likely to be screened.
The core constructs were also assessed with regards to the type of study they were utilised in. 
Harrison, Mullen and IFOBt 2(1992) conducted a meta-analysis of studies which utilised the 
HBM with older adults. They concluded that the strength of the construct relied on the type 
of study, i.e., costs and benefits were considered stronger predictors in prospective studies 
whereas severity resulted in a larger effect in retrospective studies. Unfortunately, no 
conclusion was drawn as to why this was the case.
Transtheoretical Model (TTM)
The transtheoretical model of behaviour change was developed by Prochaska and 
DiClemente (1982) to explain the adoption of behaviour. This model stipulates that 
individuals need to successfully pass through four distinct changes in order, to adopt health 
behaviours such as screening. The model allows for the possibility that individuals may not 
successfully pass through a stage, relapsing to an earlier one, and they may pass through 
stages many times before achieving an action (Sutton, 2005). The first stage 
‘precontemplation’ refers to when no action has been taken and there is no intention to do so. 
‘Contemplation’ is the stage whereby the individual is considering taking action.
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‘Preparation’ follows when the individual starts taking steps to adopt the action. Finally, 
‘action’ heralds the carrying out of the behaviour.
The model also includes the constructs of decisional balance, confidence and temptation. 
According to Sutton (2005), decisional balance is when the individual considers the 
advantages and disadvantages of carrying out health behaviours. An example of this would 
be early detection of BC versus carrying out a FOBt. Confidence is similar to self-efficacy as 
seen in the HBM, whereby individuals have the confidence in their ability to carry out health 
behaviours, e.g., completing a FOBt. Finally, temptation occurs when an individual is 
tempted to engage in unhealthy behaviours, which in this context would mean that they 
would choose not to be screened. However, as Sutton (2005) concludes, the model does not 
describe the causal relationship between these constructs and the stages of change.
Finally, the TTM incorporates the constructs ‘pros’ and ‘cons’. These are considered to be 
very similar to the benefits and costs outlined in the HBM (Rawl, Menon, Champion, May, 
Loehrer, Hunter, Azzouz, Monahan and Skinner, 2004). Rawl et al. (2004) conducted a study 
to address how these pros and cons affect the stages of change. Overall they found that cons 
significantly affected the stage at which participants were, i.e., precontemplators perceived 
there to be more barriers to screening than contemplators or actors. They concluded from this 
study that making decisions about BCS participation is complex for the individual, and that 
the stages of change, pros and cons are just part of that process. They speculated that it 
would be useful to conduct a study which addressed all of the factors associated with BCS in 
relation to the TTM, as they believed it to be a beneficial model to address the changes of 
behaviour seen in this process.
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Precaution Adoption Process Model (PAPM)
The PAPM was developed as another stages of change model (Weinstein, Lyon, Rothman, 
and Cuite, 2000). Weinstein conceived that in order for individuals to adopt new protective 
health behaviours, they need to pass through five distinct stages of change in their beliefs 
and/or attitudes. In essence, a shift from stage to stage marks a shift in the individual’s 
attitude and subsequent behaviour.
Stage one states that individuals are unaware of any risk to themselves. Stage two states that 
individuals are aware that there is a risk, but that this risk is for others, not for themselves 
which instigates a state of optimistic bias, or ‘it will never happen to me’ syndrome. Stage 
three heralds the awareness of personal risk and that precautionary action would be 
beneficial. Stage four develops the notion that the precautionary action would be beneficial 
and manufactures this into a need to take action. Stage five is a parallel stage of stage four, 
whereby individuals are aware that a precautionary action would be beneficial but that action 
is not required at this time. These stages can be translated to BCS as not being aware of BC, 
being aware of BC but unaware of personal risk, deciding whether to do a FOBt, deciding 
not to do a FOBt, and deciding to do a FOBt but have not yet carried it out.
Therefore, as highlighted by Weinstein and Sandman (1992), the PAPM differs from the 
TTM in three ways. Firstly, the PAPM allows a stage for those who are unaware of a risk 
whereas the TTM does not. Secondly, the PAPM clarifies the dichotomy which seems to 
appear in the precontemplation and contemplation stages of the TTM. Precontemplation 
categorises individuals who have not considered the benefits of adopting health behaviours 
with those who have. Similarly, in contemplation, individuals who remain undecided about 
an action are banded with those who have reached a decision. Therefore, the TTM clarifies 
precontemplation into stages one, two and three, and contemplation into stages four and five.
39
Constanza, Luckmaim, Stoddard, Avrunin, White, Stark, Clemow and Milagros (2005) 
applied the PAPM stages of change to BCS. Their findings highlighted the usefulness of the 
PAPM model in categorising individuals into groups who share the same beliefs and 
attitudes to BCS. This finding implicates that tailored interventions could be developed to 
target specific groups, e.g., providing information about the risk of BC to individuals in stage 
two may prompt them to enter stage three, hence increasing BCS adherence.
Lipkus, Lyna and Rimer (2000) utilised the PAPM to gauge BCS perceptions and concerns 
in an African-American population. The authors claimed that if the adoption of health 
behaviours initially relied on the individuals’ perception of BC risk and concerns about BC 
that these should be looked at specifically. The results demonstrated that participants who 
were aware of their risk, and had more concerns about BC, were more likely to report that 
they were planning to be screened in the next two years, i.e., stage four.
Conflict Theory Model (CTM)
The CTM is a cognitive model which addresses the issues around decision-making (Janis 
and Mann, 1977). Janis and Mann listed components in this decision-making process which 
dealt with the likelihood and severity of the event, coupled with the advantages and 
disadvantages of the alternative outcomes (White, Wearing and Hill, 1994). However, Janis 
and Mann (1977) suggested that a conflict may arise in the individual if there are an equal 
amount of positive and negative outcomes to the event, resulting in decisional stress for the 
individual (White et al., 1994). To cope with this stress, the individual will select a particular 
method of coping from five distinct categories which will depend on the level of conflict, 
any acceptable alternatives available and time to find an alternative. The first four categories, 
namely ‘unconflicted adherence, unconflicted change, defensive avoidance, hypervigilance’ 
are considered to result in a negative outcome for the individual, whereas the fifth category, 
‘vigilance’ is considered a positive outcome. The example offered by White et al. (1994) to
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illustrate this process is as follows. If an individual has encountered a small amount of 
conflict in decision-making, expectations for another solution and time to find that solution, 
then they are selecting the vigilance coping mechanism; resulting in a favourable outcome. 
Therefore, the most commonly known construct operationalized from this theory is 
‘decisional conflict’ or the uncertainty in carrying out an action (Janis and Mann, 1977).
The CTM was initially applicable to address ‘real-life’ dilemmas and the decision-making 
processes associated in reaching a solution. Historically such dilemmas included, what were 
considered to be, major life events such as marriage (Beach and Beach, 1982). However, 
such life events do not tend to occur frequently, so could the CTM be adequately applied to 
what is considered an important, but not major event, such as screening? This was a question 
addressed by White et al. (1994) with regards to cancer screening. Cancer screening was 
thought to be an important event because although the process of screening itself may not 
constitute an important dilemma, the absence of screening could be life-threatening, i.e., 
allowing the development of cancer. This is the first study, to knowledge, that applies the 
constructs of the CTM to cancer screening. Unfortunately, this study looks at the CTM with 
regards to cervical cancer screening; however it is felt that its findings could be applicable 
to BCS.
The main finding from this study showed that women who were overdue for their 
Papanicolaou test exhibited greater decisional conflict resulting in defensive avoidance. This 
was thought to be the case because the women considered there to be as many disadvantages, 
as advantages, to having the test; resulting in conflict and subsequent avoidance of the test 
altogether. It was concluded from this that the CTM can be applied to screening behaviours, 
but there must be a level of conflict and thus decisional stress present to enable this to work. 
Hence, White et al. (1994) summarised that the CTM was a useful model to decipher the 
reasoning behind overdue cervical screening. The one question this raises with regards to
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BCS is whether the CTM would work as effectively with both genders. As BCS is offered to 
males and females, can it be assumed that their decision-making processes are similar 
enough to generalise? This would have to be considered if the decisional conflict was 
utilised in the current research.
Health Action Process Approach (HAPA)
The HAPA was developed by Schwarzer (1992). This continuum model instigated that 
individuals hold certain beliefs which then lead to the intention to cany out or change health 
behaviour. Schwarzer (1992) outlines that there is a definite shift between the intention to 
cany out health behaviour, and actually carrying out the behaviour. Hence, the model is 
described in two phases, the intention or motivation stage and the actual behaviour or 
volitional stage. The motivation stage includes three separate elements, outcome 
expectancies, appraisal of threat and self-efficacy (Ogden, 2000). Outcome expectancies can 
be personal, i.e., ‘BCS will help to detect BC, and this will be good for my health’, or social, 
i.e., ‘by participating in BCS I will gain endorsement from others’ (Ogden, 2000). Threat 
appraisal is similar to the severity construct in the HBM, i.e., the perceived seriousness of 
BC as a disease. Self-efficacy, also seen in the HBM, was the only component from the three 
considered to play an important role in both of the motivational and volitional stages, 
enabling the individual to motivate themselves to organise an action, and then being able to 
cope with the execution of the action.
The volition stage was said to be made up of two separate groups. One group would contain 
individuals who were motivated to take action and were able to the carry out the action, 
whereas the other group, although motivated, were unable to carry out the action because 
they lacked the confidence to do so. An example of this would be an individual who believed 
they were at risk of BC, and therefore intended to be screened when offered. However, when 
they were offered and they saw the FOBt, they were not confident in carrying out the test
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hence declining screening. The model goes on to explain how health behaviours are 
maintained, however, it is not deemed necessary by the author to discuss this element of the 
model as the crux of this review is to explore participation in BCS, not the maintenance of 
this behaviour over time. As Ogden (2000) states, the three constructs of the HAPA have 
been assessed in various studies, and each of these will be discussed later in this chapter. 
However, there does not appear to be any literature employing the whole of the HAPA in 
relation to BCS.
Preventive Health Model (PHM)
The PHM was developed to explain the adoption of preventive health behaviours (Myers, 
Ross, Jepson, Wolf, Balshem, Millner and Leventhal, 1994). To put the PHM into the 
context of BCS, Myers et al. (1994) utilised the model to measure adherence. Myers et al. 
(1994) outlined a range of factors which would affect BCS adoption including 
sociodemographic, representation, social and programme factors. Representation factors 
include severity and susceptibility from the HBM. They also contain the factors such as 
‘curability of occurrence’, i.e., likelihood BC could be treated if found, ‘worry about 
consequences’, i.e., concern about an abnormal result and ‘salience and coherence’. Salience 
and coherence refers to the consideration an individual gives to completing the FOBt, i.e., 
the effectiveness, convenience and benefit of the test, plus the approval of others in carrying 
out the test, and how this makes sense in everyday life. As an operationalised construct, the 
author considers a majority of salience and coherence as response efficacy, as seen in the 
protection motivation theoiy. Social factors include social norms, as seen in the theory of 
reasoned action, relationship with the GP and health locus of control. Finally programme 
factors incorporate exposure to promotional materials, for example leaflets and 
advertisements etc.
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The results from Myers et al. (1994) study show salience and coherence was strongly 
associated with BCS participation, suggesting that the degree to which BCS is thought to 
make sense in everyday life is a key predictor. Tiro, Vernon, Hyslop and Myers (2005) 
tested the PHM to measure differences in perceptions about BCS between cultural groups. 
Their findings validated the use of the PHM constructs to measure perceptions, plus the 
measures were reported as invariant between groups. Vernon, Myers and Tilley (1997) 
operationalized the PHM constructs by developing a questionnaire to measure adherence to 
bowel cancer screening. Sun, Basch, Wolf and Li (2004) conducted a study utilising these 
questionnaire items. The findings reported that the more individuals perceived themselves at 
risk from BC, the more likely they would be to participate in screening via FOBt or FS. 
Similarly, the less fearful or worried individuals were about screening finding polyps or 
cancer, the more likely they would be to participate in screening via FOBt or FS. These 
results support the usefulness of the constructs to predict screening behaviour; however no 
comment was made as to the validity of Vernon et al.’s (1997) questionnaire.
Theories predicting screening participation 
Protection Motivation Theory (PMT)
Rogers (1983) developed the PMT to expand upon the HBM. Therefore although the two 
models share similarities, the way in which they are organised differs. The HBM consists of 
a catalogue of constructs which contribute to preventive health behaviours; whereas 
constructs within the PMT follow two distinct processes, threat appraisal and coping 
appraisal. Similar to the HBM, threat appraisal encompasses severity and susceptibility. 
Rogers also acknowledged the role of fear in this part of decision making process. Ogden 
(2000) noted that the constructs of severity, susceptibility and fear contribute to the 
assessment of the threat encountered.
44
Coping appraisal is surmised as a combination of response efficacy, e.g., belief in the 
effectiveness of BCS, self-efficacy, e.g., ability to carry out a FOBt and response costs e.g., 
the FOBt is messy to complete (Edelmann, 2000). These components are also affected when 
the individual receives information from intrapersonal, e.g., past experience of bowel 
investigation and/or environmental sources, e.g., advice from a GP. This may result in 
adaptive or maladaptive coping, i.e., taking part in BCS versus non-participation. Norman, 
Boer and Seydel (2005) also outlined the role of intrinsic and extrinsic rewards upon the 
adoption of maladaptive coping. For instance, an individual may avoid completing a FOBt 
because it is perceived as messy, i.e., intrinsic reward, and feel they are gaining approval 
from others for doing so, if they perceive others would find the test distasteful, i.e., extrinsic 
reward. However, as there has been little distinction found between these maladaptive 
rewards and response costs, they have not been discussed further within this review 
(Abraham, Sheeran, Abrams and Spears, 1994).
Therefore, an individual who perceives BC as a serious illness, feels vulnerable and fearfiil 
of the disease, believes that participating in BCS will reduce risk and are confident in 
carrying out a FOBt would be more likely to intend to take part in BCS. This intention to 
take part may be mediated by factors such as past experience of bowel investigation, which 
if the experience was positive, may reinforce participation. Two meta-analytic reviews of 
research utilising the PMT have recently been conducted (Floyd, Prentice-Dunn and Rogers, 
2000; Milne, Sheeran and Orbell, 2000). They both found that healthier attitudes and 
behaviours were significantly associated to each of the PMT components. However, Milne et 
al. (2000) found that the coping appraisal components were better at predicting health 
behaviours than threat appraisal, and that overall, the PMT was good for predicting 
intentions, but not so much for future behaviours.
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Theory o f Reasoned Action (TEA)/ Planned Behaviour (TPB)
The TRA was developed by Fishbein and Ajzen (1975). Similar to the HBM and the PMT, 
this theory outlines that the anticipation of a health threat is counterbalanced by a need to 
avoid the threat, thus motivating action (Weinstein, 1993). Behavioural intention is the 
result of the individuals’ beliefs and attitudes being weighed up with what they perceive to 
be the ‘subjective norm’, i.e., societal and peer group expectations of what they should do, 
and should they be motivated by this. The result of the latter then governs whether the 
individual is motivated to fulfil this expectation and engage in the intended action or not. 
Fishbein and Ajzen (1975) proposed that carrying out health behaviours is the outcome of 
behavioural intention (Taylor, 2006).
In 1991 the TPB expanded on the existing TRA to include the concept of ‘perceived 
behavioural control’, i.e., perceived capacity to cany out behaviour, based on past 
behaviours (Ajzen, 1991). Ajzen stipulated that the existent concepts of the TRA namely, 
attitudes and subjective norm interrelate with perceived control to form the intention to 
engage in a behaviour. Ajzen claims from this that individuals’ who perceive that they have 
the ability to engage in a behaviour will usually plan to carry out that behaviour; thus 
allowing, once more, for behaviours to be predicted. Ajzen (2002) claimed that the construct 
of perceived behavioural control is made up of two components; self-efficacy i.e., 
confidence in carrying out a behaviour and controllability i.e., control an individual has over 
their behaviour. Perceived controllability in this context is deemed to be similar to the locus 
of control in that there are internal and external factors which are said to govern 
controllability (Ajzen, 2002). The TPB has been deemed praiseworthy by Ogden (2000) for 
encompassing past behaviours, social and environmental factors.
Therefore, an individual who believes BCS is a positive behaviour, who believes society 
thinks screening is a good idea and they are motivated by this, plus they feel capable in
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carrying out a FOBt, would be more likely to intend to be screened for BC (Montano, Selby, 
Somkin, Bhat and Nadel, 2004). The findings from Montano et al.’s (2004) research were of 
particular interest with regards to the use of the TRA. One finding from this study showed 
that social influences had a correlation with screening interest. Here, seven social influences 
were stipulated ranging fi*om family and friends to health practitioners and the media. These 
findings reflected that participants regarded their strongest social influence to be their 
partner/ spouse. Montano et al. (2004) hypothesised from this that individuals who 
participate in FS screening could actively support their partner/ spouse to do the same.
Theoretical constructs 
Susceptibility
Susceptibility, as seen in the HBM, PMT, and HAPA, explains individual perceptions about 
their susceptibility to, or likelihood of developing, BC (Ogden, 2000). The author was 
mindful of Macrae et al.’s (1984) important point that there is a difference between ‘real’ 
susceptibility and ‘perceived’ susceptibility. Real susceptibility refers to individuals who are 
at risk of BC, i.e., they have a family histoiy. Perceived susceptibility, as referred to in many 
of the studies cited here, relates to the individuals perception of risk, i.e., how susceptible to 
BC the person perceives themselves to be. Therefore, the evidence cited within this 
discussion refers to cases of perceived susceptibility only.
Vulnerability to BC was previously discussed in chapter two. Most studies identified that the 
more vulnerable to BC an individual feels, the more likely they are to participate in 
screening. Reasons for susceptibility included their age (O’Sullivan and Orbell, 2003; Jerant 
et al., 2004; Jepson et al., 2000), family history (Vernon, 1997) and symptoms (Robb et al., 
2004). Wardle et al. (2000) considered how other factors were associated with the HBM 
constructs. It was found that susceptibility was linked to having bowel symptoms, having 
had a past history of bowel problems and having a family history of cancer, all of which
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increased perceived risk or susceptibility to BC, hence increasing the likelihood of being 
screened.
Janz, Wren, Schottenfield and Guire (2003) conducted a study to look at the relationship 
between attitudes and behaviour. They found that perceived risk or susceptibility to BC was 
one of the best predictors of BCS participation. This was supported by McCaffeiy et al.
(2001) who also found that participation was the result of higher perceived susceptibility. 
They also deemed that individuals who were more optimistic appeared to have a lower 
perceived susceptibility, highlighting an overlap with the construct of optimistic bias 
discussed later in this chapter.
Although each of the studies discussed here deem susceptibility to be a good predictor of 
participation, other research has found that this construct is not as useful in predicting 
intention to participate in screening (Floyd et al., 2000; Milne et al., 2000). The explanation 
for this is that unlike the studies here, where increased perceived susceptibility results in 
increased participation, perceived susceptibility can also result in anxiety and denial, hence 
lower participation (Norman et al., 2005).
Severity
Severity, in both the HBM and the PMT, also explains individual perceptions about the 
threat of BC, but with regards to the severity of the disease, i.e., BC is a serious illness 
(Ogden, 2000). Both the model and the theoiy outline that the perceived severity of a disease 
motivates the individual to engage in health behaviours, but these are counterbalanced; i.e., 
by costs and benefits (HBM) or intrinsic and extrinsic factors (PMT) (Abraham and Sheeran, 
2005; Norman, Boer and Seydel, 2005). Severity has been utilised to successfully predict 
behavioural intentions as seen in Harrison et al.’s (1992) meta-analysis. Contrastingly,
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severity was excluded from an instrument measuring the HBM, as it was not considered to 
be as relevant to preventative health behaviours (Vernon et ah, 1997).
However, these studies view severity as a singular construct, whereas O’Sullivan and Orbell
(2003) found that severity was separated into two; ‘physical’ and ‘psychosocial’ severity. 
The physical implications of BC accounted for participant’s perceptions about the mortality 
rate and the discomfort of the disease. Psychosocial severity was described as the lifestyle 
changes which may result from bowel surgery, i.e., having a colostomy bag. The 
psychosocial severity of BC, with regards to a colostomy bag has been reported to instil 
fear into individuals (O’Sullivan and Orbell, 2003; Broughton et ah, 2004)
Costs
In the HBM, individuals hold beliefs about the costs of carrying out the health behaviour and 
these are utilised to evaluate whether they should participate in BCS or not (Johnson and 
Johnson, 2001). Similarly, response costs are considered to form part of the coping appraisal 
in the PMT (Roger, 1983). Furthermore, Wardle et ah (2000) likened costs to the construct 
of cons from the TTM therefore both constructs shall be considered here. Both Janz and 
Becker (1984) and Harrison et ah (1992) concluded from their reviews of the HBM, that 
costs or barriers were the best predictors of behaviour. As seen in chapter two, barriers to 
BCS via FOBt include embarrassment (McCaffery et ah, 2001), distaste (Schroy, 2002), 
perceiving the test as messy (Weitzman et ah, 2001) or unpleasant (Janz et ah, 2007).
Wardle et ah (2000) found that costs decreased BCS participation. This was reported by 
individuals who perceived the test as worrying or time consuming. Janz et ah (2003) also 
found that costs reduced the likelihood of participation in BCS. Here, costs were noted to be 
‘test is not needed’ and ‘the test is embarrassing’. Contrastingly, Power et ah (2008) found 
that costs were not significantly related to the action of BCS. They claimed that one
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explanation for this was that if individuals are aware of the potential costs of an action, they 
may be more prepared to deal with them, hence more likely to act.
Benefits
According to the HBM, the benefits of carrying out health behaviours are also used by 
individuals to weigh up whether they take part in BCS (Johnson and Johnson, 2001). 
Benefits to screening were highlighted in the UK pilot to include convenience, privacy of 
home testing, having control over when and where the test is conducted and reduced 
embarrassment (O’Sullivan and Orbell, 2003). Historically, Janz and Becker (1984) claimed 
that benefits were the least useful factor in predicting BCS behaviour. This was supported, to 
an extent, by McCaffery et al. (2001) who found that participants who declined screening 
still reported the benefits of BCS. Two assumptions could be drawn from these results. 
Either, as Janz and Becker suggest, benefits do not predict actual behaviour or the perceived 
costs of decliners outweighed these benefits. Contrastingly, Wardle et al. (2000) found that 
the benefits of screening were the most significantly associated with increased interest in 
BCS.
In a study specifically looking at the benefits and costs of different modalities of BCS, i.e., 
FOBt, FS and colonoscopy, in an African American population, higher perceived benefits 
did not affect FOBt rates (James, Campbell and Hudson, 2002). James et al. (2002) reasoned 
that this was due to different perceptions being held about different tests. The FOBt was 
considered by participants to have more costs as it is a preventive measure, not early 
detection behaviour like a colonoscopy.
Health motivation
The author could only locate one research paper which tested the construct of health 
motivation in relation to BCS. This paper investigated the constructs of the HBM in relation
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to BCS frequency in African American Women (Frank, Swedmark and Grubbs, 2004). 
Health motivation in this study was measured using the HBM scale developed by Champion 
(1999) whereby individuals seeking health information and regularly attending health 
examinations were considered to have higher health motivation. Unfortunately, Frank et al. 
(2004) found a negative relationship between health motivation and frequency of BCS 
attendance. They suggested that this was because although the participants were motivated, 
this did not increase their rate of attendance.
Cues to action
According to Abraham and Sheeran (2005) cues to action from the HBM, have not been 
studied as much as the four core beliefs because the definition of this construct is widely 
variable. This is supported in this literature review, as the author found papers examining 
cues to action per se difficult to find. Therefore, cues to action are considered as three 
distinct guises here; as suggested by Abraham and Sheeran (2005). Firstly, experiencing 
symptoms was considered to be a cue to action (Wardle et al., 2000; Robb et al. 2004). In 
both of the latter studies, individuals were more likely to participate in screening if they were 
experiencing bowel problems, as individuals perceived themselves to be at greater risk of 
BC. Secondly, GP recommendation has been found to be a successful cue to action. This was 
discussed in detail in chapter two where a number of studies concluded that GP 
recommendation improves BCS participation (Tessaro et al., 2006; Jerant et al., 2004; 
Shapiro et al., 2001). Furthermore, if endorsement by a GP was received by letter, i.e., 
invitation to BCS, this too increases screening participation (Hansen and Hannon, 2005; 
Vernon, 1997; Schroy, 2002). Finally, advertisement campaigns have been thought to be a 
useful cue to action.
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Decisional balance
Decisional balance originates from the TTM and denotes the weighing up of pros and cons 
by the individual before adopting health behaviours. The author deems this process as 
similar to weighing up the costs and benefits to screening as seen in the HBM. A specific 
scale was designed by Rakowski, Clark, Pearlman, Ehrich, Rimer, Goldstein, Dube and 
Woolverton (1997) to measure this construct in relation to screening behaviour. Constanza et 
al. (2005) utilised this scale to see how decisional balance affected BCS behaviour. They 
found that the higher individuals scored on the scale, i.e., more agreement with ‘pros’, the 
more likely they were to adopt the screening behaviour. In this context, increasing decisional 
balance was strongly linked with the later stages of the TTM.
Decisional conflict
Decisional conflict, from the CTM, is deemed by the author to share some similarities with 
decisional balance. Conflict is said to occur when the individual is confronted with a 
decision with which they have difficulty in ascertaining the costs and benefits (O’Connor,
1993). O’Connor specified that this conflict can result in the individual becoming distressed 
which can delay the decision-making process. The decisional conflict was operationalized in 
the Decisional Conflict Scale, which was devised and validated by O’Connor (1995). In 
relation to BCS, the lowering of conflict actively increases participation. This was found in 
O’Connor, Stacey, Entwistle, Llewellyn-Thomas, Rovner, Holmes-Rovner, Tait, Tetro, Fiset 
Barry and Jones (2006). Their systematic review found that decision aids reduced the 
conflict by increasing people’s knowledge and maintaining realistic expectations about the 
costs and benefits of screening, which improved participation.
Fear
The construct of fear has been included in both the HBM and the PMT. The term cancer 
instils fear in individuals, as there is the assumption of dying from the disease (Tessaro et al..
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2006). Therefore, fear of having BC, or cancer in itself was considered to be a major barrier 
to BCS (Tessaro et al., 2006). This research has shown that individuals are frightened that, if 
they receive a positive or abnormal result from being screened, they are going to die from 
cancer, thus insinuating the reluctance to accept BCS (Tessaro et al., 2006). Similarly, fear 
in individuals can stem from the possible outcomes of BCS, i.e., BC diagnosis and the 
subsequent lifestyle changes it may dictate, e.g., requiring a colostomy after BC surgery 
(Broughton et al., 2004). In the UK pilot, the possibility of having a colostomy bag after 
surgery was considered to be one of the biggest psychosocial threats of being diagnosed with 
BC, with one individual linking the distress of having a colostomy to suicidal behaviour; 
again a possible reason for declining screening (O’Sullivan and Orbell, 2004).
Individuals have also reported that fear can stem from the unknown, and this has been linked 
to the screening process itself and the possibility of diagnosis (McCaffery et al., 2001). A 
qualitative study based upon the decision-making process involved with completing a FOBt 
was conducted by O’Sullivan and Orbell (2004). Here, the perceived barriers to screening 
were analysed, with fear being a major component with regards to the possible outcome. 
However, although fear of a positive result did constitute a barrier to screening, some 
individuals stated that although this frightened them, it was outweighed by the knowledge 
that the result may have a positive outcome, e.g., the removal of polyps that have not yet 
become cancerous. Individual’s lack of awareness about the characteristics of BC also 
resulted in fear of FOBt participation. Here, individuals were confusing the term colostomy 
with the procedure of colonoscopy; posing the worrying question of whether they believe all 
individuals with a positive FOBt go on to have a colostomy (O’ Sullivan and Orbell, 2004).
Behavioural intention
Behavioural intention was outlined in the TRA/TPB. Within these theories behaviour is said 
to be driven by the individual’s motivation to cany out behaviour, their willingness to tiy the
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behaviour and the effort they are prepared to put into carrying out the behaviour (Conner and 
Sparks, 2005). Therefore it is thought that individuals with stronger intentions will put more 
effort into carrying out the behaviour (Norman, Sheeran and Orbell, 2003). There does not 
appear to be much literature detailing the role of behavioural intention specifically. This is 
thought to be because behavioural intention appears to be both a predictor of screening 
participation, and an outcome of other screening predictors. For instance, McCaffeiy, Wardle 
and Waller (2003) conducted a study to look at the relationships between intention, 
knowledge and attitudes. At the outset of the study, behavioural intention was listed as a 
predictor of screening, however by the end it was an outcome of the knowledge and attitudes 
held by the participants, i.e., the more knowledge and positive attitudes held by the 
participants towards BCS, the higher their intention to be screened. It is important to note at 
this point the difference between intention and action, in that a significant amount of the 
literature found in chapter two is based on individual’s intention to be screened. As Power et 
al. (2008) pointed out, the transition from intention to action is not clear cut, and therefore 
good intentions may not result in BCS participation.
Self-efficacy
This construct, described as having control over one’s life, has been developed over the 
years by Bandura. Bandura (2006) conveyed that self-efficacy is a person variable which 
concedes that individuals can acquire, enhance or even decrease beliefs that they can 
perform behaviour and have the confidence that it will yield a favourable outcome. Self- 
efficacy is found in the HBM, PMT, HAPA and the TPB. Kremers et al. (2000) addressed 
this construct in a Netherlands pilot study, whereby the adherence to BCS was low at only 
forty five percent. They found that self-efficacy was the strongest predictor of BCS 
participation, but unfortunately did not discuss as to why this was the case.
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Myers, Vernon, Tilley, Lu and Watts (1998) investigated the determinants of intention to be 
screened in male workers. They found that self-efficacy was significantly related to intention 
to be screened, although no conclusion was drawn as to why this was the case. Stokamer, 
Tenner, Chaudhuri, Vazquez and Bini (2004) investigated whether patient education would 
increase adherence to BCS. They found that participation was increased by almost fifteen 
percent by the implementation of one-to-one patient education. A significant factor in this 
education was increasing the patients’ confidence in completing a FOBt at home, which 
increased response rate.
A study investigating barriers to BCS found that self-efficacy was a barrier to screening 
(Brouse, Basch, Wolf, Shmukler, Neugut and Shea, 2003). Here, it was found that 
participants possessed the motivation to participate in screening, but were unable to translate 
this into action because they lacked the self-efficacy to do so. This implies that self-efficacy 
may be good predictor of action.
Response efficacy
Response efficacy has only been considered in the PMT (Rogers, 1983). Response efficacy 
was implicitly highlighted in the results of the UK pilot, whereby participant’s stated that 
participation results in rapid results and treatment O’Sullivan and Orbell (2003). Mack, 
Cook, Walley, Temple, Carlson, Hilsden and Paolucci (2009) examined the relationships 
between the perceived benefits and costs of BCS held by BC patients’ first degree relatives. 
They found that response efficacy was a contributing factor to BCS participation. Kremers 
et al. (2000) also supported the importance of response efficacy whereby findings revealed 
that if beliefs are held that there will be a positive outcome to taking part in BCS, increased 
participation will result. Myers et al. (1998) found that if participants believed in the efficacy 
of a screening test, their intention to be screened would increase. There were also elements 
of salience and coherence, as discussed earlier, which seem to tie in with response efficacy.
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Myers et al. (1998) outlined that salience and coherence includes ‘technical effectiveness’ of 
the test and the importance of canying out a screening test. In this respect, as seen earlier, 
salience and coherence was a strong predictor to intention to be screened, and it is deemed 
by the author that response efficacy had an important role here.
Health Locus o f Control (HLC)
The HLC was specifically developed by Wallston, Wallston and DeVellis (1978) to look at 
the degree to which individuals perceive their health to be controlled by themselves i.e., 
internal locus of control, or others, i.e., external locus of control. This construct states that 
possessing a strong internal locus of control results in more positive outcomes (Myers et al.,
1994). Azaiza and Cohen (2008) looked at the predictors of, and intentions to be screened for 
BC in an Israeli population. Here, they highlighted the role of ethnicity in the HLC. For 
instance, they found that locus of control is inextricably linked to religious beliefs, i.e., 
health was in the hands of God, and a traditional ‘collectivistic’ society i.e., personal 
responsibility is not considered to be as important as responsibility to society. Azaiza and 
Cohen (2008) found that Arab participants tended to have a lowered internal locus of control 
as a result of cultural norms.
Gili, Roca, Ferrer, Obrador and Cabeza (2006) utilised the ‘Multidimensional Health Locus 
of Control Scale (MHLC)’ to investigate how adherence to BCS was related to psychosocial 
factors. The MHLC was developed to assess health belief expectancies in three aspects; 
health is governed by the individual, i.e., internal, by powerful others (PHLC) or by chance 
(CHLC) (Wallston et al., 1978). Surprisingly, no relationship was found between internal, or 
external, locus of control and health beliefs. However, it was found that individuals, who 
relied on others to influence their participation in BCS, did not participate. Findings from 
Azaiza and Cohen (2008) concurred with the two dimensions outlined by Wallston et al. 
(1978). Arab participants exhibited a higher external locus of control which was deemed to
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be because they are less likely to take part in screening unless it is recommended by a GP 
(PHLC), and they were more fatalistic with regards to their health (CHLC). Gili et al. 
(2006) found a significant difference between participants accepting BCS and those 
declining. Here it was found that those declining screening had a stronger PHLC, which 
corresponds with the latter findings here.
Optimistic bias
Optimistic bias, also known as dispositional optimism or unrealistic optimism, occurs when 
an individual perceives themselves to be at less risk to negative events than others (Klein and 
Helweg-Larsen, 2002). This perception can be direct, i.e., the individual compares their risk 
to an ‘average’ other, or indirect, the individual compares their risk of experiencing the event 
in the future with that of the average other (Weinstein and Klein, 1996). If individuals then 
perceive their susceptibility to bowel cancer as lower, it could be said that they are 
employing optimistic bias. Klein and Helweg-Larsen (2002) pointed out that in terms of 
other models, e.g., PMT; optimistic bias may be considered to be a maladaptive response. 
This was supported by Klein and Kunda (1994) who suggested that optimistic bias may 
result in more risks and less precautions being taken, as individuals misjudge the risk and 
perceive that they have control.
Robb, Campbell, Evans, Miles and Wardle (2008) conducted a study to assess optimistic 
bias in relation to BCS information. This study found that showing risk based information 
about BC to participants did not impinge upon their perception of risk to BC, i.e., they still 
perceived themselves to be at less risk than the average person. Klein and Helweg-Larsen
(2002) commented on the relationship which has been found in past research between 
perceived control and optimistic bias. Here it was considered that the greater the degree of 
optimistic bias, the more control a person feels they have over an outcome. The results from
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their meta-analysis supported this relationship. This implies that the increased optimistic bias 
may result in a decrease in BCS participation.
Lu, Andrews and Hou (2009) conducted a Taiwanese study exploring the impact of 
optimistic bias upon intention to be screened for cancer. They found that individual’s 
displaying optimistic bias did not perceive cancer to be a serious illness or that treatments 
were successful. They also found that theses individuals felt less susceptible to cancer 
because they had not suffered from a serious illness before and currently led a healthy 
lifestyle.
Earlier in the discussion it was mentioned that McCaffeiy et al. (2001) found an overlap 
between perceived susceptibility and optimistic bias. This was also found to be the case with 
Wardle et al. (2000). However, even though those who were more optimistic perceived 
themselves as less vulnerable, Wardle et al. (2000) argued that those individuals were more 
susceptible to information regarding risk control. This, they suggest may increase their 
participation in the long run.
Conclusion
The author has now outlined the main models, theories and constructs believed to predict 
screening behaviour in this context. In regards to the models and theories, each possesses its 
own merits as discussed, but they also have limitations. Ogden (2000) summarised that the 
HBM, PMT, HAPA, TPB and the TTM do not clearly outline the direction of their 
constructs. For instance the HBM, PMT, HAPA, and TPB do not clarify if the constructs 
have a linear progression or not. Similarly, the TTM does not outline if the stages are on a 
continuum. Constanza et al. (2005) stipulated an equivalent issue with the PAPM as it was 
difficult to ascertain from findings whether participants’ beliefs had governed the stages or 
vice versa. The HBM, PMT, and HAPA all assume that individuals are illogical when
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making decisions and there appears to be no environmental or social roles within the process. 
However, the latter drawbacks are addressed, to an extent, with the TPB which allows for 
individuals to be rational and for the role of social and environmental factors in the adoption 
of health behaviours (Ogden, 2000). The PHM has utilised constructs from the HBM and the 
TRA and consequently assumes the same problems with resolving causality. Conversely, 
unlike its predecessors, the PHM includes the role of social and environmental factors, plus 
the role of past health behaviour (Myers et al., 1994). Finally, there were also disadvantages 
with the CTM. Firstly, if as White et al. (1994) suggest, there needs to be a certain amount of 
stress to enable the model to work, then the stage of screening to be assessed by the author’s 
research, i.e., invitation and participation, may not be appropriate. For instance, there is 
evidence to suggest that the invitation and deciding whether to take part does incur stress for 
some individuals, but would this be enough to allow this model to work? Would the model 
require more stressful stages of the screening pathway, e.g., abnormal results, to succeed? 
This would need to be taken into consideration if constructs from this model were to be 
tested, especially as the author could find no evidence of the CTM having been utilised with 
a BCS population.
On the whole the constructs which seemed to provide the strongest consistent prediction of 
screening behaviours, in this discussion, are susceptibility, costs or barriers, cues to action, 
fear, self efficacy and response efficacy. The validity of severity, benefits, health motivation, 
behavioural intention and health locus of control appear to have been questioned in the 
studies cited here. Unfortunately decisional balance and decisional conflict did not have 
enough supporting evidence from which to draw an adequate conclusion. The author had 
difficulty in outlining usefulness of each of constructs because although some constructs 
appeared in several models/ theories, the way in which they were operationalised differed. 
Vernon et al. (1997) made the relevant point that although studies are technically 
investigating the same constructs their operational definitions of the same construct may
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vary. They went on to report that many studies do not state the reliability and validity of the 
measures used. There also appeared to be an overlap between constructs which was often 
difficult to decipher. For instance, constructs within models were said to overlap, e.g., self- 
efficacy and perceived costs in the HBM, and between models, e.g., optimistic bias and 
susceptibility (Vernon et al., 1997; McCaffery et al., 2001).
Overall, this discussion has highlighted that screening behaviour cannot be explained by a 
single theory as stated by Cuny and Emmons (1994). Furthermore, caution should be utilised 
in operationalising certain constructs from models and theories within this area, and the 
necessity to be very clear as to what is to be achieved by utilising such constructs. Therefore, 
having considered the theoretical framework that underpins factors affecting BCS 
participation, the empirical research was then commenced as outlined in chapter four.
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Chapter Four
Qualitative Studies
Introduction
The literature in chapters two and three identified psychosocial factors and barriers which 
may result in an individual declining BCS. After conducting this review, it was apparent that 
there was a limited amount of research specific to BCS via FOBt, and to participation in the 
new NHS BCSP in the UK. Furthermore, there had been relatively little research to date 
dedicated to the reasons why individuals chose to decline screening when invited to 
participate in the first round of BCS, in this new programme.
As discussed in chapter one, BC and BCS are sensitive subjects that required careful 
consideration with regards to data collection. Qualitative methods were considered to be 
the most appropriate method of data collection to commence the research for two reasons. 
These methods seek to develop the existing knowledge in a particular area of interest, and to 
explore the personal experiences of individuals, to understand how they view the world 
(Lyons, 2000).
In regards to these points, the author hoped to expand upon the existing knowledge about 
BCS via FOBt in the new BCSP by gaining an insight into individual’s personal experiences 
of being invited to take part in the programme, and declining. This chapter outlines the 
qualitative research undertaken, in four parts. The first part outlines the initial study 
conducted, which utilised semi-structured interviews to evaluate personal experiences of a 
FOBt. The subsequent parts detail the research that was carried out as a result of study one.
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Part One
Study One: Evaluation of personal experiences of faecal occult blood testing.
Aim
• To explore the psychosocial factors and barriers which affect participation in the BCSP.
Methodology
Design
Participants
The BCSP Southern Hub free phone helpline records when any individual contacts the 
programme to decline their invitation to participate in the BCSP. These records are a 
mandatory requirement of the BCSP in order to remove an individual from the current round 
of screening. Eveiy individual who contacts the programme to decline screening is requested 
to give a reason for declining participation; these reasons are recorded by the helpline 
assistants. Individuals who declined their invitation to participate in screening, in this way, 
were approached for participation in the interviews. A stratified random selection procedure 
was utilised to select participants for interview. The inclusion criteria for participants were 
that they were aged between 60-69 years old and had been offered BCS via FOBt in the last 
two years. Participants were only excluded from selection if they had a clinical reason for 
declining screening, i.e., recent BC or other bowel related diagnosis, e.g., ulcerative colitis.
Materials
Each prospective participant was sent an invitation letter (Appendix 7) and an information 
sheet (Appendix 8), explaining the aims of the research. A consent form (Appendix 9) and a 
stamped addressed return envelope were also included. When the consent form was received 
from the participants, an information pack was issued to each of the participants, which 
included the initial invitation to screening letter (Appendix 2), BC information leaflet
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(Appendix 3) and test kit instructions (Appendix 5). This information was referred to during 
the course of the interview schedule.
A semi-structured interview (Appendix 10) was then utilised, via telephone, to explore the 
participant s beliefs and attitudes to BC and BCS as regards to their personal experience of 
FOBt. The semi-structured interview was considered to be a good way of eliciting personal 
experiences from participants, utilising open-ended questions and prompts guided by the 
interviewer (Willig, 2001). Furthermore, the structure in the interview provides a basis for 
comparison, which was deemed important for data analysis (Willig, 2001).
The questions utilised were as follows:
1. How did you feel when you were invited to take part in bowel cancer screening?
2. What do you think are the main causes of bowel cancer?
3. Who do you think is most likely to be diagnosed with bowel cancer and why?
4. What do you think about bowel cancer screening via faecal occult blood testing?
5. What do you think about the following statement? “By the time these tests find 
something, it is too late to treat it successfully.” (Quotation from ACS, 2004)
6. What were your thoughts about the information you were sent regarding bowel cancer 
screening:
• How did you feel about the information booklet?
• How did you feel about the invitation letter?
• How did you feel about the test kit instructions?
7. What was your reasoning behind not taking part in bowel cancer screening?
8. Is there anything else you would like to add to what we have just discussed?
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Two demographic questions were also asked;
9. Please could you confirm your current age?
10. Please could you confirm your ethnic origin?
Epistemological approach
The epistemological stance was considered to be realist in nature as the author wanted to 
observe the participants experiences of reality (Braun and Clarke, 2006). This approach was 
thought to sit well with the data to be collected because it assumes that experiences of BCS 
will be based upon participants’ perceptions of reality.
Data analysis
Inductive thematic analysis was the chosen method of data analysis. This technique was 
chosen as it allows the sensitive extraction of theory from participant’s views, e.g., themes 
emerge from the participant’s responses during the data collection (Braun and Clarke, 2006). 
The author was aware that there were different ways of employing thematic analysis, e.g., 
Boyatzis (1998), however for the purpose of this data analysis Braun and Clarke’s (2006) six 
stage process was considered to be the most straightforward:
Stage 1 - Each of the interviews were transcribed and re-read. Notes were made about any 
patterns emerging.
Stage 2 - For each interview, sentences were analyzed and then coded into units.
Stage 3 - Similarities and differences were then sought between these codes and these were 
grouped to form preliminary themes and an initial thematic map.
Stage 4 - Initial themes for each interview were compared and contrasted within the 
interview, and then with the others in the data set.
Stage 5 - The initial themes were refined to produce a final thematic map.
Stage d -  Findings were reported by theme.
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Ethical Considerations
AH participants were made aware of the aims and objectives of the research, their right to 
withdraw, the treatment of data collected, and that participation in the study would not affect 
any current or future treatment within the NHS. Participants were also made aware that 
should the interview cause any psychological distress that they should contact the BCSP. 
Ethical approval for this study was granted by the NHS Research Ethics Committee at the 
Royal Surrey County Hospital.
Results
Reliability
An independent researcher was requested to read excerpts from the interview transcripts with 
the themes that had been assigned. The independent researcher was then asked to categorise 
the quotes into the existing themes. To measure their agreement, the inter-rater reliability 
analysis Kappa was utilised. In this instance Kappa = 0.89 with p<0.001 which according to 
Landis and Koch (1977) is an exceptional score. Therefore, the author was satisfied with the 
themes assigned to the data.
Participants
Of the ninety participants selected for interview, only four (4%) agreed to take part in a 
telephone interview; an example transcript can be found in Appendix 11. The profiles of 
participants can be seen in Table 1.
Table 4.1: Participant labels, ages, gender and ethnicity
Participant identification Age Gender Ethnicity
Adam 63 Male British
Bill 61 Male British
Clare 61 Female British
Dave 62 Male British
65
Themes
The purpose of the interview schedule was to find out the participant’s reasoning behind 
declining BCS. The questions focussed upon their knowledge of BC, their feelings about 
being invited for screening and their thoughts about the information they were sent from the 
programme. As a result of thematic analysis, four distinct themes emerged from the 
interview data collectively. Each of these themes and their codes are now discussed with 
accompanying illustrative quotes.
Theme 1; Fear
The theme of fear translated into a number of separate codes. Firstly, participants appeared 
fearful about the information they received from the BCSP:
BILL “but I can imagine, may be an elderly person receiving that and thinking, oh 
my god”
CLARE “Um, a little nervous to be honest”
Secondly, there seemed to be a fear about what the invitation could mean, i.e., some people 
may find the invitation frightening because they think they have been sent the letter because 
they are more at risk of developing BC:
BILL “I can imagine people who might, might receive that and think agh, you know, 
um, I mean they could, could find it possibly fiightening, almost to the extent that 
gosh they think Fve got it, that’s why Fve been sent it.”
Thirdly, fear was reported with regards to cancer in general:
ALAN “If you have got it, you don’t know if it, what it’s going to do to you as a 
person yourself’.
Finally, there seemed to be a fear attached to a negative past experience of bowel 
investigation; here there seemed to be a fear of a positive result which may lead to further 
investigation which he did not want to go through:
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BILL “Because I mean I was already aware of a lot of the procedures, that any, 
should I say any slightly debatable results would have prompted a reaction to my GP 
which would have prompted me going through what I have already experienced 
thank you”
Theme 2: Beliefs
When participants were asked who they thought would be most likely to be diagnosed with 
BC the responses were varied. Participants categorised those who they perceived at higher 
risk of developing BC into three codes which were gender, i.e., one gender more predisposed 
to BC than another, age, i.e., older age groups are more at risk, and history of cancer, i.e., a 
diagnosis of BC is higher if someone has had cancer before.
Gender is considered to be a barrier to screening as it was reported that either gender, as 
opposed to both, are more at risk than the other. In one instance males were perceived to be 
more at risk:
ALAN''I don’t want to be rude, but I think gay people... I can’t see a lot of women 
getting it”
Whereas, according to another participant females are perceived to be at a higher risk in 
comparison to males, because they are at risk of other cancers, i.e., breast cancer:
DAVE “you know you take like breast cancer and that, I mean ah, that is another 
form of cancer and I think um, it could be that they [females] are more prone to 
getting it than men you know’
The subject of age appeared during two of the interviews. One participant commented that 
they felt susceptible to BC because of their age:
ALAN^Tm. at that age all these kind of things, you can get these bowel cancers’
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They went on to say that:
ALAN “When you get to a certain age, everything does tend to go down hill”
This was supported by a comment made during another interview:
BILL “I mean once you’ve, once you’ve hit the age of fifty it seems you’re up for 
about anything that’s going”
In both cases it appears that the participants felt more vulnerable to ill health as their age 
increases.
One participant did seem to be aware of what can cause BC. They believed that an unhealthy 
diet, lack of exercise and being a smoker can contribute to a BC diagnosis; they also appear 
to be engaging in preventative health behaviours:
DAVE “what you eat and lack of exercise possibly...I think it’s got more to do with 
lung cancer regarding smoking. Now I’m not a smoker anyway, I don’t like 
smoking and never have had a cigarette in my life”
They also added:
DAVE “more or less down to your diet... I eat a lot of vegetables"
One participant also commented they considered someone who has experienced cancer in the 
past to be more likely to develop BC:
CLARE “you might be more prone to getting cancers, so you go for your regular 
breast screening and all the other things because you’ve already had one type of 
cancer”
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Theme 3: Knowledge of BC and BCS
In relation to the causes of BC, a majority of the participants appeared to be unaware of any 
particular reasons why BC occurs; generating responses to the question what causes BC such 
as:
BILL “I haven’t the faintest idea”
CLARE “Not really no”
This was a similar case when asked if they knew any of the symptoms of BC:
ALAN^lAo, I wouldn’t to be truthful”
CLARE “Not really no”
One participant seemed aware of one type of symptom:
BILL “I’m aware of bleeding from the anus”
However in this instance, although there was an awareness of one of the symptoms, there 
was a lack of awareness as to the asymptomatic nature of BC, and that unless they were 
experiencing this symptom, they were not going to participate in screening:
BILL “Unless I find blood again, forget it”
Another participant felt that the individual should seek advice from their GP if they felt 
something was wrong:
ALAN “Well, the thing is, if a person knows that there is something wrong with 
them, then they should go to their doctor, before, before you do your test and 
find out that there is a cancer init, because you know that if you aren’t a hundred 
percent, what do you do, you go to your doctor”
This participant also appeared unaware that BC can be asymptomatic, hence how would the 
person they are referring to in this comment know to go to their GP? This response 
inadvertently suggests that only people who are having bowel problems need to take part in 
screening. This is similar to the following response, again it is apparent they feel screening is
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more important for those with existing bowel problems; and possibly a waste of time and 
money for others:
CLARE “I think it makes people think well it seems pointless doing the test if its 
going to be too late by the time you’ve done all this complicated test and what 
have you, and the result comes through, it’s too late then anyway and what’s the 
point..,! think if it, if it can serve some purposes to diagnose um people who are 
likely to get it, then yes it’s a good thing. If like you say, the test is going to 
come back and it’s too late to do anything about anything, then yes it is a 
waste of taxpayer’s money”
There appeared to be a lack of awareness with regards to the actual purpose of the screening
test with responses such as:
BILL “Not only does it do your bowel, but it does all the rest of your body as well”
Further to this, one participant explained that they thought BC was less common than other 
types of cancer, and that this is why they had not contemplated directly what causes the 
disease:
ALAN “I don’t know, you know. I’ve never actually thought of it to be truthful, 
because you know. I’ve never really heard of a lot of people having bowel 
cancer, but mostly it’s the other parts innit, the prostate cancer”
Another barrier to screening appeared to be a lack of understanding about the information 
received from the BCSP. When asked about ‘The Facts’ leaflet (see Appendix 3) they were 
sent out initially, one of the participants claimed that they had not read it thoroughly:
ALAN “I haven’t read it properly”
One participant was concerned, that although they found the information clear, that the 
information could be difficult for others:
BILL “Yes, I mean, well to me it was all perfectly straight forward and clear...it 
may prove a little forbidding to somebody, with the best will in the world, not as 
well educated and literate as me”
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Having made this comment, this participant also went back to say they had to re-read the 
information, demonstrating that may not have found the information as easy to follow:
BILL “You know, there were a couple of paragraphs I sort of read again just to 
make sure...hang on a minute, even I need to read that a second, a second, just to 
make sure what it says”
Whereas another found it easy to understand:
DAVE “Pretty well straight forward. Yes”
When they were asked about the test kit instructions and kit (see Appendix 4 and 5) they 
were sent; only one thought the FOBt would be easy to use:
ALAN “Oh yeah, how to use everything and that, I find that was easy”
One participant, who had made up their mind not to participate when they received the 
invitation, commented when asked that they did not look at the test kit:
BILL “No, I didn’t actually to be fair”
Another found the test kit instructions too complicated and long-winded:
CLARE “Well, to be honest, I think most people would sort of read half of it and get 
terribly complicated and bored by the time they got halfway through, you probably 
wouldn’t read it completely...! mean, I had to read it through twice to really 
understand what it was all about, and I thought it was a bit too.. .No, I think all of it 
really; I think it was too much information to take in, in one go.”
Theme 4: Issues with FOBt
There appeared to be difficulties with the practicality of carrying out the test kit, fitting it in 
with daily life and questions regarding its usefulness.
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Two participants questioned the practicality of the test as regards carrying out the test and 
posting it back to be tested:
ALAN ""I think the only thing that could be very hard is to get your faeces”
CLARE “Yes, and it was a little complicated about, you know, the actual 
procedure...Remembering to do it all in the right order and things...this is too 
fiddly...the whole process was messy”
ALAN “I  wouldn’t like to be the post man delivering it... Can you imagine it going 
through the line and all of a sudden one burst open (disgusted noise)”
One participant claimed they had not taken part because they found the kit too difficult to 
cany out, and would have been more likely to take part if the test was conducted in a 
hospital setting.
CLARE “it was a little complicated and two because I’m disabled, I was worried 
about sort of my hands and stuff like that, and ways of doing it, and how it was 
being done, and felt it would be better if it was like in a hospital”
When asked what their reasoning was behind declining the screening invitation, two
concluded that it was because they had too many family commitments going on at the time
of receiving the invitation:
“Because the thing is I’m her twenty-four seven carer”
DAVE “I had a couple of bereavements and I had to leave it”
Participant’s responses were favourable regarding the usefulness of BCS via FOBt:
ALAN “I think it could be useful, because, you know, it’s like, if you give a blood 
test, you don’t know what’s in it. You know, I could be walking about, I don’t know 
what’s wrong inside your body. Because with a blood test you can tell if you’ve got 
diabetes, you’ve got cancers, you’ve got anything”
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However, one participant felt that although the test was a good idea, its usefulness was 
questionable due to the way in which it was carried out:
CLARE “I think it should be a thing, but I don’t know about doing these at home, I 
don’t think that’s a very safe option to be honest...if it was done under sterilised 
conditions, you’d get a truer reading...when it’s done in the home, you don’t 
know what other germs have contaminated the sample”
In regards to the fatalistic statement, in question five, responses were mixed. One participant 
appeared to defend the screening programme:
DAVE “Well because um, if there is a possibility of you, you know if, it detects it at 
an early stage doesn’t it...even if bowel cancer was caught at a later stage it 
would still be good to know so that it could be treated?”
Other participants were not as supportive:
CLARE “I think if it, if it can serve some purposes to diagnose um people who are 
likely to get it, then yes it’s a good thing. If like you say, the test is going to 
come back and it’s too late to do anything about anything, then yes it is a waste of 
taxpayer’s money.”
Discussion
Semi-structured interviews, via telephone were utilised to evaluate the personal experiences 
of males and females who have been offered BCS via FOBt in the last two years, but have 
declined. From this it was hoped that the psychosocial factors and the barriers that stopped 
them from taking part would emerge. The results from this study are considered important 
because they highlighted particular themes which could pose major barriers to BCS.
Fear
Fear in this context appeared firstly when participants spoke about receiving information and 
an invitation from the BCSP. This may have been fear of the unknown, as this was a new 
programme, hence participants may not have been aware of it when they received 
notification of their eligibility. This may have led to feelings of fear and nervousness as they 
were not aware why they had received the information, i.e., was it because they were
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unknowingly predisposed to BC. Secondly, there seemed to be a fear of cancer in general 
which supported findings from Tessaro et al. (2006) where the fear of having BC, or cancer 
itself was a major barrier to BCS. One participant was concerned about what cancer could do 
to them as a person. This supported previous research which found that fear can stem from 
the possible outcomes of BCS, i.e., a BC diagnosis (Broughton et al., 2004; McCaffrey et al., 
2001).
Furthermore, after this qualitative research was conducted, research findings were 
disseminated by Chappie, Ziebland, Hewitson and McPherson (2008). Their interviews also 
found that the fear of a BCS outcome contributed to unwillingness to take part in BCS. 
Thirdly, fear was detected with a participant whose main reason for declining screening was 
a negative past experience of bowel investigation. This was considered interesting by the 
author because it represents an example of how fear affects coping appraisal as outlined in 
the PMT. In this instance a negative experience has resulted in a maladaptive response, i.e., 
non-participation, whereas with an adaptive response bowel problems would make the 
individual more vigilant, hence making screening a priority. Overall, these results suggest 
that fear is a good predictor of BCS participation as specified by the HBM and the PMT.
Beliefs
Research outlined in chapter two found that if individuals believe their risk of BC to be low, 
they are less likely to take part in BCS. The findings here, regarding gender, age, health 
behaviours and a predisposition to cancer appear to support this research to an extent. Firstly, 
participants believed the opposite sex to be more likely to develop BC than they were. This 
supported Robb et al. (2004) who found that men were less likely to participate in BCS than 
women, because they felt they are at a lower risk of developing BC, and Weinberg et al.
(2004) where women were less likely to participate because they thought that BC was a 
disease mostly found in men.
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Secondly, participants believed that susceptibility to illness increases with age, suggesting 
that risk of BC is higher in older people. This supported Jerant et al. (2004) who found that 
older people were more likely to take part because they believed their risk of BC to be higher 
than younger individuals. However, this perception of risk due to age in the current study 
was not enough to make them take part in the screening. Could it be, as suggested by Jerant 
et al. (2004), that participation usually increases in the older population because they were 
presenting with symptoms, i.e., rectal bleeding? In this way it could be that although there 
was a perceived risk of BC due to age, that in the absence of symptoms, the risk was not 
perceived as high enough to take part.
Similarly, individual’s risk perception has been found to be lower if they consider 
themselves to be healthy people (Robb et al., 2004). The comments made during one of the 
interviews, about diet and smoking were deemed interesting because the individual was 
highlighting what they understood to be the causes of BC, and then stating how they did not 
perceive themselves to be part of those groups. From this it is possible to deduce that they 
perceived themselves at a much lower, or no risk of developing BC. They had not considered 
that there may be other or indeed no particular causes of BC. Similarly, another participant 
believed that BC was more predominant in individuals who have had another type of cancer. 
Overall, there seems to be an optimistic bias running through these responses in the respect 
that each participant believed that they did not belong to a group more likely to be diagnosed 
with BC, e.g., homosexuals, people who have had cancer before, females, or those with an 
unhealthy diet.
Knowledge
Unlike the UK pilot focus groups (O’Sullivan and Orbell, 2003) participants in these 
interviews were unaware of the causes and symptoms of BC. This was considered worrying 
as this can result in a lowered awareness of risk and delay in seeking medical advice if
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symptoms are present (Robb et al., 2008; Broughton et al., 2004). Participants also seemed 
unaware of the asymptomatic nature of BC, i.e., that symptoms are not often identified until 
progressed stages of the disease, and thought that the disease was more likely to occur in 
those with previous bowel disorders (Tessaro et al., 2006). Furthermore, there was a lack of 
awareness about the frequency of BC, and the misperception that the prevalence rate was 
low. The author detected from the responses given that this lack of awareness made their 
perception of susceptibility to BC lower than the average person of their age and gender. 
There also seems to be a link here between perceived risk and optimistic bias, as suggested 
by McCaffery et al. (2001). However in this context, it was not possible to establish whether 
optimism altered perceived susceptibility or vice versa.
Generally the participants seemed to lack an understanding of the information leaflet, 
invitation and the FOBt instructions which concerned the author as this information has been 
specifically developed to enhance informed decision making (Appendix 3 and 5). In one case 
this appeared to be because the information had not been read, however in other cases 
participants reported that the information was complicated and too much to take in at one go. 
It is considered that by the participants hot grasping or understanding the information and its 
content, they too had a lack of awareness about BC and BCS, hence their non-participation 
in the screening. One could speculate from this that they have not made an informed 
decision, as they have inadvertently not been made aware of the information necessary. The 
author concluded from this that awareness may have been a main contributing factor to why 
screening was declined.
Issues with FOBt
Concerns about completing a FOBt have been proven to be a barrier to BCS, as seen in 
chapter two. Therefore, one could conclude that the more issues individuals have with 
completing a FOBt, the less likely they are to take part in BCS. During a couple of
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interviews practical issues with completing a FOBt were mentioned with regards to sample 
collection, test completion and postage. These factors reflected the findings from Chappie et 
al. (2008). With another participant, possibly due to dexterity, issues with the FOBt seemed 
to be the main reason why they declined screening. However, it was difficult to decipher 
which aspect they found most problematic; the fact that they found the instructions 
complicated or because, as in Weitzman et al. (2001) they thought the test was too fiddly and 
messy to complete.
One participant seemed to lack confidence with completing the test, which seemed to 
enhance their reluctance to complete the FOBt, as found by Schroy (2002). This participant 
talked about how it would be better if the test was carried out in a hospital environment. The 
author gathered from this that they lacked confidence in carrying out the FOBt because they 
found the instructions complicated. Also, as this was a female participant, there was the 
possibility that they were recalling other screening programmes whereby screening is carried 
out by a screening practitioner. This highlights the fact that this is the first screening test to 
be performed by the individual at home, something which may make individuals nervous, 
particularly those with lowered self-efficacy. This finding is akin to that of Brouse et al. 
(2003) whereby even motivated participants did not take part in BCS because they lacked the 
self confidence to do so.
There were also issues regarding the timing of the test, i.e., receiving the test when they had 
other commitments to deal with, as found in Vernon (1997) and Kremers et al. (2000). It was 
assumed from the responses that participants did not find the test convenient to use, i.e., to fit 
it into their daily schedule. Furthermore, it could be that they could not deal with the 
possibility of having further investigation at that point in time. For instance, being a full-time 
carer for a spouse, it may not be that they have no time to do the test, but rather that a 
positive result may lead to a colonoscopy which they may find difficult to attend. This would
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have benefited from more in-depth questions by the interviewer to decipher why participants 
felt that they could not take part at that time.
With regards to the usefulness of the test, research has shown that the less faith individuals 
have in a screening test detecting the onset of cancer, the less likely they are to take part in 
screening (Myers et al., 1994). Responses were mixed as to the usefulness of the test. One 
participant thought it would be useful, but another thought that canying it out at home would 
in effect reduce its usefulness. Once again, looking elsewhere within this discussion it can be 
seen that it is possible to be positive about a programme and still not take part. Furthermore, 
lowered confidence in the self could mean that they then perceived the test as less useful. For 
instance they may perceive that as they are canying out the test, they could get something 
wrong, affecting its usefulness and therefore the point of doing the test.
The ability of the FOBt to detect BC at an early stage also came under debate with regards 
to the fatalistic question “By the time these tests find something, it is too late to treat it 
successfully”. One participant considered it to be beneficial because the sooner BC is 
discovered, at any stage, the sooner it can be treated. Others thought that people should seek 
advice from their GP if they think there is something wrong. This reinforces an earlier 
conclusion made by the author in that participants may be unaware of the asymptomatic 
nature of BC. It also indicates that individuals may not take part in screening as they would 
see a doctor if there was anything wrong with them. Finally, there were comments that this 
test would only be useful if it diagnoses those who are more predisposed to developing the 
illness, and otherwise it is a waste of NHS resources. Again this relates to the fact that there 
is little awareness that this disease can affect anybody, and this is the fundamental reason for 
a population based screening programme.
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Conclusion
The main limitation of this study was the low response rate, thought to be related to the 
difficult nature of this kind of research, i.e., talking about a potentially embarrassing topic, 
was considered to be the reason for less people wanting to take part. Furthermore, it was not 
ideal from a methodological standpoint, as Willig (2001) stipulates, comparison of semi­
structured interview data is more fruitful if there are more interviews to compare. Therefore 
although the results highlighted some interesting points, it is not possible to conclude that the 
themes found here are necessarily representative of individuals who have declined the first 
round of BCS. Additionally, during the data analysis, the author noted that the interviewing 
skills may have affected the quality of the data, i.e., there were times when more in depth 
questions could have been asked or more prompts would have been useful. The author 
concluded that this may have been due to canying out the interviews over the phone; i.e., if 
the interviews were conducted face-to-face it may have been easier to prompt individuals 
based on their facial cues and body language, as suggested by Pridemore, Damphousse and 
Moore (2005). Furthermore, individuals are more likely to disclose sensitive information in 
face-to-face interviews (Pridemore et al., 2005). On the whole, it was felt that the 
interviewing skills did improve through the course of the four interviews.
The author was not satisfied with the validity of the fatalism question; question five. It was 
intended to generate responses regarding participants’ perceived control over cancer 
prevention, as highlighted in ACS (2004). However, the responses here related only to the 
usefulness of the test, which produced some interesting data, but not what was intended. In 
general, this study found that the reasons why participants declined screening reflected 
barriers to BCS found in recent research. Overall, participants seemed fearful of taking part, 
believed they were not part of a group generally affected by the BC and this may have been 
the result of lowered knowledge. Additionally, they shared concerns about the FOBt, lacked 
confidence in deciding to take part and completing a test without intervention from a health
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practitioner. However, the findings show that these are not stand alone barriers, i.e., there 
was not one particular reason why an individual declined screening per se; the reasons for 
declining screening are more complex. Therefore, the barriers to BCS emerging from the 
data would benefit from further exploration. From this, it was considered useful to cany out 
a further study to look at responses from individuals who have ‘opted-out’ of the initial 
round of BCS. Such exploration, it was hoped, would not only validate the themes found 
here, but also help to clarify whether there are particular barriers to screening which are 
more predominant than others, which would then give an idea of why a high percentage of 
people decline BCS.
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Part Two
Study Two: Reasons for declining BCS via FOBt.
Aim
• To explore the reasons for declining BCS.
Methodology
Design
Participants
As mentioned in study one, eveiy individual who contacts the programme to decline 
screening is requested to give a reason for declining participation; these reasons are recorded 
by the helpline assistants. A record of these reasons, along with gender and age, were 
maintained for the purpose of this study. As with the initial study the inclusion criteria were 
that responses came from individuals aged between 60-69 years old and had been offered a 
FOBt in the last two years.
Epistemological approach and data analysis
The epistemological approach remained the same as study one, i.e., realist, because the 
author deemed reasons for declining BCS to also be based upon participants’ perceptions of 
reality. Content analysis was utilised initially to quantify the frequency of responses received 
from callers (Hinds, 2000). Following this, the data was analysed utilising thematic analysis, 
as in study one, using stages of coding to identify predominant themes emerging from the 
data (Braun and Clark, 2006).
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Ethical considerations
Permission to maintain these records was given by the Director of the NHS BCSP Southern 
Hub. The records were securely stored at the BCSP Southern Hub during the data collection. 
The records of the reasons for declining screening were anonymised prior to data analysis.
Results
Reliability
Inter-rater reliability was also satisfied by another researcher. Once again Kappa was utilised 
to measure the level of agreement. Here, Kappa = 1.00 with p<0.001, which was a flawless 
score. Therefore the author was happy with the themes assigned to this data.
Participants
The mean age of participants was 66 years (SD = 3.24), which included 54 males (36%) and 
97 females (64%). Thirty-seven percent of responses were received from individuals aged 69 
years old; this was the highest amount of responses received from any one age. Responses 
from individuals were only excluded from selection if they quoted that they had no reason 
for declining screening, or had a clinical reason for doing so. Furthermore, some individuals 
had more than one reason for declining screening; each of these responses was included in 
the data analysis. In total, one hundred and seventy three responses were included in the data 
analysis.
Themes
The analysis identified three main themes; namely beliefs, emotions and issues with 
completing a FOBt. Table 4.2 shows these themes initial codes, and the frequency of which 
each was reported; along with an accompanying illustrative quote.
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Table 4.2: Content analysis themes
Theme Codes Instances Illustrative quote
Beliefs No
symptoms
39 “Does not feel it is necessaiy at present after 
reading the information.”
Health-
behaviours
15 “Thin, healthy vegetarian; does not think she 
is at risk.”
Fatalistic 6 “Would refuse treatment even if the test was 
positive.”
Confidence 4 “Does not believe in screening 
programmes.”
Age 3 “Did not want to partake as he had turned 70 
recently.”
Emotions Fear 22 “Does not want to take part, said this was 
because of ‘fear’, scared to do it.”
Offended 7 “He found the invitation offensive.”
Anxiety 5 “Gets herself in a state over screening, had 
breast cancer screening invitation four weeks 
ago; cannot cope anymore.”
Issues with 
FOBt
Practicality 2P “Feels sick by thinking of putting faeces on 
windows [of test kit].”
Timing 15 “Too busy with other things.”
Past
experiences
10 “Had a barium enema two years ago; can’t 
face doing test.”
Health 10 “Has lots of other health problems to deal 
with at present.”
Theme 1: Beliefs
The main reason for declining the first round of BCS appeared to be because individuals 
believed they were at low, or no risk, of BC because they were currently asymptomatic, i.e., 
displaying no symptoms of BC. Other examples of this were ‘does not want to partake, as 
has had no problems in the past’, ‘feeling fine no problems at present’ and ‘feels healthy at 
the moment, does not want to take part’. Individuals who thought they eat healthily, also 
perceived themselves to be at a lower risk of BC, hence a FOBt was not considered
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necessaiy. In addition, the type of diet also influenced this perception Ts a vegetarian, takes 
regular exercise, does not want to do it after reading booklet’ and ‘Does not want to take 
part, eats plenty of fruit and veg’. Similarly, it appears that those who feel they have a 
healthy lifestyle are at a lower risk of BC, negating the need for a FOBt. In line with this, 
there was also the perception that lifestyle, e.g., ‘Does not want to take part, has an 
‘alternative lifestyle’ and ‘no symptoms’ precludes them from BCS.
When some individuals were considering taking part in BCS, it was apparent they were 
thinking about the possibility of being diagnosed with BC. This became a barrier to 
screening, as some believed that if they were to be diagnosed with BC they would not wish 
to be treated for it; ‘Does not want to participate, if he has a fatal disease he wants it to take 
its course’ and ‘Does not want to go into hospital due to the expectation that the nurses will 
not provide good care’. If it is BC nothing can be done -  would not have treatment’. There 
were a range of responses with regards to individual’s confidence in the BCSP. From the 
example given in Table 4.2 it is apparent that the individual does not believe in the screening 
programme, perhaps not having confidence in its ability to detect BC early. Another example 
reads ‘Did not believe the test could detect adequately, i.e., in accordance with the leaflet’. 
Here it is apparent that the actual usefulness of the FOBt is in question, hence becoming a 
barrier to screening.
Finally, age appeared to be a barrier for some individuals, as demonstrated in Table 4.2 
whereby the quote denotes they feel too old to take part. This suggests there are individuals 
in the 65-69 age bracket who feel they are too old for screening because if they have cancer, 
they do not want to know, e.g., ‘Believes that at his age (69) if he has cancer then so be it’, 
or they have not experienced any bowel problems to date so they feel at a lower risk, e.g., 
‘Nearly 70 if she has something wrong, will go to GP’.
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Theme 2: Emotions
Fear was another main barrier to screening in the current research. There was fear about 
completing the actual FOBt, as seen in Table 4.2. It is not clear from this statement whether 
they were not confident about doing the test or whether they were fearful about the results, 
and possible diagnosis from the results. Other statements were more obvious; they appeared 
to be directly linked to the possible diagnosis of BC Tf there is anything going on, rather not 
know.’ As Table 4.2 stipulates, some individuals were literally offended by the information 
sent to them from the BCSP. As seen, this ranged from being offended about the invitation to 
the accompanying information, e.g., ‘Was disgusted that he was sent BCSP information. If 
there was something wrong, he would go to the doctor’ and ‘Does not want to partake, feels 
bothered by our correspondence’. Unfortunately, it is not clear from these responses as to 
what it was about the invitation or information that caused such offence. Nevertheless, it still 
proved to be a barrier to screening.
Anxiety was reported by some individuals, but at varying different points across the 
screening pathway. Initially there are those who become anxious at the thought of screening 
as seen in Table 4.2, a lady for whom previous experience of screening has resulted in 
anxiety. There are also those who appear anxious about doing the FOBt ‘Nervous about 
doing the test’; however it is not clear why this is the case, i.e., nervous about the possible 
results or the actual completion of the test kit. There are those who have had experience of 
screening and find that the anxiety lies in waiting for the results to arrive ‘Becomes too 
stressed waiting for screening results’ and those for whom anxiety lies predominantly in the 
possible diagnosis ‘Does not want anxiety of being tested / being diagnosed -  would rather 
not know at this time; would rather get full blown cancer and die of it than be ill’. 
Unfortunately all of the reasons for anxiety have prevented individuals from taking part in 
BCS.
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Theme 3: Issues with FOBt
The actual completion of a FOBt is a practical barrier to screening. Here, responses state 
they had difficulty with the nature of the test because they had to deal with small quantities 
of faecal matter as seen in Table 4.2, and as put by another ‘Does not have the stomach for 
if . It appears this may be a similar experience for those who stated that they were ‘Not too 
good with doing those kinds of kits’; however this could be considered to be related to their 
perceived ability to cany out an FOBt successfully.
Timing, or convenience, was also quite a large barrier to screening with individuals claiming 
they were too busy to complete the test kit or too busy to deal with the consequences. An 
example of the former can be seen in Table 4.2, where as an illustrative quote of the latter 
read ‘Is caring for her mother 24/7, simply not got time for a follow-up if it turns out to be 
positive. Rather does not want to know’. With the last quote however, the author could not 
help but feel that the person was fearful about doing the test in case there was anything 
wrong primarily, and then worrying about how her ‘illness’ may impact on the care she is 
providing for an elderly relative. In either respect time constraints appeared to prevent some 
individuals from taking part.
Past experience of bowel investigation, experience of another type of cancer and 
experiencing family or friends being treated for cancer were all reasons for declining BCS in 
this round. For some, bowel investigation, as illustrated in Table 4.2, appears to be a barrier, 
because individuals do not feel more investigation is needed. For others it is simply a case of 
having had a bad experience during previous investigation, ‘Does not want to take part 
because of a previous bad experience of colonoscopies’. Having experienced another type of 
cancer is also a barrier ‘Has been a cancer patient in the past, and does not want anxiety of 
another test. Feels she would know the symptoms if it occurred’. The experience of seeing a 
loved one go through BC is also a barrier ‘Lost wife 5 years ago due to BC, knows the
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signs’. There is also the possibility that individuals, having seen friends go through treatment 
for BC and found it harrowing, that this in itself would exclude them from BCS ‘Two friends 
having treatment for BC- put off screening’.
It seemed that some responses pertained to individual’s general health concerns at the time 
they were invited to participate in BCS. If individuals considered themselves too ill ‘Not in 
good health’ or were trying to deal with other health concerns ‘Has too much else wrong 
with her to do it’ then this in itself would prove to be a barrier to screening. It could be 
assumed from this that having other health concerns means that the possibility of the worse 
case scenario, i.e., a BC diagnosis, would be too much to cope with.
Discussion
The primary objective of this study was to identify the reasons why individuals declined 
FOBt BCS via telephone in the first round of the national BCSP. The analyses revealed that 
there were three predominant themes for declining screening, namely beliefs, emotions, and 
issues with completing a FOBt. These main themes were subdivided by thirteen codes. These 
findings relate to both those found in study one and recent research in this area, which shall 
now be discussed.
Beliefs
The most commonly occurring barrier to BCS appeared to be a lack of symptoms; 
individuals considered themselves to be at a low risk of BC because they are currently 
asymptomatic. This supported Robb et al. (1994) who found that individuals presenting with 
symptoms are more likely to be screened as they perceive their risk as higher. However, this 
is not considered to be simply a matter of lack of awareness. As Hart et al. (1997) found, 
some individuals who decline screening do not think it is necessary for well people. In the 
current study, individuals declining screening may perceive they are able to control their
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own health by only seeking medical help if symptoms are present, and that without 
symptoms they are less likely to develop BC than the average person. This supports the 
literature suggesting that optimistic bias occurs when individuals perceive events as 
controllable by them, however this also means they take more risks, in this case declining 
screening (Klein and Kunda, 1994).
Diet and lifestyle seemed to be two barriers to BCS which coincided. Some individuals 
concluded they did not require BCS because they consume a healthy diet, e.g., vegetarian, 
and have what they consider to be a healthy lifestyle, e.g., exercising, which supported 
findings from Robb et al. (2004). It is these factors, in combination with a lack of symptoms, 
which contributed to their misperceptions and thus lack of awareness about BC. It is of 
course positive that individuals do maintain a healthy diet and lifestyle as preventative health 
behaviours. However, the lack of awareness particularly with regards to the asymptomatic 
nature of the disease and that it can occur regardless of diet and lifestyle habits, seems to be 
lacking. This supports findings from Tessaro et al. (2006).
Fatalistic beliefs about cancer have been found to be a reason for not taking part in BCS 
(Powe and Finnie, 2003). This was supported in this study whereby individuals have decided 
that they would rather not know if they had BC, and even if they did they would not accept 
treatment. Unfortunately, it is not possible to determine what the reasoning was behind this 
decision. It could be assumed that they have had past experience of seeing someone they 
know being treated for cancer, and found the process too distressing. There is also the 
possibility that they are effectively ‘burying their head in the sand’ denying the possibility 
that cancer could affect them. Either way, in these instances, it seemed to be the main reason 
why they declined screening.
Confidence here pertained to individual’s lack of faith in the BCSP and the FOBt, i.e., their 
ability to detect BC at an early stage. It appeared that individuals came to this conclusion 
based on the literature they received about the programme. To knowledge, this barrier to 
screening has not been identified extensively in other research. However, this finding is 
similar to that found in research where men are less likely to participate in BCS as they have 
less faith in its salience (Myers et al., 1994; Brawarsky et al., 2003).
As discussed elsewhere in this chapter, age appears to be a barrier to screening whether it is 
because individuals feel they are too young or too old to participate. In this instance it 
appears that individuals do not want to take part as they approach 70 years of age. There are 
three possible explanations for this. Firstly, the literature that is sent to individuals specifies 
that people will be automatically called for screening between the ages of 60-69 years old, 
and that people over that age can request screening. It is possible that older individuals saw 
this age range and assumed that they did not need to take part because they would soon fall 
out of that age category; possibly thinking that screening is not necessary over the age of 70. 
The second rationale for this is that, as previously specified, older individuals perceive 
themselves to be at less risk, hence often decline BCS more readily (Tong et al., 2000; Robb 
et al., 1994). Thirdly, there was also an element of fatalism in responses from individuals 
aged 65-69 years old, in that if they have not experienced cancer so far in their lifetime then 
‘so be if. This implies that fatalistic beliefs may have resulted in an avoidance of the 
information sent out by the programme, as found in Miles et al. (2008), hence declining 
screening.
Emotions
Fear was another main barrier to screening; fear of the FOBt, and being fearful about the 
possible diagnosis of BC. Fear can stem from the unknown as McCaffeiy et al. (2001) 
explained. This coincides with this new BCSP as individuals may be fearful about carrying
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out a test which they have never done before at home, and the subsequent screening process. 
Fear about a possible diagnosis was also found by Broughton et al. (2004) as individuals 
worry about the outcome of a diagnosis. This was reflected in the responses gained from 
individuals phoning the helpline. As O’Sullivan and Orbell (2004) stipulate, this fear of the 
unknown or possible diagnosis is usually outweighed by the knowledge that even a positive 
result may have a good outcome, i.e., non-cancerous polyps being removed. This was 
obviously not the case for the individuals declining for this reason here.
Individuals who declined screening because they were offended by the information they 
received have done so for different reasons. Firstly, it was quoted that some found the idea of 
completing a FOBt repulsive. This coincides with the practical reasons for declining 
screening, examined later in this discussion. Secondly, it is possible that individuals are 
offended by the information because they are fearful of taking part, as we do not know why 
they were bothered by the correspondence, e.g., did they have symptoms that have not been 
investigated or did they know someone who has been recently diagnosed with BC? Thirdly, 
when it was quoted that they found the invitation offensive, we do not know what it was 
about the invitation which was offensive, and might have been due to miscomprehension. 
Unfortunately this finding has not been found in recent literature, hence is difficult to 
compare.
With regards to anxiety, the responses ranged from those who were anxious at the thought of 
screening, those who were anxious about doing the FOBt, those who become anxious whilst 
waiting for results, to those whose anxiety lies in a possible BC diagnosis. As detailed in 
chapter two, there were originally concerns over the BCSP information people would receive 
and its potential to increase anxiety about BC (Wardle et al., 1999). Unlike the current 
research, Wardle et al. found their information to be more reassuring than not. However, the 
responses in this study show that the information still arouses anxiety in some individuals.
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preventing them participating. In regards to canying out the test and waiting for the results, 
there is the possibility that the individuals are intrinsically anxious; i.e., they would then 
perceive themselves to be at a higher risk due to a pessimistic outlook and refuse screening 
as seen in Robb et al. (2004). There is also the possibility that their anxiety is driven by the 
thought of the screening process and the uncertainty of results as found in Hansen and 
Hannon (2005). Overall, these findings disprove those found in Parker et al. (2002) and 
Miles and Wardle (2006) who both claimed that anxiety was not detrimental to BCS 
participation
Issues with FOBt
The practical elements of completing a FOBt also seemed to be a predominant barrier to 
screening. The necessity of providing stool samples for analysis was too much for some 
individuals, hence deterring them from taking part. This supported Schroy (2002) where the 
completion of a FOBt was considered distasteful which resulted in non-participation. Here, 
this factor appeared to be mediated by self-efficacy. There is the possibility in the current 
study that this was also the case, but not directly reported. The issue of time constraints was 
considered of interest to the author as there may have been many causes for this response. 
This mirrored findings from Kremers et al. (2000) whereby BCS was declined as it was not 
convenient for them to take part at that time. The question being in this study, did they really 
have little or no time to complete the test or was there another underlying reason for not 
taking part, e.g., did they not perceive the test to be important to them at that time as they 
have no symptoms, do they have more misperceptions about the information they have been 
sent, i.e., are they fearful or embarrassed? The fact is that they did not just say they had no 
reason as others have done, they specified they had no time to do so; unfortunately it is 
unclear as to the reasoning behind this.
91
Non clinical responses which pertained to previous experience of bowel investigation were 
surprising to the author as the information sent to individuals specifies that BCS is 
appropriate every two years. Assuming individuals understand the reasons why they have 
had bowel investigation in the past, and the consequences if they did not have it, it could be 
determined that lack of awareness or the fear of more investigation may be the reasoning 
behind declining. Therefore, it could be that individuals felt that as they have had 
investigation before, and that BC was not detected, that there is no need to be screened. 
Additionally, they may be fearful about having further investigation if the FOBt result is 
positive and what the consequence of that investigation may hold. This is considered to be 
quite worrying in the respect individuals who may even have had BC specifically in the past, 
are so fearful about it happening again, that they have refused screening and would prefer to 
wait until symptoms are present. Similarly, the experience of seeing a loved one go through 
BC may also be considered to make individuals fearful of completing a FOBt in case they 
too are diagnosed.
Individuals who considered themselves too unwell, or to have other health concerns, were 
also found to decline screening. It could be concluded that having other health concerns 
means that the worse case scenario, i.e., a BC diagnosis, would be too much to cope with. 
Unfortunately there does not appear to be any supporting evidence for this barrier. However 
it is a factor thought to mediate others in this area as research deals predominantly with an 
aging population which may have associated medical problems. Individuals may be fearful 
about another diagnosis or subsequent treatment for BC. Alternatively, they may be 
fatalistic, i.e., would rather not know if they had BC, as they may not be able to cope this in 
addition to other underlying health concerns.
92
Conclusion
There were some limitations to this study. More females provided reasons for declining 
screening than males, and these individuals are not a true representation of everyone who 
declined screening, as they are the ones that called the helpline. Therefore it is difficult to 
generalise these findings to a larger population. The difficulty with drawing conclusions 
from responses in this way is that individuals may not have reported their reasons for 
declining screening either accurately or fully. Therefore, conclusions have been drawn by the 
author on potentially inaccurate responses, e.g., reported that they were ‘not interested in the 
screening programme’ when actually their first instinct was that they were fearful of cancer, 
or complete response, e.g., reported that they were ‘fearful of completing a FOBt’ because 
they have a fear of going into hospital for further investigation if needed. Furthermore the 
helpline assistants may have inadvertently distorted these results in their interpretation of the 
responses they received on the helpline. Finally it was not clear from the responses as to 
what point individuals declined screening, i.e., after they received the invitation, or after 
FOBt. This may have affected the results in that the barriers to screening may lie in one part 
of the screening process more than another.
The strength of this study lies in its findings as they support the results of past research. 
Furthermore this study has commenced the validation of results from study one, as the 
themes beliefs, fear and issues with the FOBt have emerged here. Beliefs about who requires 
screening was the commonest reason for non-participation, as individuals believed that as 
they were asymptomatic and engaging in good health behaviours, that screening does not 
apply to them. Fear was also a strong barrier to screening, as were the practical elements of 
taking part in the programme. From these findings, it was decided that one more qualitative 
study was necessary to develop these themes, and those from the first study, further.
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Part Three
Study Three: Expectations of faecal occult blood testing in an older population - a focus 
group study.
Aim
• To explore the psychosocial factors and barriers which may affect participation in the 
BCSP.
Methodology
Design
Participants
The focus group participants were derived from individuals living in a residency in the local 
Surrey community who would be eligible for the NHS BCSP when it is rolled out to the 
Surrey population; i.e., aged between 60-69 years old.
Materials
Initially, the head of the residency was approached and verbal permission was granted to 
display an advertisement about the forthcoming focus group (Appendix 12). Individuals who 
were interested in the advertisement were then requested to contact the author, to volunteer 
their contact details and receive an information pack. The information pack included an 
invitation letter (Appendix 13), information sheet (Appendix 14), a consent form (Appendix 
15) and a stamped addressed return envelope. A semi-structured schedule of questions were 
then utilised with participants to explore their beliefs and attitudes with regards to their 
understanding of FOBt (Appendix 16). During the course of the focus group, subjects were 
issued with information to read regarding BC (Appendix 3), the test kit instructions 
(Appendix 5) and the FOBt (Appendix 4). The purpose of this information was to initiate 
discussion within the group, and also to create a basis for comparison with studies one and
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two; where individuals had seen the BCS information. The questions addressed the themes 
found in the latter studies, i.e., fear, beliefs, knowledge and issues with the FOBt:
1. What do you know about bowel cancer screening?
2. What do you understand by the term bowel cancer?
3. What do you think are the main causes of bowel cancer?
4. Who do you think is most likely to be diagnosed with bowel cancer and why?
5. Do you think you, yourselves, are at risk of developing bowel cancer?
6. What are your first impressions about this information? (BCS -  ‘The Facts’ leaflet, test- 
kit instructions and FOBt).
7. How confident do you think you would be carrying out this test kit at home?
8. Do you think that if you received an abnçrmal faecal occult blood test result, that bowel 
cancer was still preventable?
9. In light of this discussion, are you worried or fearful about being invited to participate in 
the bowel cancer screening programme?
10. Do you intend to participate in the bowel cancer screening programme when offered?
11. Is there anything further anyone would like to add to what we have discussed today?
The focus group was digitally recorded and then transcribed.
Epistemological approach and data analysis
Focus groups are considered to be similar to semi-structured interviews, in that a group 
discussion is guided by the researchers’ questions and prompts (Willig, 2001). Therefore, the 
epistemological position remained as realist, as expectations of BCS were also expected to 
be driven by the participant’s perceptions. Once again, Braun and Clarke (2006) considered 
inductive thematic analysis to be a useful tool to analyse focus group data. Similar to studies
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one and two, the data gathered was subjected to stages of coding to draw out themes in the 
data.
Ethical considerations
All participants were made aware of the aims and objectives of the research, their right to 
withdraw, the treatment of data collected, and that participation in the study would not affect 
any current or future treatment within the NHS. Participants were also made aware that 
should the interview cause any psychological distress that they should contact the BCSP. 
Ethical approval for this study was granted by the University of Surrey Ethics Committee.
Results
Participants
Each participant satisfied the inclusion criteria, i.e., aged between 60-69 years old and was 
currently residing in a Convent in the Surrey area. There were six female participants in 
total, and the mean age was 65 years old (SD = 0.89), each of Irish origin.
Reliability
After the data had been collected, transcribed and coded, inter-rater reliability was satisfied 
by another researcher, who looked at quotes and assigned themes. Here, Kappa = 1.00 with 
p<0.001 which was another faultless score. Therefore the author was content that the themes 
had been correctly assigned.
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Themes
Two main themes emerged from the focus group data which shall be discussed as follows. 
Theme 1: Beliefs
The risk of BC was perceived to increase as individuals get older. In one instance, this meant 
that the participant felt more at risk because of their age:
“As I get older I am more likely to get something...So that’s why I thought well if 
there is something I can test, you know, yes, I am all for having the test.”
In another instance it appears the participant only considers much older individuals, i.e., 70 
years old and above to be at risk of BC:
“Well older. An older person, I do not think younger ones so much late seventies
and eighties.”
There appeared to be a gender bias with regards to who may be at a higher risk of BC. It 
was apparent that participants considered women to be at a higher risk:
“I would say that it would be more females that you would actually see on the wards 
having bowel surgery rather then men.”
There was an awareness that lifestyle contributes to the causes of BC. Participants mentioned
that people are more at risk of BC if they were ‘obese’ or had a ‘sedentaiy western lifestyle’.
Additionally there was awareness that a healthy diet lowers the risk:
“I mean you think of the immediate sort of things like dietary as one of the main
causes. You know, people not having their five a day...”
However later in the quote there appears to be a contradiction, as the participant states that a
healthy diet did not reduce risk in their mother:
“...but knowing from well my mother’s point of view, she was a real five a dayer, so 
I don’t know why. You know, she was somebody who likes her vegetables and 
things like that. So it wasn’t that.”
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In relation to perceived risk, it appears in this quote that although there is an awareness of 
family history they still perceive their risk is lower:
“I thought it was just the one off with my Mother, so it didn’t bother me after that... 
I mean I wouldn’t personally think that I am at risk and I would ever request 
screening.”
Finally when participants were asked if they intended to take part in BCS when offered, the 
response was a unanimous ‘yes’.
Theme 2: Issues with FOBt
The practicality of completing the FOBt was a real issue for the participants in this context 
as they currently reside in a residential setting whereby sharing bathrooms and toilet 
facilities is mandatoiy. In this respect they considered storage of the FOBt during sample 
collection slightly difficult as they would have to store their test kit in their bedroom:
“I think we would probably keep it in our own room, because too many people use 
the bathroom.”
They were also concerned, with regards to central heating that the test kit may get affected 
during sample collection; seeking reassurance about if this would affect the test kit:
“the heating system in this house is very warm, you know, our central heating 
system is very warm”
The focus group participants made reference to the fact that younger, i.e., under retirement 
age and still working, may have difficulty in completing the FOBt due to time constraints:
“Whereas with somebody younger, I am too busy at work and it just gets put to one 
side.”
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During the course of the group discussion, participants were asked to read information about 
BC, BCS and the FOBt. From this information, participants raised the following issues. 
Participants appeared unsure as to whether the FOBt was capable of detecting early stages of 
BC i.e., if polyps do not always bleed there may be cancers that are missed in a round of 
screening. In relation to this, participants were concerned that individuals, who were in 
receipt of a normal result, may be lulled into a false sense of security, i.e., they may still have 
polyps that were not bleeding at the time of completing the test kit:
“it may be a false negative”
Thirdly, participants felt that the number of people who were being diagnosed with cancer 
subsequent to being screened was not very high; this, they attributed, could be something to 
do with the effectiveness of the test kit. Further to this one participant went onto say:
“a colonoscopy will pick up a lot more”
This again suggests they are questioning the usefulness of the FOBt in detecting BC. This 
was questioned directly by one participant who responded:
“But it is only sixteen percent they have picked up on a two year screening thing... 
you could also say that they wouldn’t pick up the earliest ones.”
Discussion
A semi-structured schedule of questions was utilised to explore the psychosocial factors and 
barriers affecting BCS. The results demonstrated that there were two main themes which 
were beliefs and issues with the FOBt.
Beliefs
Firstly, participants perceived the risk of BC to increase as you got older. This supported the 
findings from study one and Jerant et al. (2004), although it was not clarified why
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participants perceived this to be the case. As the discussion progressed, it became apparent 
that participants thought that much older people are more at risk from BC as it was stated 
that ‘older people’ meant individuals in their seventies and eighties, which could mean 
anything up to 14 years beyond the mean age of the focus group. Therefore it is possible that 
individuals considered themselves to be at less risk than those older than them and therefore 
less likely to participate in BCS when offered. This result was similar to findings from the 
BCS and Quality Assurance of Endoscopy Conference (2005), where younger individuals 
are more likely to decline BCS because they do not perceive their risk of BC to be as great as 
older individuals. However, as Jerant et al. (2004) revealed, older individuals are more likely 
to take part as they may be presenting with symptoms of BC. Therefore, it could be possible 
that individuals perceived themselves at less risk, not so much because of their age, but 
because they have no symptoms in combination with being younger than the population they 
perceive to be at risk.
Results from this group discussion found that there was a misperception as to who is more 
likely to develop BC. Here, it was considered that females are more at risk of developing the 
disease. This disproved the findings of Weinberg et al. (2004) who stipulated women thought 
BC was a disease mostly found in men which meant they were less likely to take part. This 
was considered to be a positive finding in this setting, because not only were all the 
participants female, but they also live in a predominantly female residency which meant that 
this could prove to be a precipitator to participation in settings such as these.
Having a healthy lifestyle, i.e., active and good diet was considered to put you lower risk of 
BC. This is positive in one respect because there is awareness that a healthy lifestyle is 
contributoiy to preventing BC. However, it appeared to the author here that individuals 
perceived themselves to be at a lower risk of BC because it was only those who are ‘obese’ 
and ‘sedentary’ that are at risk. Therefore lifestyle may be conceived to be a barrier to
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screening because individuals who do not perceive themselves to be part of these groups 
perceive their risk of BC as lower and thus decline screening. There was also the 
contradiction that a healthy diet does not necessarily lower risk, possibly insinuating that this 
is not a risk factor. This could be an indication that they do not think there are ways of 
reducing risk, suggesting that there may be individuals who do not participate in other health 
behaviours, such as screening, because they do not perceive BC as preventable.
In regards to the statement made by a participant about their risk of BC following a family 
member having the disease, there appears to be an element of optimistic bias. As stated, the 
participant feels that this was a ‘one-off occurrence hence has had no desire to be screened 
for BC. It may be that they felt less at risk because they were not suffering from, and have 
not suffered from, bowel problems, as found in Kremers et al. (2000). However, this may 
have been due to two other factors found in previous research. McCaffery et al. (2001) 
proposed that a family histoiy can make people more fearful of BC, hence more likely to 
decline screening. There is a possibility that the participant may have been fearful about 
being diagnosed with BC themselves hence perceiving her risk as lower. Also, Glanz et al. 
(1999) pointed out that there can still be a lack of awareness about BC despite family history 
and thus it may be this which influences their expectations of BCS. This finding also 
conflicted with previous studies whereby those who have an inherited risk of BC are more 
likely to take part because their perceived risk is also higher (Vernon, 1997; Robb et al., 
2004).
Finally, the intention to be screened within this group was unequivocally high. However, the 
author was wary that responses to this question may have been subject to response bias; i.e., 
participants responded the way they thought they should. Furthermore, it was not determined 
which factors affected their intention to be screened. Therefore, the reasoning behind the 
intention to be screened requires further exploration.
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Issues with FOBt
In a practical light, the participants during the focus group spoke about possible difficulties 
in completing and storing a FOBt because of their shared living accommodation. However, 
this is a practical issue shared by others as outlined in O’Sullivan and Orbell (2004). Here, 
although the prospect of carrying out a FOBt was acceptable, it was the storage of the FOBt 
once commenced that was a barrier to screening. Participants in this group also discussed 
that some people may have difficulty completing the test if they have busy lives. This 
reflected findings from Kremers et al. (2000) who found that individuals declined BCS 
because of timing and convenience to them. Once again, the potential benefit of screening is 
outweighed by a particular cost to the individual, in this case time. This touched upon 
findings from other research whereby the perceived convenience of the test was paramount 
to BCS participation, i.e., if the test was perceived to be too awkward to fit into their daily 
routine, screening would be declined more readily (Vernon, 1997; ACS, 2004). These 
examples of practical issues facing the population to be screened may also prove to be a 
barrier to BCS, simply because it may lead to individuals to question whether they have the 
ability to cany out the test kit effectively.
The focus group participants all questioned the usefulness of FOBt. Their beliefs about this 
were generated predominantly from the information they were presented with during the 
session. Here, their main concern was that the FOBt may not detect the early stages of BC 
and that statistically not many BC’s were being detected via this method of BCS. This was 
worrying as Weinberg et al. (2004) found that women were more likely to accept screening 
if they thought that it would significantly reduce the risk of developing BC. Additionally, 
although not cited in previous research, they also highlighted that there may be a false sense 
of security with a normal result. This too, as with the latter, may be a considerable barrier to 
screening as some may think 'what is the point in taking part' if it does not reduce their risk 
of developing BC.
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Conclusion
The main limitation of this study was that the sample only contained females, which meant 
that the results cannot easily be generalised to a larger ageing population. This would have 
been easier to do if the sample had included males; however this was not possible due to the 
nature of the residency where the participants resided. The limitation of focus groups in this 
context is the level of sensitive information participants are happy to disclose in the company 
of their peers (Krueger, 1994). Overall, the author did not sense that any of the participants 
were uncomfortable disclosing information, but this is not to say that they did not withhold 
information they may have divulged on a one-to-one basis. It was also considered easier to 
prompt individuals in a face-to-face setting, unlike the phone interviews in study one. The 
findings were considered important as they reflected two of the themes which arose in the 
first and second study. These themes were beliefs about who was more at risk of BC and 
issues with the FOBT. Again participants did not believe themselves to be at much risk of 
BC and they had concerns about the practical issues, convenience and usefulness of the test. 
Fear did not appear in the data analysis, however this could be because the participants had 
not yet been invited formally to take part in the programme and therefore retained some 
emotional distance. Overall, the intention to be screened was high within this study; however 
it could not be determined why this was the case. To look at how these findings interrelate 
with the previous two studies discussed within this chapter, it was considered necessary to 
conduct a triangulation between the three studies.
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Part Four 
Triangulation of Barriers to screening
Methodology
The concept of triangulation is to enrich the quality of the data collected (Willig, 2001). 
Here, it has been stated that the reliability of findings can be improved by effectively 
comparing data. If these comparisons prove to be consistent, then there can be more 
confidence in the interpretation of the results. Therefore, the author chose to conduct a 
triangulation of the findings from each of the three studies detailed within this chapter. The 
main reasons for this process were to establish the observations from each of the studies, to 
see if they converged, and to reduce the impact of biases existing in each individual study, as 
suggested by Willig (2001).
As the data collected in each of the three studies was analysed utilising inductive thematic 
analysis to seek barriers to BCS, a between-methods methodological triangulation was used. 
This method, as suggested by Denzin (1978), was deemed appropriate to use because three 
different methods of data collection were utilised, namely interviews, content analysis and 
focus groups. Essentially the results from the analyses of the three studies discussed, were 
compared and contrasted to see if their findings were consistent with one another.
Results
Table 4.3 illustrates the similarities found across the three studies, detailing the themes and 
codes arising from each study. From the table, it is apparent that although there were four 
themes overall, only three were recurrent in each study; namely beliefs and issues with the 
FOBt. Each of these themes also contained reoccurring codes, which were considered by the 
author to be the main barriers to BCS.
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Discussion
The generic aim of these studies was to determine the psychosocial factors and barriers 
affecting screening, and in this respect, the aim has been achieved. The themes and codes, 
which were recurrent in all three studies, shall now be discussed.
Emotions
As illustrated in Table 4.3, emotions affected the perception of BCS. However, fear was 
recurrent in the first two studies; in relation to the information, invitation and FOBt from the 
programme as well as fear of cancer itself. In retrospect, the fear detected in these studies 
appeared to be related to the individual’s perceived severity and susceptibility to BC. In 
relation to severity, BC was considered to be a serious illness with negative outcomes, e.g., 
individuals stated that they were scared to take part and that they were concerned about the 
outcome of a cancer diagnosis. In regards to susceptibility, there seemed to be fear of 
vulnerability to BC, e.g., fi-ightened that the invitation meant that they were predisposed to 
BC. Individually these constructs, from the HBM and the PMT, were theorised to motivate 
the individual to participate in BCS, to reduce the threat of BC; as seen in chapter three. 
However, in the current studies, it appears that fear has interacted with severity and 
susceptibility to lower participation. This is thought to be because these individuals did not 
conceive the benefits of the programme to outweigh the costs, as specified by Taylor (2006). 
This finding indicates that fear is a good predictor of actual behaviour when mediated by 
severity and susceptibility. However, unlike the studies reviewed, fear has been found to 
reduce BCS participation.
Beliefs
As seen in Table 4.3, demographic, i.e., gender and age, and psychosocial factors, i.e., health 
behaviours and predisposition dominated beliefs. Gender appeared in the first and third 
study, but for different reasons. In the first study, individuals believed the opposite gender to
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be more at risk of BC, whereas in the third study, participants believed their own gender to 
be at a higher risk. The literature in chapter two outlines the research on who is most likely 
to take part in screening; it does not appear to illustrate the beliefs held by each gender in 
respect to who they think is at a higher risk. Therefore, although lowered awareness of BC 
in males (Katz et al., 2004), and lowered participation by females than any other screening 
programme (Weinberg et al., 2004) accounts for a part of these beliefs, the author felt that a 
majority of responses were biased, i.e., participants did not believe themselves to be part of a 
group at risk of BC.
Age was a theme which appeared in all thee studies. However, the content of this theme 
differed. In the first and third study, older individuals were considered to be at more risk of 
BC than younger people, whereas in study two, individuals thought they were too old to take 
part. These findings were supported by the literature outlined in chapter two, whereby older 
people were deemed to be more likely to participate, e.g., Weller et al. (2006), or less 
interested in screening as they get older, e.g., Vernon (1997). As concluded in chapter two, 
although beliefs about age are an important barrier to screening, it is a barrier which is inter­
related with others.
Health-behaviours were a theme which appeared in all three studies. It was believed that 
individuals who consume a healthy diet, take regular exercise and don’t smoke are at a lower 
risk of developing BC, which reflected results found by Robb et al. (2004). Furthermore, the 
author found it interesting that individuals who felt they were engaging in preventative 
health behaviours also saw themselves at less or no risk of BC. It appears from this, that once 
again individuals do not perceive themselves to be in an at risk group. Finally, a 
predisposition to BC was found to affect responses. In study one, it was believed that people 
are generally more at risk of BC if they have been diagnosed in the past. Unfortunately, none 
of the literature reviewed in chapter two found this per se; however, the author thought that
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this belief indicated individuals did not consider BCS to be necessary in good health, as 
found by McCaffeiy et al. (2001). However, in study three what should have been classified 
as a predisposition, i.e., FDR with BC was not; this supported Glanz et al. (1999) whereby 
lowered awareness resulted in lowered perceived risk.
From these beliefs, there appears to be underlying optimistic bias, in that individuals do not 
perceive themselves to be vulnerable because they do not belong to what they consider to be 
an at risk group. This is likened to findings whereby feeling less prone to BC may result in a 
misjudgement of risk, hence declining screening (Lu et al., 2009; Klein and Kunda, 1994).
Issues with FOBt
Table 4.3 shows that practicality, timing and usefulness were predominant problems 
individuals had with the FOBt. Practicality appeared in all three studies. The predominant 
reason for this was that individuals had difficulty with the collection of faecal samples for 
testing; whether it is in relation to completing or storing the FOBt at home. It was not clear 
from these studies if responses were driven fi-om a self-efficacy standpoint, i.e., they 
perceived sample collection and storage difficult because their confidence in carrying out a 
FOBt was lower; as found in Schroy (2002) and Brouse et al. (2003). Alternatively, it may 
just have been the result of general concern about carrying out the test as found by 
O’Sullivan and Orbell (2004).
The usefulness of the FOBt was questioned by participants in study one and three. Research 
to substantiate this finding was found in chapter three regarding response efficacy. Myers et 
al. (1998) found that lowered faith in the test reduces intention to be screened. This was of 
concern to the author, as in study three, doubts about the test were cast from the information 
being sent to the UK population; therefore indicating that the information could be 
misinterpreted by individuals resulting in non-participation. Finally, time was a theme which
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appeared in both the second and third study. In both studies, individuals specified that BCS 
may be declined because people are too busy to do the test kit, due to work or home 
commitments. This lack of convenience was supported by findings fi-om Vernon (1997). 
Either way, these factors were considered by the author to be costs which outweighed the 
benefits of the programme for these individuals. Therefore, the author concluded that issues 
with the FOBT are costs which may outweigh the benefits of the programme.
Conclusion
Overall, it is considered that these over-arching themes form predominant barriers to 
screening, which have been supported in previous literature. These themes included 
demographic and psychosocial factors, plus barriers which affect BCS participation. 
Furthermore these have been aligned, where possible, with theoretical constructs. Therefore, 
it was deemed necessary to further these results by conducting a wider-based quantitative 
study to operationalize these themes, and to discover if there were any barriers that are more 
predominant than others.
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Chapter Five
Quantitative Study
Introduction
The qualitative research discussed in chapter four, analysing both individuals experiences of 
being invited for BCS and expectations of individuals who are due to be invited or screening 
will be available to them in the future, brought to light a number of perceptions which clearly 
seem to affect an individuals decision to participate in the NHS BCSP. These attitudes 
included age e.g., BC is more common in older people and gender, e.g., females are more 
likely to be diagnosed with BC. These findings reflected those in the literature outlined in 
chapter two whereby age and gender were deemed to be specific demographic factors 
affecting BCS participation (Vernon, 1997). The other attitudes included lifestyle, e.g., 
individuals with a sedentaiy lifestyle are more likely to be diagnosed with BC, fear, e.g., 
screening will result in a BC diagnosis, optimistic bias, e.g., the risk of BC is lower due to 
lack of symptoms, response efficacy, e.g., the FOBt may not detect BC, time, e.g., not 
enough time to complete the test kit due to other commitments, and practicality, e.g., the test 
is embarrassing and messy to complete. These also supported the findings outlined in the 
literature reviews whereby lifestyle (Shapiro et al., 2001), fear (Tessaro et al., 2006), 
optimistic bias (Wardle et al., 2000), response efficacy (Mack et al., 2009), time and 
practicality (Schroy, 2002) were also thought to be factors affecting BCS participation.
From these results the author concluded that these over-arching themes required affirmation 
from a wider-based quantitative study which would effectively address if there were any 
barriers that were more predominant than others; and if so what implications lie in the way 
of targeting them hence increasing participation to BCS via FOBt. To do this, the identified 
factors affecting screening needed to be conceptualised as theoretical constructs which could 
be quantitatively tested. This being the case, the factors mentioned here would fall under the
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categories of beliefs about screening, vulnerability to BC, severity of BC, self-efficacy in 
carrying out the FOBt, response efficacy and optimistic bias.
As discussed in chapter three these constructs are aligned with the following. Rogers (1985) 
Protection Motivation Theoiy (PMT) includes severity, vulnerability, self-efficacy, response 
efficacy, psychological costs and fear. Therefore, both the assessment of the threat 
encountered and the assessment of coping, as suggested by Ogden (2000) required 
addressing here. Weinstein’s (1980) construct of optimistic bias also applies here as if 
individuals perceive their vulnerability to BC as lower than their peers for whatever reason, 
it could be said that they are employing optimistic bias. Stemming fi-om this, the author was 
also interested in another cognitive factor which may intention to participate in screening; 
fatalism. Although fatalistic beliefs were not a predominant reason for declining screening in 
study two, as discussed in chapter four, they did appear. Therefore, as previous research has 
shown that cognitive factors fatalism and optimistic bias can strongly infiuence an 
individual’s motivation to participate in BCS in comparison to psychosocial factors, a 
measure of fatalistic beliefs was deemed important to include (Wardle et. al 2004).,
To date there has been little research utilising a combination of the constructs from the PMT, 
optimistic bias and fatalism with regards to BCS. There has also been no research, to 
knowledge, of all of these constructs being utilised together to ascertain intention to be 
screened for BC via FOBt. Therefore, the overall aim of the current research was to 
effectively operationalize the constructs mentioned here, namely severity, vulnerability, self- 
efficacy, response efficacy, psychological costs, fear, optimistic bias, and fatalism to find out 
if they have a significant affect on individuals intention to be screened for BC via FOBt. The 
findings from this research would inform the design for the intervention study in chapter 
seven.
I l l
Study Four: Bowel cancer screening via a faecal occult blood test -The reasoning 
behind the intention to be screened.
Aims
• To explore individuals attitudes towards BC and BCS.
• To ascertain if the attitudes to BC and BCS significantly affect individuals intention to 
be screened in the NHS BCSP.
Methodology
Participants
During September and October 2008 publicity events were held across shopping precincts in 
Surrey, South East England, by the NHS BCSP. At each of these events, representatives 
offered members of the public information about the screening programme (Appendix 3) and 
the opportunity to take part in a short questionnaire (Appendix 17). No inclusion or 
exclusion criteria was specified prior to the questionnaires being given out, simply because 
there was a risk that this would reduce the response rate, i.e., representatives would have had 
to effectively guess individuals ages prior to approaching them.
Materials
A questionnaire was assembled by the author to address the barriers to BCS outlined in 
previous research (Appendix 17). An item addressing convenience was omitted from this 
questionnaire as participants were not requested to look at a FOBt. Therefore nine items 
were utilised in total, each based on items used in previous studies, as seen in Table 5.1. 
Here, one item was used to test each of the barriers. Each item was assigned an appropriate 
five point likert scale on which participants were asked to gauge their responses to each item. 
Participants were also asked to report their gender, and age category, i.e., under 60, 60-64, 
65-69 or 70 years old and over.
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Statistical Analyses
Four types of statistical analyses were carried out. T-tests were conducted to test significant 
differences between males and females and analysis of variance to test significant 
differences between the different age groups. Bivariate correlations and partial correlations 
were then carried out to test significant relationships between items, followed by a multiple 
regression to assess the significant contribution of variables in the model of intention to be 
screened.
Ethical considerations
All participants were requested to read a consent statement, situated at the bottom of the 
questionnaire, and to indicate their consent by ticking the boxes by the statements. These 
statements incorporated consent to the answers being used for research purposes, 
understanding that the questionnaire was anonymous, agreement that data collected may be 
shared with other researchers or interested parties, understanding that all data is held and 
processed in the strictest confidence, and in accordance with the Data Protection Act (1998) 
and finally understanding that if the questionnaire generates any questions and/or concerns 
that they should speak to their GP. This study was also reviewed by the University of Surrey 
Ethics Committee which raised no objection to it.
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Table 5.1: Barriers to screening and associated questionnaire items:
Barriers Questionnaire item (reference) Likert Scale
Susceptibility ‘My chances of developing BC in the future 
are’
(Hodgkins and Orbell, 1998)
Very low- 
Very high
Fear ‘The thought of BC makes me feel ’ 
(Hodgkins and Orbell, 1998)
Extremely 'worried- 
Not worried at all
Response efficacy 7 think that bowel cancer screening is an 
effective way o f detecting bowel cancer 
early ’
(Hodgkins and Orbell, 1998)
Strongly disagree- 
Strongly agree
Practicality 7 would feel awkward collecting stool 
samples at home, to be posted, and tested in 
a laboratory ’
(Hodgkins and Orbell, 1998)
Strongly disagree- 
Strongly agree
Severity ‘BC is a very serious illness ’ 
(Wurtele, 1988)
Strongly disagree- 
Strongly agree
Self efficacy 7 would be confident in collecting stool 
samples at home, to be posted, and tested in 
a laboratory ’
(Hodgkins and Orbell, 1998)
Strongly disagree- 
Strongly agree
Optimistic bias ‘Compared with other men and women my 
age, my chances of getting BC are ’ 
(Weinstein, 1980)
Very low- 
Very high
Fatalism ‘What do you think about the following 
statement: 'It’s not worth having the test 
because ‘what will be, will be”
(Wardle et al., 2004)
Strongly disagree- 
Strongly agree
Intention 7 intend to participate in the bowel cancer 
screening programme when offered/ 
becomes available ’
(Hodgkins and Orbell, 1998)
Strongly disagree- 
Strongly agree
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Results
Prior to analysis, the raw data was screened for outliers, normality and homogeneity of 
variance to ensure parametric assumptions were met. The data collected from two items of 
the questionnaire, relating to practicality and fatalism, were reverse-coded due to their 
negative wording.
When the completed questionnaires were collected, only the questionnaires completed by 
individuals aged 60-69 years old and over were included in the analyses, as this reflected the 
age groups being offered screening by the NHS BCSP in England. A total of four hundred 
and thirty four completed questionnaires were collected throughout the publicity events; 
three hundred and thirty four (77%) were included in the data analysis because participants 
were in the correct age range. Seventy six percent of these were completed by females, and 
twenty four percent by males. Participant characteristics can be found in Table 5.2.
Table 5.2; Participant characteristics by age
Characteristics
60-64 65-69 70+
Gender
Male 30 26 24
Female 133 93 28
Prior to an in-depth analysis of the data, the frequency of different types of response to each 
item was calculated as seen in Table 5.3.
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Table 5.3 Descriptive results for attitudes towards BC and BCS
Questionnaire item M(SD) Response N %
Susceptibility 3.09 (0.61) Very Low 5 1.5
Low 24 7.2
Unsure 251 - 75.1
High 45 13.5
Very High 9 2.7
Fear 2.62(1.06) Extremely worried 31 9.3
Very worried 161 48.2
Worried 66 19.8
Slightly worried 55 16.5
Not worried at all 21 6.3
Response efficacy 4.38(0.64) Strongly disagree 2 0.6
Disagree 1 0.3
Unsure 14 4.2
Agree 167 50.0
Strongly agree 150 44.9
Practicality 4.15 (0.77) Strongly disagree 1 0.3
Disagree 16 4.8
Unsure 23 &9
Agree 186 55.7
Strongly agree 108 32.3
Severity 4.52 (0.54) Strongly disagree 0 0
Disagree 1 0.3
Unsure 4 1.2
Agree 147 44.0
Strongly agree 182 54.5
Self efficacy 4.08 (0.63) Strongly disagree 1 0.3
Disagree 6 1.8
Unsure 29 8.7
Agree 226 67.7
Strongly agree 72 21.6
Optimistic bias 3.08 (0.46) Very Low 0 0
Low 15 4.5
Unsure 284 85.0
High 27 8.1
Very High 8 2.4
Fatalism 4.68 (0.57) Strongly disagree 1 0.3
Disagree 3 0.9
Unsure 4 1.2
Agree 84 25.1
Strongly agree 242 72.5
Table 5.3 revealed that participants were unsure about their susceptibility to BC, and whether 
their chances of getting BC were higher or lower than their peers. However, results for the 
other items were more definite, i.e., fear of BC, response efficacy and perceived severity of 
BC was higher. Additionally, participants’ perceived awkwardness in completing a FOBt 
and their fatalistic beliefs about BC were also higher.
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The author was also interested in finding out the overall percentage of individuals who 
reported that they intended to be screened when invited. It was found that 0.3 % strongly 
disagreed, 0% disagreed, 2.1% were unsure, 38% agreed and 59.6 % strongly agreed.
Figure 5.4: Graphical representation of responses to intention
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An independent samples t-test was conducted initially to compare the scores for the 
questionnaire items for males and females. There were significant differences between the 
two groups responses which are detailed in Table 5.5
Table 5.5: Means and standard deviations for attitudes to BC and BCS for males and 
females.
Questionnaire Item Males Females t(332) P partial eta 
squared
Response efficacy 4.20 (0.70) 4.44 (0.61) -2.96 p=.003 -0.001
Severity 4.43 (0.59) 4.56 (0.52) -1.94 p=.053 -0.001
Self efficacy 3.80 (0.74) 4.17(0.56) 4.78 p<.0005 0.01
Fear 2.25 (0.91) 2.74(1.1) -4.01 p<.0005 -0.01
Practicality 3.79 (0.77) 4.36 (0.73) -5.01 p<.0005 -0.01
Fatalism 4.42 (0.72) 4.77 (0.49) -3.95 p<.0005 -0.01
Intention 4.34 (0.55) 4.64 (0.56) -4.21 p<.0005 -0.01
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The findings in Table 5.5 demonstrate that there were significant differences between males 
and females with regards to the responses to all bar one of the questionnaire items; however 
the effect sizes were considered to be small (Cohen, 1988). Females perceived the detection 
of the FOBt to be better, would feel more confident in carrying out the FOBt, and thought 
BC was a more serious illness than males. Furthermore, females found the thought of BC 
more worrying than males, would feel less awkward than males carrying out the FOBt, were 
less fatalistic with regards to BC, and their intention to be screened was higher than males.
A one-way multivariate analysis of variance (MANOVA) was used to look at the differences 
between the three age groups. Land and Shepherd (1988) stipulate that ANOVA tests are 
robust enough to manage continuous data. The MANOVA found significant differences 
between the three age groups on the questionnaire item responses, F (18,646) =3.40, 
p<.0005; Wilk’s Lambada=.83; partial eta squared=.09. However, the effect size was 
considered to be small, as age only accounts for nine percent of the variance (Cohen, 1988). 
When each of the age groups was considered in turn a Bonferroni adjustment was added 
providing an alpha level of .017. The results of this test showed a significant difference 
between age groups with regards to intention to be screened for BC, practicality of 
completing a FOBt and fatalistic belief with regards to BC as shown in Table 5.6.
Table 5.6: Means and standard deviations for attitudes to BC and BCS for age groups.
Questionnaire Item
60-64 65-69 70+ F(2,331) P
Intention 4.66 (0.59) 4.54 (0.52) 4.33 (0.55) 7.34 p=.001
Practicality 4.26 (0.77) 4.18(0.67) 3.75 (0.86) 9.15 p<.0005
Fatalism 4.79 (0.42) 4.72 (0.49) 4.27 (0.91) 18.40 p<.0005
A Tukey HSD test revealed that there were significant differences between the 60-64 and 
70+ year olds for intention. The 70+ year olds also differed to the 60-64 and 65-69 year olds 
on practicality and fatalism. Therefore it appears that the intention to participate in BCS
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decreases as age increases. Secondly, practicality or awkwardness in carrying out a FOBt 
and fatalism both increase as age increases.
Pearsons product moment correlations was computed to explore the relationships between 
questionnaire items; see Appendix 18. However, due to the findings from the t-test and 
MANOVA, partial correlation was deemed necessaiy to control for age and gender of 
participants. The significant correlations for this are detailed in Table 5.7. On comparing the 
results from the Pearsons product moment correlation with the partial correlation, it was 
apparent that age and gender had little effect on the relationships between questionnaire 
items.
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The partial correlations revealed that there were positive relationships, of varying strengths, 
between many of the variables. According to Cohen (1988), small to medium strength 
relationships were found between the following variables:
• Higher susceptibility was related to higher perceived severity, higher fear, lower 
awkwardness and lower fatalistic beliefs.
• Higher response efficacy was related to higher perceived severity and self efficacy, 
lower optimistic bias, lower awkwardness and lower fatalistic beliefs.
• Higher perceived severity was related to higher susceptibility and response efficacy, 
lower optimistic bias, higher fear, lower awkwardness and lower fatalistic beliefs.
• Self efficacy was related to higher response efficacy, lower optimistic bias and fatalistic 
beliefs.
• Optimistic bias was related to higher response efficacy, severity, self-efficacy, fear and 
lower awkwardness.
• Higher fear was related to higher perceived susceptibility, severity, optimistic bias and 
lower awkwardness.
• Lower perceived awkwardness was related to higher response efficacy, severity and self- 
efficacy, lower optimistic bias, fear, and fatalistic beliefs.
• Fatalism was related to higher perceived susceptibility, response efficacy, severity, and 
self-efficacy, plus lower awkwardness.
Strong relationships were found between optimistic bias and susceptibility, and between self- 
efficacy and practicality. This meant that lower optimistic bias was correlated with higher 
perceived susceptibility, and higher self-efficacy was correlated with lowered perceived 
awkwardness of the test. Finally, intention to be screened was related to all of the eight 
questionnaire items suggesting that each of the items affected participant’s intention to be 
screened for BC.
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To find out which of the questionnaire items had the most effect on intention to be screened, 
multiple regression was utilised. Using the enter method, a significant model emerged 
whereby F (9,324) = 14.70, p<.0005; R^=0.29. The results are summarised in Table 5.8.
Table 5.8: Results from multiple regression - relationship between predictor variables 
and intention to be screened for BC:
Predictor variable Beta P Part correlation coefficient squared
Gender 0.06 0.20 0.003
Susceptibility -0.08 0.17 0.004
Response efficacy 0.13 0.01 0.01
Severity 0.09 0.08 0.01
Self-efficacy -0.02 0.66 0.02
Optimistic Bias 0.14 0.01 0.01
Fear 0.13 0.01 0.01
Practicality 0.28 <.0005 0.04
Fatalism 0.15 0.01 0.02
From Table 5.8 it is apparent that the significant predictors of intention are response 
efficacy, optimistic bias, fear, practicality and fatalism. The part correlation coefficient 
squared revealed that response efficacy, optimistic bias, and fear accounted for one percent 
each of intention to be screened, whereas fatalism accounted for two percent and practicality 
for four percent (Pallant, 2005). Therefore, practicality had the most significant effect on 
intention to be screened, suggesting that individuals may decline screening on the basis of 
the perceived awkwardness of canying out a FOBt. Furthermore, the beta values for the 
significant results reveal the direction of the relationship between predictors and intention 
(Field, 2009). Here it is apparent that intention increases when response efficacy and fear are 
higher and optimistic bias, perceived awkwardness and fatalistic beliefs are lower.
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Discussion
The aims of this study were to explore individual attitudes towards BC and BCS and to 
ascertain if these attitudes significantly affected an individuals intention to be screened in the 
NHS BCSP. When asked if they ‘'intend to participate in the bowel cancer screening 
programme when offered /  becomes available ' a majority of participants responded that they 
agreed or strongly agreed, which contrasts with the UK Pilot whereby only sixty percent of 
the population participated in BCS (O’Sullivan and Orbell, 2004). However, even though the 
intention was high, which could suggest participants would be more willing to take part in 
screening (Conner and Sparks, 2005), there were many factors to take into consideration.
The results from the independent samples t-tests and the one-way MANOVA highlighted 
that there were many significant differences between the genders and the different age 
groups. The results from the partial correlations demonstrated that there were significant 
relationships between questionnaire items when controlling for age and gender. To identify a 
model, a regression analysis was performed to address the strength of these significant 
relationships. These analyses identified five particular items or barriers to screening, which 
significantly affected the intention to be screened, i.e., practicality, response efficacy, fear, 
fatalism and optimistic bias.
Gender
In relation to gender, males appeared to have less favourable responses to the questionnaire 
items than females. The males’ perception of the detection of the FOBt was worse and they 
would feel less confident in carrying out the FOBt. The results also implied that males 
perceived BC as a less serious illness; however the results for this were only approaching 
significance. Moreover males found the thought of BC to be less worrying, would feel more 
awkward carrying out the FOBt, were more fatalistic and their intention to be screened was 
lower. Differences in responses to these items will be discussed in due course. Overall,
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gender has been highlighted in previous research as a key barrier to screening for males 
(O’Sullivan and Orbell, 2003). This was thought to be because this is the first screening 
programme available to men; hence men may not want to participate as they have never been 
targeted before. In this respect, the present study invited the thoughts and attitudes of males 
in Surrey, who may never have even heard about the BCSP or BCS. This was considered to 
be both positive, i.e., there may have been no preconceptions which may have affected their 
responses, but also negative in that their responses may have been biased because they have 
not been requested to take part in a screening programme before. Gender was a theme which 
appeared in both the first and third study, detailed in chapter four. However, it was the 
findings from the first study to which parallels can be drawn, as participants felt that the 
opposite sex were more likely to develop BC than they were. Therefore, it could be that 
despite the novelty of the programme men do not feel there is a necessity to participate in 
screening because they think females are at a higher risk. It is thought that the latter factors 
may have moderated responses from males.
Age
The implication that age affected intention was identified when significant differences 
between older adults, i.e., those aged 70 years old and over compared with the younger 60- 
64 and 65-69 year old age adults, were found. Older adults reported that they would feel 
more awkward canying out a FOBt, were more fatalistic with regards to BCS and their 
intention to participate in BCS was lower than for 60-64 and 65-69 year olds. These points 
shall be examined in more detail later in the discussion. Generally, research has found age to 
be a barrier to screening; however findings have been contradictory. For instance, increasing 
age has been found to increase perceived risk, hence participation (Weller et al., 2006; 
loannou et al. 2003), whereas in other studies participants believed older individuals to be 
more at risk (Tong et al., 2000; Robb et al., 2004). The latter was reflected in the beliefs of
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participants in studies one and three, whereby older individuals were also considered to be at 
greater risk.
Therefore, it was the findings fi-om the second study which appeared to be supportive of the 
present research. Here it appears that individuals do not want to take part as they approach 
70 years of age, therefore similar conclusions could be drawn. Firstly, the publicity event 
advertised that the screening programme automatically called individuals between 60-69 
years old, and that people exceeding that age could request screening. Again, it is possible 
that older individuals saw this age range and assumed that they did not need to take part 
because they were currently, or soon would fall out of that age category; possibly assuming 
that their age group is at less risk. Alternatively, older individuals may perceive themselves 
to be at less risk as suggested by Robb et al. (2004). This may be because they are not 
currently experiencing any problems, nor have done in the past as found by Jerant et al. 
(2004).
There was limited research from chapters two and three from which to draw comparisons 
with, with regards to intention to participate in BCS; as a majority of studies considered 
facilitators and barriers to screening in populations who actually participated or declined 
BCS. Jerant et al. (2004) found that participation to BCS increases with age. This was found 
to be the case as an aging population was believed not only to realise that their risk is higher, 
but also that they tend to be experiencing more symptoms, e.g., bleeding from the rectum, 
than their younger peers. This was not the case in the present study, whereby it was found 
that intention to be screened decreased with age. This appears to support Sandman and 
Simantar (2000) who suggested that fewer people take part in BCS as they get older. This 
was also the case in Robb et al.’s (2004) paper. Here it was specified that the factor of 
perceived risk of BC decreases with age; which has been supported by the present study’s 
findings. The reasoning behind this was that older individuals may hold misperceptions
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about BC resulting in non-participation, something which requires addressing in future 
interventions.
Severity
According to the results, males did not perceive BC to be as serious an illness as the female 
participants did. Although the reason for this was not clear, and the result was only 
approaching significance, tentative conclusions were still considered. Research, discussed in 
chapter two, regarding the severity of BC does not seem to reflect significant gender 
differences. However, the results from the present study do seem to agree with those found 
with regards to perceived risk. Perceived risk has been found to be higher in individuals who 
consider BC to be a more serious illness (Wardle et al., 2000). Therefore the present study 
appears to reflect the findings of Robb et al. (2004) who suggested that males were less 
likely to participate in BCS than women because they perceive that they are at a lower risk of 
developing BC. An alternate reason for perceiving BC as a less serious illness is presence of 
family history or knowing someone who has been diagnosed with BC. Chappie et al. (2008) 
found that this was the case whilst conducting interviews with individuals who had 
participated in the NHS BCSP; individuals were more likely to have taken part if they had a 
family history and were concerned about the serious implications of not doing so.
Sieverding et al. (2008) explored this relationship further with regards to gender differences 
and found that men did not appear to be as well informed about their family history. If this 
was the case with the present study, then it implies that male participants regard the severity 
of BC as lower because they perceive their risk as lower, yet may be unaware of their risk 
level. The results of the partial correlation in relation to severity support the literature 
outlined in chapter three; i.e., increased severity increases intention to be screened. In the 
current study elevated severity was related to higher susceptibility, response efficacy, and 
fear, plus lowered awkwardness which appears to support the PMT (Rogers, 1983).
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Increased perceived severity was also related to lower optimistic bias and fatalistic beliefs. 
These results are explained by literature outlining that optimistic bias results in a lower 
perceived threat of BC (Klein and Helweg-Larsen, 2002), and fatalistic beliefs result in the 
avoidance of cancer information (Miles et al., 2008); both of which can result in non­
participation (Wardle et al., 2000; Kremers et al. 2000).
Self efficacy
The results showed that males displayed lower self-efficacy than females when considering 
canying out the FOBt. Schroy (2002) also found that a lack of self-efficacy or confidence in 
carrying out a FOBt lead to non-participation; however, there were no differences found 
between genders. On the other hand Myers et al. (1994) found that males are less likely to 
participate because they tend to lack self-efficacy in canying out a FOBt. Therefore, there 
may be a link here between self-efficacy and the modality of screening opted for by males. 
As before, the choice of BCS could simply be because males perceive the FS to be a more 
reliable method to detecting BC (Evans et al., 2005). However, it may also be the case that a 
procedure conducted by a medical practitioner is sought because men have a lower 
confidence in canying out a FOBt themselves.
It could also be concluded from this that men have lower confidence in canying out the 
FOBt because this is the first screening test they may have been invited to take part in. Once 
again, it is deemed necessary to differentiate these factors in a study where participants see 
the FOBt, so that an intervention can seek to address them. The results also found a weak 
relationship between self efficacy and response efficacy which supports the PMT. This 
implies that confidence in carrying out a FOBt is reinforced by the perceived effectiveness of 
the test. Self-efficacy was also related to optimistic bias and fatalistic beliefs suggesting that 
confidence in carrying out a test is strengthened by a realistic perception of risk. There was 
also a strong relationship found between self efficacy and practicality, suggesting that if
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participants were more confident in canying out the test, they would not perceive the test as 
awkward to perform. However, more investigation into this relationship is warranted as there 
was no literature outlined in chapters two and three to support this suggestion.
Response efficacy
In the current study males were found to have lowered response efficacy in comparison to 
females. Reviews of research in this area, such as Evans et al. (2005) have looked at gender 
differences that occur in BCS, i.e., in relation to the type of screening method utilised and 
why these gender differences exist. Here, it was stated that men were less likely to complete 
a FOBt than women, but were more likely to opt for the invasive sigmoidoscopy procedure. 
The limitation of this review is that it does not seek to identify why men favour one modality 
of screening over another. For example, men may favour the sigmoidoscopy procedure as 
they feel that it is more likely to detect the early signs of BC. However, the authors go on to 
highlight evidence for why men are less likely to participate in BCS than women. This is 
thought to be because men are often less convinced about the benefits of preventative health 
behaviours, they are for instance less likely to visit a GP for preventative advice and 
consultation. This in itself suggests that men may not see the point of screening unless they 
are experiencing symptoms. As with the present research, the reasoning behind the attitudes 
towards FOBt response efficacy is not known, hence future research should hope to identify 
this reasoning to help increase participation.
The results also revealed that higher response efficacy was related to higher perceived 
severity and self efficacy, and lower perceived awkwardness which appears to support the 
PMT as outlined previously. Higher response efficacy was also related to lower optimistic 
bias and fatalistic beliefs, as discussed elsewhere. Response efficacy was the fourth most 
significant effect on intention to be screened; i.e., higher response efficacy resulted in more 
intention to be screened. During focus groups discussing knowledge of, and barriers to, BCS
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Tessaro et al. (2006) found that participants appeared to have little knowledge about the 
FOBt compared to a colonoscopy, and this had a direct effect on their attitude to its 
usefulness. Here, up to a quarter of participants claimed that they had never heard of a FOBt 
and that this was a significant barrier to screening. Similarly, it is considered that this may 
also be the case in the present study. Participants here were basing a judgement upon what 
they perceived the FOBt to be; and this decision may have been made on limited knowledge. 
As discussed elsewhere in this chapter, this may also be the case for individuals taking part 
in the NHS BCSP; they too may be making a judgement about the usefulness of the FOBt 
based on limited, or even no information.
Questions about the response efficacy of the FOBt appeared in both the second and third 
qualitative study. In the second study there appeared to be a lack of confidence in the FOBt 
ability to detect BC at an early stage. Contrary to the present research individuals came to 
this conclusion based on the literature they received about the programme. This reaffirms the 
question of whether the participants in the present study had a lack of awareness of BC and 
BCS, which led them to question the response efficacy of the test. In study three, participants 
again questioned the usefulness of FOBt based on limited information. The implication from 
this is that regardless of the level of information individuals receive, they still have doubts as 
to the usefulness of the FOBt. Thus, the information provided to individuals in the screening 
population needs to address this issue with care.
Fear
Fear has been deemed in recent research to be a barrier in itself to BCS, as males have 
reported they did not want to be screened because they were fearful something would be 
found (Tessaro et al., 2006). However, in the present study, males believed the thought of 
BC to be less fear inducing than females. One would hope from this that they would be more 
likely to participate in BCS as they are less fearful of possible BC detection. Unfortunately,
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this did not appear to be the case as intention to be screened was lower in males. However, in 
Evans et al. (2005) review, an interesting factor was raised with regards to particular gender 
characteristics affecting participation in BCS. In particular it was suggested that men often 
conform to a gender role of strength and control which makes them less likely to obtain 
advice for preventative health behaviours, as mentioned before. If this is considered in 
relation to fear, it could be concluded the males in the present study responded to the item 
about fearing BC, less strongly than the female participants to conform to this stereotype, 
simultaneously lowering their intention to be screened. Whether this portrayal of perceived 
fear of BC can then be trusted is unknown. For instance, are they responding less strongly to 
the question to conform to a gender role, or do they actually perceive their fear of BC as 
less? Once again, this is an issue which needs further investigation.
The results also found that higher fear was related to higher perceived susceptibility, 
severity, and lower optimistic bias as discussed elsewhere in this discussion. The relationship 
between elevated fear and lowered perceived awkwardness is thought to be the result of the 
threat of BC outweighing the costs of taking part, as outlined by the PMT. Fear was the third 
most significant effect on intention to be screened; increased fear of BC results in more 
intention to be screened. This result was contrary to findings outlined in chapter three, 
whereby greater fear was found to be a barrier to screening (Tessaro et al., 2006). Fear was a 
theme which appeared in both the first and second study discussed in chapter four, and once 
again greater fear was a barrier to being screened. It is thought that the results for fear in this 
study may differ from those in studies one and two as individuals were invited to take part in 
the BCSP, whereas the participants in this study were not. This suggests that fear could be 
resultant for different reasons. In studies one and two it seemed that fear was the result of 
receiving the information and test from the programme, as well as fear of cancer itself. 
Unfortunately, in the current study, the source of the fear could not be determined. As 
previous literature suggests fear can stem from many sources, i.e., the thought of BCS
130
outcomes, e.g., BC diagnosis, the possibility of having a colostomy bag after surgery, or 
even fear of the unknown (Broughton et al., 2004; UK Colorectal Cancer Screening Pilot 
Group, 2003a; McCaffery et al., 2001). However, as the cause of fear could not be attributed 
here the results implicate the need to address the effect of fear further.
Fatalism
Past research incorporating fatalism in relation to both age and BCS is limited and therefore 
it was difficult to draw direct comparisons with the present research findings. Niederdeppe 
and Levy (2007), as discussed in chapter three did find that the fatalistic belief ‘everything 
causes cancer’ was significantly associated with age. However, there was only a negative 
association with the statement that ‘there’s not much a person can do to lower their chances 
of getting cancer’. If it is considered for a moment that participants in the present study with 
higher fatalistic beliefs also believed that everything seems to cause cancer, one could 
assume that they believe that there is little that can be done to prevent it. The question in the 
present study relating to fatalism asked if participants held the attitude that there is no point 
in BCS participation, as they cannot control whether they develop BC or not. Once again, 
this demonstrates the belief that prevention is pointless. Therefore, there is a need to identify 
why this is the case. Is it for example because of fear, i.e., an abnormal result from the FOBt 
may equate to a death sentence and therefore induces a fear of taking part, or could it be 
related to denial, i.e., if I have cancer I would rather not know (McCaffery et al., 2001)? 
Finally, could it be that older individuals who hold these beliefs perceive their risk as lower 
because they have not had any bowel problems in the past and are currently asymptomatic? 
Further research is deemed necessary to identify why these beliefs exist in older adults so 
that an intervention can be developed to address them.
The results also showed that lower fatalistic beliefs were related to higher perceived 
susceptibility, response efficacy, severity, and self-efficacy, plus lower awkwardness. Once
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again, the constructs related to lower fatalistic beliefs support the PMT. This suggests that as 
fatalistic individuals feel the prevention of BC is not in their control (Straughan and Seow, 
1998), they are more likely to follow maladaptive coping. More investigation is warranted to 
identify this link. Fatalism was the second most significant effect on intention to be screened, 
i.e., lower fatalistic beliefs result in a higher intention to be screened. According to 
Niederdeppe and Levy (2007) individuals with fatalistic beliefs may be at a higher risk of 
developing cancer because of the way in which these beliefs interact with their lack of 
preventive health behaviours, e.g., not smoking etc. Similarly, Michielutte, Dignan, Sharp, 
Boxley and Wells (1996) found that fatalism significantly reduced participation in 
preventative behaviours. The present research indicates that higher fatalistic beliefs result in 
lower intention to participate in FOBt suggesting that participants who felt that developing 
cancer was out of their control may go on to decline early prevention through screening. As 
suggested by both Niederdeppe and Levy (2007) and Michielutte et al. (1996) it appears that 
only education in targeting this group may increase their participation in such screening 
programmes. It is also felt that even if the individuals underlying beliefs cannot be shifted, 
and that they truly believe there is nothing they can do to prevent BC, by stressing the 
benefits of early detection it may prompt some of this group to participate because they want 
to prevent a possible BC from getting worse. In this way, maybe an intervention addressing 
early response efficacy rather than prevention may be useful in this group.
Optimistic bias
The results revealed weak relationships between optimistic bias response efficacy, severity, 
self-efficacy, and fear as discussed elsewhere in this chapter. However, a strong relationship 
was found between optimistic bias and perceived susceptibility. This supported findings 
from Klein and Kunda (1994) concluding that optimistic bias results in less precautions 
being taken as perceived risk is low. This supports findings from the qualitative studies 
whereby individuals appeared to perceive their risk to BC as lower because they considered
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themselves not to be part of a group at risk. It also supports literature indicating that the two 
constructs overlap (McCaffery et al., 2001). Optimistic bias was the fifth predictor of 
intention. Here it was considered that the higher the optimistic bias, the more likely 
screening would be declined. This supports previous research whereby optimistic bias 
reduces intention to be screened (Lu et al., 2009). It is not known from the responses why 
individuals would hold these beliefs in relation to BCS; however, it is thought that such 
individuals may have misjudged their risk of BC resulting in lower intention to be screened 
(Klein and Kunda, 1994; Lu et al., 2009).
Practicality
The practical elements of carrying out a FOBt have also been found to be a barrier to BCS, 
as seen in chapter two. According to O’Sullivan and Orbell (2003), males did not appear to 
differ from females in their attitudes to carrying out a FOBt; they found that the practical 
elements were not believed to be a barrier to BCS. The present study did not support these 
findings as males were found to consider canying out a FOBt to be more awkward than 
females. This supported the practicality findings in all three qualitative studies. Individuals 
in each of the studies reported that they had difficulty with the collection and storage of 
faecal samples for testing. Once more, it was not clear from these studies collectively if 
responses were driven from a self-efficacy standpoint, whereby a lack of confidence in 
carrying out the FOBt may have led to a biased opinion of carrying out the FOBt, or whether 
this was perceived as a response cost.
As specified earlier, the questionnaire responses in the present study were generated from a 
population who may not have had any, or little knowledge about BC or BCS. The question 
regarding the practical element of carrying out a FOBt asked if respondents would feel 
awkward collecting stool samples for analysis. At this point, they may not have had any idea 
about how this sampling collection was carried out, i.e., in pots etc, hence were basing their
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opinion on something they knew very little about. This could be viewed positively, because 
you are getting an automatic response on how people feel about handling their own faeces. 
However, because respondents may not have the knowledge or awareness of what a FOBt 
involves, they may have a biased response to the question, as they are envisaging a task far 
harder than is actually necessary. In relation to the latter, once again, the attitudes conveyed 
by males in this study could be due to an assumption they are making about the test, i.e., it is 
distasteful, embarrassing etc. However, their response may also be based upon their self- 
efficacy, i.e., their perceived confidence in carrying out the test may affect how awkward 
they think the test may be to carry out.
In the present study, the results showed a significant relationship between practicality and 
age, in that the acceptability of the FOBt decreased with age. However, studies discussed in 
chapter two which looked at psychosocial influences on older adults to participate in BCS 
(Wardle et al., 2000) and even at different methods of sampling for FOBt (Ellis, Wilson, 
Holder and McManus, 2007) did not find this to be the case. In both of the latter studies age 
was not a factor significantly related with the practicality of carrying out a FOBt, although 
the ages only ranged from 50-69 years old, which could suggest that age may have been a 
significant factor in an older age group, like the present study.
Practicality was the most significant effect on intention to be screened, i.e., higher perceived 
awkwardness lowered intention to be screened. This finding reflected the results found in 
previous research in this area. Kremers et al. (2000) found that individuals have declined the 
FOBt because of timing and convenience, Schroy (2002) reported that the FOBt was deemed 
as embarrassing or distasteful; both resulting in non-participation. O’Sullivan and Orbell 
(2003) found that general concerns about the FOBt were raised around the handling of faeces 
and the FOBt storage. Furthermore, both the second and third qualitative studies, and past
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research, have suggested that BCS may be declined because people do not have time to do 
the test kit (ACS, 2004).
The issue with the current research is knowing exactly which of the latter, if any, contributed 
to the participant’s attitude towards carrying out a FOBt. As outlined earlier, participants 
may not have been aware of what was involved with the FOBt procedure, and hence made a 
snap decision on what they thought may be involved. It may be considered here that this 
finding is difficult to generalise to the population of individuals currently being invited to 
take part in the NHS BCSP. However, it is important to remember that there may be 
individuals invited by the programme who decline screening prior to receiving the test kit, 
which arrives after the initial invitation letter. They too, for whatever reason, may not be 
aware of what the test kit involves or how long it takes to complete, hence basing their 
decision to decline screening upon a perception of what is involved. It is felt that these 
factors need to be addressed in some detail to find out what aspects of carrying out the FOBt 
are the most troublesome, and whether these are affected by seeing the FOBt, so that they 
can be targeted in the intervention study.
Limitations
The limitations of this research predominantly lie in the way in which participants were 
recruited for the study and the questionnaire items that were utilised to gauge the reasoning 
behind intention to be screened. The sample achieved throughout the publicity events was 
not a true representation of the population the research was addressing. The sample was 
biased in the respect that more females took part than males; however this could have been 
due to a higher amount of females shopping in the precincts at the time of recruitment. Also, 
although gender and age of participants was recorded, the ethnicity of participants was not 
recorded; hence any ethnic differences in responses were not differentiated. The reason why 
the author chose not to monitor ethnicity was because in the Surrey areas incorporated in the
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publicity events, the population is dominated by up to ninety three percent white British 
population (National Statistics Census, 2001). Therefore, it was not considered to be a useful 
question to include.
Selection bias may have occurred during the recruitment of the participants. The 
representatives at each of the publicity events were required to give out BC information, in 
the form of a leaflet, to both ‘apprOachers’, i.e., individuals who approached the publicity 
stand to actively request information, and ‘non-approachers’, i.e., individuals who walked 
past the publicity stand within an approximate one metre zone. In both cases, individuals 
who were given an information leaflet were offered the opportunity to complete the research 
questionnaire. Unfortunately, the representatives could not differentiate between the 
approachers and non-approachers due to the volume of individuals in the vicinity at any one 
time. It was for this reason that the non-response rate was also approximated. Furthermore, it 
was very difficult for a response rate to be calculated due to the volume of people walking 
past the publicity stands at any one time. It was estimated, from a busy mid-week lunch hour 
that two hundred and thirty adults had walked past the publicity stand without interest. 
However, it is unknown from this how many of those individuals had repetitively walked 
past the stand, and were still counted. Also, the volume of people altered dramatically at 
different times of the day, on different days of the week and in different shopping precincts; 
hence this approximate response rate is not considered to be wholly reliable.
In relation to the questionnaire items, it was considered by the author that the questionnaire 
was limited. Each item addressed a particular barrier to screening. It was understood from 
the outset that not only may the item not fully address the barrier in just one question, but 
that the data generated from the questionnaire in itself would be limited, and this would 
affect the conclusions drawn. For instance, although practicality was found to be a main 
predictor of screening, no conclusions could be drawn as to what participants felt awkward
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about. Furthermore, the direction of relationships between correlated items could not be 
determined, e.g., it was not known if self-efficacy affected awkwardness or vice versa. The 
questionnaire also did not take into account other mediating factors which may underlie 
individuals’ responses to the questions. An example of such factors would be a family 
history of BC, i.e., a participant’s response to the question regarding perceived severity of 
BC may be very different depending upon whether they have a family history of BC. 
Additionally, as family history was not reported, it was not known if the susceptibility was 
perceived or actual (Macrae et al., 1984). Finally, although conclusions were drawn from the 
data generated from these items with regards to participation, it is deemed important to 
remember that although participants may intend to be screened when offered, this does not 
guarantee participation. For instance, a participant here may have every intention to take 
part, but when invited for screening may decline, e.g., because they do not have time, or the 
FOBt is too embarrassing to complete. However, in a positive light, those who reported that 
their intention to be screened was lower may be more likely to take part, e.g., because they 
hear about a friend who has been diagnosed with BC.
However, it is deemed important at this point to reiterate to the reader, on both counts, why 
these limitations were considered to be outweighed by the strengths of the sampling and the 
questionnaire design. The questionnaire was being delivered in an environment where 
convenience sampling was the most effective method of participant recruitment to increase 
the response rate. There were also time constraints, i.e., individuals out shopping would not 
want to spend longer than ten minutes completing a voluntary questionnaire. Therefore, the 
questionnaire had to be short and simple to complete in order to attract the respondents. 
Finally, as referred to in the qualitative studies in chapter four, it was felt that individuals 
often provide a more honest and realistic response to questions which require an instant gut 
reaction than they do over a series of questions in the same area. Therefore, one item for
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each barrier was deemed, in this scenario, to be the best way to gauge individuals instant 
reaction to screening barriers and the effect these had on their intention to be screened.
Conclusion
The strengths of this study lie firstly in its identification of particular populations who 
require further specific investigation, i.e., males and older adults. With both of these 
populations it is apparent that they hold particular attitudes towards BC and BCS which 
require addressing. Although this study was only able to hypothesise why these attitudes 
were held, due to the limitations of the questions utilised, it was apparent that findings not 
only reflected the results in current research but found that gender and age specific research 
was quite limited. In regards to the five items which significantly affected the intention, not 
only was there a significant relationship between practicality, response efficacy, fear, 
fatalism and optimistic bias and intention to be screened, but a significant model arose 
identifying practicality as the key predictor of intention, implicating that it could be a barrier 
to BCS.
Secondly, the results have shown support for the PMT as it has been found, on the whole, 
that increased severity, susceptibility, fear, response efficacy and self efficacy related to a 
higher intention to be screened. However, as specified during the discussion, only two of the 
PMT constructs appear to be have been supported as predictors of intention to be screened, 
i.e., fear and response efficacy, whereas the remaining constructs were not; i.e., 
susceptibility, severity and self-efficacy. However, severity and susceptibility have been 
previously found to be weak predictors of intention, and the results for self efficacy may 
have been the result of participants not seeing the FOBt.
As practicality was found to be the strongest predictor of intention, this area requires further 
investigation; i.e., to explore the practical elements of a FOBt which may decrease intention
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to be screened. Therefore, the next study aims to operationalize the constructs of the PMT 
once more, but this time in the form of an intervention. Prior to this, a more in-depth 
examination of how FOBt’s affect screening participation was deemed necessary. Therefore, 
a systematic review of literature to identify this area specifically was carried out, as detailed 
in chapter six.
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Chapter Six 
Systematic Review
Introduction
Chapter five concluded that the perceived awkwardness of carrying out a FOBt was a major 
barrier to screening, but no conclusion was drawn as to why this was the case. This was 
because there was only one item affirming the awkwardness perceived by participants. 
Furthermore, study four was only able to identify intention to be screened, not actual 
participation. Therefore the author was interested in why the test was perceived as awkward 
and how this may affect actual BCS participation.
To address the awkwardness of the FOBt, the author decided to conduct a systematic review of 
literature identifying the affect of a FOBt on screening participation. Whilst researching this 
area, the author found there are different types of FOBt, each of which have been found to 
have an effect on screening participation. Therefore, a review was carried out to explore these 
effects. From this the author was interested in finding out how different types of FOBt were 
perceived in recent research and whether the type of test would make any difference to the 
participation rates.
Review: How do non-invasive bowel cancer screening tests affect participation rates- a 
comparison between guaiac-based and immunochemical- based tests.
Research Question:
Population- adult population eligible for BCS 
Intervention- immunochemical FOBt’s 
Control- guaiac FOBt 
Outcome-participation rate
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Background
FOBt’s have been shown to reduce BC mortality rates by detecting BC at an early stage 
(Halloran, 2009). A FOBt detects traces of occult blood which may be an early indication of 
polyps inside the large bowel wall which are bleeding. For many years the commonest form 
of FOBt was a guaiac based test (GFOBt), whereby individuals were requested to apply 
small samples of bowel motion onto a test card with the aid of cardboard spatulars (Halloran, 
2009). Recently, researchers have sought to improve the sensitivity and specificity of the 
FOBt by developing immunochemical versions of the FOBt (IFOBt), which have been 
shown to be more specific and sensitive to detecting blood than the guaiac predecessor 
(Launoy , Bertrand, Berchi, Talbourdet , Guizard , Bouvier and Caces, 2005; Halloran, 
2009). However, regardless of the merits of a particular test type, the reduction of BC 
mortality also depends heavily upon the participation of individuals in BCS (Weller et al., 
2009).
Barriers to BCS participation have been well documented, as seen in chapters two and three. 
However, less research has been conducted into the issues directly related to completing a 
FOBt which may be a barrier to screening in itself. Studies have shown that individuals are 
more reluctant to participate in BCS if they perceive the practicality of completing a FOBt as 
awkward (Schroy, 2002). For instance, if the test is considered embarrassing or distasteful, 
or individuals do not feel confident in their ability to carry out the test successfully, 
participation will be lower. Similarly, even if a FOBt is considered to be an acceptable 
concept, the manipulation of faeces and storing of the completed test can also prove 
problematic (O’Sullivan and Orbell, 2004).
The IFOBt has been heralded to be the more acceptable alternative to a GFOBt, as they are 
considered by the developers to be simpler and more convenient to use (Weller et al., 2009).
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Therefore, the aim of this systematic review was to bring together research which has looked 
specifically at how the test type, i.e., GFOBt or IFOBt, affects participation rates in BCS.
Objective
To systematically review randomized controlled trials comparing the participation rates 
generated from using a GFOBt or an IFOBt.
Criteria for considering study for this review
The type of studies considered for the review were those that assessed non-invasive methods 
of screening, i.e., FOBfs, in an asymptomatic population. Each study would be required to 
compare two or more types of FOBt, which should include both a GFOBt and an IFOBt. The 
studies should assess how the type of test affects participation rate, and participation rate 
should be measured by return rate of completed tests. Finally, each participant should only 
have completed one type of test, either GFOBt or IFOBt.
Search methods for identification of studies
The following electronic databases were utilised to find journal papers that met the criteria: 
Cochrane Libraiy, AMED, BNI, EMBASE, HMIC, MEDLINE, PsychlNFO, CINAHL, and 
HEALTH BUSINESS ELITE. Papers were also derived from the reference sections of 
journal papers found through these databases. The following search terms were used to 
identify journal papers of interest:
• (screen* OR early detection) AND (colorectal cancer OR bowel cancer) AND 
(comparison OR versus) AND (non-invasive test* OR screening test* OR faecal occult 
blood test* OR guaiac OR immunological test* OR colorectal neoplasia screening test) 
AND (participate* OR uptake OR adherence)
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• (colorectal cancer OR bowel cancer) AND (comparison OR versus) AND (non-invasive
test* OR screening test* OR faecal occult blood test* OR guaiac OR immunological
test* OR colorectal neoplasia screening test) AND (participate*OR uptake OR 
adherence)
• (screen* AND colorectal AND cancer AND (faecal OR fecal) AND occult AND blood 
AND test AND refuse)
• (screening AND colorectal AND cancer AND new AND faecal AND test AND 
participation)
• (screening AND colorectal AND cancer AND guaiac AND immunochemical AND test* 
AND participation)
• (guaiac-based AND test* AND immunochemical-based AND test*)
• (guaiac AND immunochemical AND compliance)
• faecal AND sampling AND acceptability
• guaiac AND immunochemical AND comparison
• evaluation AND immunochemical AND test AND faecal
Description of studies
Five randomised control trials were identified for this review in total; a summary of which 
can be found in Table 6.1. It is important to note that the studies selected were 
predominantly medical in context, therefore the author has only commented upon factors 
relating to the subject matter of this review; i.e., effect of test on participation rates. One 
study compared three different screening methods for BC whereas the four remaining studies 
compared two types of screening devices. Each study compared the use of both guaiac faecal 
occult blood tests (GFOBt) with immunochemical faecal occult blood tests (IFOBt) with 
regards to their effect upon participation rates in BCS. The characteristics of the included 
studies can be seen in Table 6.1.
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An Australian RCT investigated how the type of FOBt could affect participation in BCS 
(Cole, Young, Esterman, Cadd and Morcom, 2003). Three randomised cohorts of 606 
individuals, aged between 50-69 years old, were offered one of three types of FOBt; the 
Hemoccult SENS A, the Flexsure OBT and the InsureTM. The Hemoccult SENS A and the 
Flexsure OBT (GFOBt’s) required three stool samples taken with a spatula and applied to a 
card, whereas the Insure TM (IFOBt) only required two samples utilising a brush. The 
Hemoccult SENS A also enforced dietaiy and medicinal restrictions. Cole et al. (2003) 
specified that they were addressing separate outcomes within this study. They aimed to find 
out if removing dietaiy and medicinal restrictions and simplifying the test improved 
participation and whether demographic factors affect the relationship between the type of 
test and participation rates.
Table 6.1: Characteristics of included studies by Author
A uthor and 
year
Sam ple (n) 
and study  
design
D evice, type guaiac 
(g),
im m unochem ical (i)
Apparatus Dietary or
m edicinal
restrictions
Samples
required
Cole et al. Australia HemoccultSENSA, g Spatula/card Yes 3
(2003) (1,818) FlexSure OBT, i Spatula/card No 3
RCT InSureTM, i Brush No 2
Federici et al. Italy Hemo-Fec, g Spatula/ Yes 3
(2005) (7,320)
RCT
OC-Hemodia, i container
Tube/probe
Yes 1
Hughes et al. Australia Hemoccult-II, g Spatula/card Yes 3
(2005) (3,358)
RCT
Inform (Enterix),i Brush No 2
Ko et al. USA HemoccultSENSA, g Spatula/card Yes 3
(2003) (3,929)
RCT
FlexSure OBT, i Spatula/card N o 3
Van Rossum et Netherlands Hemoccult-II, g Spatula/card Yes 2
al. (2008) (20,623)
RCT
OC-Sensor, i Tube/probe N o 1
Similarly Ko, Dominitz, and Nguyen (2003) compared the Hemoccult SENS A and the 
Flexsure OBT to see how they affected participation rates. Patients at two GP practices, with 
a mean age of 65.4, were allocated either the HemoccultSENSA or the Flexsure OBT. As 
before, both tests required three stool samples taken with a spatula and applied to a card.
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Although utilising the same method of collection, the Flexsure OBT instructions were 
considered to be more complicated by the authors as participants were requested to place 
samples of bowel motion together on a small area of the test card, whereas with the 
HemoccultSENSA, samples were placed separately on the test card. The Hemoccult SENS A 
enforced dietary and medicinal restrictions.
Hughes, Leggett, Del Mar, Croese, Fairley, Masson, Aitken, Clavarino, Janda, Stanton, 
Tong, and Newman (2005) compared participation rates from two different types of FOBt in 
a BCS programme. 3,358 patients from GPs within a rural community, aged 50-74 years old, 
were assigned one of two FOBt’s; a GFOBt Hemoccult-II or IFOBt Inform. Hemoccult-II 
required participants to smear samples from three separate bowel motions onto a test card, 
whereas Inform only required two samples which are taken from around the bowel motion 
with a brush in the toilet water. The Hemoccult-II also enforced dietaiy and medicinal 
restrictions.
Federici, Giorgi Rossi, Borgia, Bartolozzi, Farchi, and Gausticchi (2005) assessed two 
further types of FOBt in a population of 7,332 patients, aged 50-75 years old, attending GP 
practices in Rome. Half of the patients were assigned a Hemo-Fec which required three stool 
samples to be taken using a cardboard spatula into a container. The other half were requested 
to complete an OC-Hemodia which consisted of one sampling tube with an integrated probe. 
Participants were required to use the probe to scrape the bowel motion and replace in the 
tube before returning for analysis. Patients were also divided so that half were invited to be 
screened at their GP and half at their local gastroenterology unit. The Hemo-Fec enforced 
dietary and medicinal restrictions, whereas the OC-Hemodia enforced medicinal restrictions. 
Both GPs and participants were offered an economic incentive to take part in the study.
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Finally, a more recent study by Van Rossum, Van Rijn, Laheij, Van Oijen, Fockens, Van 
Krieken, Verbeek, Jansen, and Dekker (2008) assessed participation rates for a GFOBt 
Hemoccult-II and an IFOBt OC-Sensor. 20,623 individuals aged 50-75 years old were 
randomly sent one of the two types of test kit. The Hemoccult II required three samples of 
bowel motion to be applied onto a test card with applicator sticks. The OC-Sensor test 
consisted of a sampling tube with an integrated probe to collect one sample from a bowel 
motion, much like the OC- Hemodia in Federici et al.’s (2005) study. If participants were not 
able to return the sample straight away, they were requested to refrigerate the completed test 
prior to returning. The Hemoccult-II enforced dietaiy and medicinal restrictions.
Results
Demographics
The characteristics of participants invited to take part in each study can be seen in Table 6.2. 
The variables displayed here only include gender and age. Although Ko et al. (2003) 
specified that 98% of their sample was male; they did not specify the ratio of males and 
females returning different types of FOBt. Socio-economic status was only reported by Cole 
et al. (2003). Here, individual’s postcodes were grouped into disadvantaged and advantaged 
areas. Although participants were equally matched for age and gender, this was not the case 
for socio-economic status; as a majority of those completing the Flexsure OBT were derived 
from more advantaged areas.
Participation rates
The participation rates, in comparison to the number of participants invited to take part, for 
each study are displayed in Figure 6.3. From this, it can be determined that four of the 
studies had high non-participation rates. As each of the studies reported within this review 
measured participation as the return of a completed test; Figure 6.4 shows the return rate of
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both GFOBts and IFOBts for each of the studies. From this, it is apparent that in all five 
studies, the response rate for participants completing and returning an IFOBt was higher.
Table 6.2: Characteristics of participants by Author
First author Percentage
Gender IFOBt IFOBt (2) GFOBt
Cole et al. Males 48.5 49.2 51.0
Females 51.5 50.8 49.0
Federici et al. Males 45.8 n/a 46.9
Females 54.2 53.1
Hughes et al. Males 46.9 n/a 52.5
Females 52.6 47.5
Missing 0.5 0.0
Ko et al. Males - n/a _
Females - -
Van Rossum et al. Males 48.8 n/a 47.8
Females 51.2 52.2
First author Percentage or Mean ± SD
Age IFOBt IFOBt (2) GFOBt
Cole et al. 50-59 64.9 63.0 66.3
60-69 34.1 37.0 33.7
Federici et al. 50-59 42.7 n/a 43.8
60-69 41.3 39.0
70+ 16.0 17.2
Hughes et al. 50-59 36.9 n/a 48.3
60-69 37.6 34.1
70-74 11.7 17.5
Missing 13.9 0.1
Ko et al. - 64.8 ± 10.3 n/a 65.8+ 10.6
Van Rossum et al. <60 51.7 n/a 50.4
>60 48.3 49.6
(-not reported)
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Figure 6.3: Non- participation rates by author
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Each study reported the statistical significance of participation rates, and any association 
between the demographic variables of their cohorts and participation. These are represented 
in Table 6.5.
Table 6.5: Participation and associations to demographic variables
First author Statistical test of 
difference in 
participation 
rates
Association
between
participation
and
demographic
variables
Notes
Cole et al. p<0.00001, Higher socio­ • Participation increased
x^=37.1 economic status by 28% if the test was
was associated more convenient
with better (p=0.01).
participation rates • Participation increased
(p=0.47). by 30% if sampling
However, this procedure was
association did simplified, sample
not confound the could be taken from
relationship toilet water, and there
between were less samples to
participation and take (p=0.01).
test type. • Participation improved
by 66% if the two latter
factors were combined
(p<0.001).
Federici et al. p=0.34, 
x^(l) = 0.90
-
Hughes et al. p<0.001. Age was
x^=20.7 significantly
related to the
completion of the
GFOBt (p=0.01);
i.e., 27% of 50-
59 year olds.
32% of 60-69
year olds and
35% 70-74 year
olds took part.
Ko et al. p=0.72 -  —
Van Rossum et al. p<0.01 -
(-Not reported)
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Barriers to BCS
A majority of the studies came to a conclusion that there are common barriers to the 
practicality of carrying out a GFOBt in comparison to an IFOBt. These barriers are detailed 
in Table 6.6.
Table 6.6: Summary of barriers to screening via GFOBt by Author
First author Barriers
Sampling Number o f samples Restrictions
Cole et al. Complicated sampling- 
i.e., having to sample 
bowel motion before it 
reaches the toilet water.
Three samples to take 
rather than two.
Dietary and 
medicinal 
restrictions 
lower
participation.
Federici et al. Sampling with the paper 
sampler is more 
distasteful.
Three samples to take 
rather than one.
Dietary and 
medicinal 
restrictions 
lower
participation.
Hughes et al. Sampling considered 
less convenient and more 
‘messy’.
Dietary
restrictions
lower
participation.
Ko et al. - - -
Van Rossum et al. - - -
(-No conclusions reported)
Discussion
The majority of these studies concluded that IFOBts were more acceptable to participants 
than GFOBts. However, it is important to note that in each study the reasons for test 
preference amongst participants are purely speculative, i.e., participants were not asked why 
they preferred a particular test as results were based on participation rates alone. Cole et al. 
(2003) concluded that the Insure TM achieved better participation rates as there were no 
restrictions and the sampling procedure was far simpler than the other two test kits. Hughes 
et al. (2005) concluded that the reason why participants seemingly preferred the IFOBt was 
because it is more ‘user-friendly’, i.e., convenient, less messy and does not have dietaiy or 
medicinal restrictions.
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Federici et al. (2005) concluded that participation was higher in the immunochemical group 
because there were no dietaiy or medicinal restrictions, participants only had to collect 
samples from one bowel evacuation, and they did not have to handle the faeces with a paper 
sampler. Van Rossum et al. (2008) drew no conclusions from why participation rates were 
higher for the immunochemical test. Therefore, it was concluded that IFOBt’s were more 
acceptable to participants because they were considered to be more convenient to use, the 
technique of taking the samples was not as unpleasant, and they did not require any 
particular dietaiy or medicinal restrictions meaning that participants could take part without 
compromise.
Ko et al. (2003) found no significant differences between age groups reported. Ko et al.
(2003) did notice that although participants returned the immunochemical kits an average of 
three days sooner than the guaiac tests, a high percentage of the Flexsure FOBt kits were 
cancelled on receipt as they had been completed incorrectly, e.g., specimen was not provided 
in the correct place on the test card etc. It could be concluded from this that complicated 
instructions may have resulted in incorrect sampling by participants, illustrating that 
although there were no differences in the acceptance of the different types of kit, it is 
important for these tests to be simple to use, and this includes their instructions for use.
Overall, a majority of the studies reported that IFOBt’s are considered more acceptable 
because of their sampling methods. This may be because the sampling method creates some 
distance between the participant and their faecal sample. For example, using a probe which 
can be dipped in and out of the bowel motion whilst it is submerged in the toilet water means 
that the participant would have less direct contact with the faecal sample than a GFOBt; 
whereby the bowel motion needs to be sampled before it reaches the water with a paper 
sampler.
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The number of samples required for IFOBts compared to GFOBts also raises the issue of 
aversion to contact with the faecal sample. An IFOBt requires one sample whereas a GFOBt 
requires three. Therefore the less contact, i.e., fewer samples, participants have with their 
own faeces, the more acceptable the test becomes to the individual.
The accuracy of sensitive GFOBt’s, such as the ones used in the included studies, can be 
compromised by dietary and medicinal factors (Kune, 1996). For example, it has been found 
that a high consumption of Vitamin C or the use of anti-inflammatory medication can result 
in a false-positive result (Kune, 1996). Therefore, participants were given dietary and 
medicinal restrictions to reduce the probability of a false positive result. These restrictions 
were considered to be a major barrier to screening via GFOBt in three out of the five studies, 
and therefore participation rates of IFOBt’s were higher because they did not enforce such 
restrictions. Contrastingly, it was found in Ko et al.’s (2003) study that participation 
remained the same regardless of dietary and medicinal restrictions being enforced for GFOBt 
participants.
However, the studies within this review were not without their methodological limitations. 
Four out of the five studies were subject to high attrition rates which were not discussed. 
There is the possibility that the data from these studies may have been subject to attrition 
bias, i.e., the groups characteristics may have been altered due to the drop-out rate, which 
may have affected the outcome.
Hughes et al. (2005) reported that a significantly higher percentage of participants (72%) 
received an IFOBt in comparison to a GFOBt (28%). Therefore, it was unsurprising that 
their reported percentages for participation was higher in those that received an IFOBt 
(38.7%) compared to those that received a GFOBt (30.2%). Additionally Hughes et al. 
(2005) stated that the two conditions, i.e., those receiving a GFOBt and those receiving an
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IFOBt, were treated differently in that those receiving the Inform test also received an 
information sheet about BC and BCS. Knowledge and awareness about BC and BCS has 
been found in previous research to increase participation in screening (O’Sullivan and 
Orbell, 2003). Therefore, there is the possibility that more people returned the IFOBt 
because they had added knowledge, not because the test was more preferable to use.
Ko et al. (2003) stated that participants using the IFOBt had not had a prior experience of 
using an immunochemical test as GFOBt’s were more commonly used. Research has shown 
that prior experience of bowel screening may improve future participation in screening 
programmes (Shapiro et al., 2001). Therefore, it is possible that the novelty of this type of 
test may have reduced the response rate. The cohort of participants for this study was 
considered to be gender biased as a majority of the sample were male, which suggested some 
selection bias in their methodology.
From these studies it is difficult to determine if there are any other factors, aside from those 
mentioned in Table 6.2, which may have affected participation rates in each condition. Cole 
et al. (2003) addressed the possibility of confounding variables by assessing whether gender, 
age and socio-economic status had any effect on the relationship between type of test and 
participation rates; and subsequently found that these did not have an effect. However, Van 
Rossum et al. (2008) did not explicitly state that they had addressed this issue. Furthermore 
both Hughes et al. (2005) and Ko et al. (2003) only allowed for the effect of age and gender; 
they did not appear to allow for other confounding variables.
Three of these studies came to the conclusion that participation rates are higher for IFOBt’s 
because they do not have dietary or medicinal restrictions and they are more acceptable to 
participants because they are simpler and do not involve so much manipulation of faeces. 
Unfortunately, these results are difficult to generalise because they are interpretative, i.e., the
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reasons for higher participation with IFOBt’s have been interpreted from previous literature 
as none of these studies assessed what it was about the particular tests kits which participants 
found more or less acceptable. Therefore, although these studies are useful because they 
highlight the significant relationship between the type of test and participation rate, they do 
not conclude why this is the case. This systematic review emphasizes the need for further 
investigation into this area, to ascertain what it is about FOBt’s that pose a barrier to BCS.
Conclusion
After this review had been completed, a similar review was conducted to look at the affect of 
sampling methods upon participation by Banzi (unpublished). Banzi’s review considered 
Cole et al.’s (2003) study, plus two other studies not included in this review. Banzi 
concluded that there were no particular sampling methods which improved screening 
participation. Contrastingly, this review found that IFOBt’s were considered to be more 
favourable than GFOBt’s because they were deemed by the authors, to be less awkward to 
complete. Although, the affect of the practical elements on screening participation was 
purely speculative, thus difficult to generalise, the author identified practical factors about 
these tests which could be utilised to evaluate the acceptability of the GFOBt currently being 
utilised in the BCSP. Therefore these factors, including convenience and simpler sampling 
methods, were drawn upon in the current research to assess their effect on the intention to be 
screened for BC.
154
Chapter Seven
Intervention Study
Introduction
Identifying the reasoning behind the intention to be screened for BC in study four, brought to 
light that the practical element of completing a FOBt was the main predictor of intention to 
be screened, i.e., the more awkward an individual perceived the FOBt was to carry out, the 
lower their intention to be screened. This finding supported the literature in chapter two 
highlighting various practical factors which have affected participation in BCS via FOBt. 
These factors include convenience of the test, e.g., storage, prior experience of screening, 
e.g., experience of bowel screening, psychological cost, e.g., embarrassment, beliefs, e.g., 
specificity of the test, complexity of test kit, and self-efficacy, e.g., confidence in carrying 
out the FOBt (Ellis et al., 2007; Hughes et al., 2005; Worthley, Cole, Esterman, Mehaffey, 
Roosa, Smith, Turnbull, and Young, 2006).
However, as the findings from study four could not determine the reasons why participants 
perceived the FOBt to be more or less awkward, e.g., was it perceived as embarrassing to 
complete, the objective of this study was to identify what it was about the FOBt that 
individuals dislike, and to identify if any of these factors lower their intention to be screened. 
Furthermore, literature in this area has shown that different types of FOBt are perceived as 
less awkward to complete than others, as seen in chapter six. For example, Federici et al. 
(2005) found that participation was higher for a FOBt which did not involve handling faeces; 
unlike the current FOBt being utilised in the NHS BCSP. Therefore, the second objective of 
this research was to evaluate individual attitudes towards different types of FOBt, and 
ascertain if different FOBt’s possess more or fewer barriers to BCS.
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Finally, the author was unable to find evidence of attitudes towards a FOBt changing before 
and after seeing the FOBt. This mirrors the process of the NHS BCSP pathway in England at 
the current time, i.e., the test kit and instructions are sent out seven days after the initial 
invitation (NHS, 2009). Therefore it was hypothesised that attitudes would change from 
before to after seeing the test, and that different types of FOBt would affect intention to be 
screened.
Study Five: Evaluation of non-invasive bowel cancer screening methods and effect on 
intention to be screened for bowel cancer.
Aims
• Explore attitudes towards the practical elements of completing a FOBt.
• Ascertain if these attitudes change, from before, to after seeing the test kit.
• Explore the effect of different types of FOBt upon intention to be screened.
Methodology
Participants
Participants were recruited via convenience sampling; initially from a relevant organisation 
aimed at older adults. The organisation was known to the researcher. Permission from the 
manager of the organisation was granted prior to a recruitment advertisement for the study 
being displayed at the organisation. Secondly, participants were recruited through personal 
contacts whereby individuals personally known to the researcher were directly issued with, 
by hand, an advertisement for the study. Finally, participants were recruited via the 
University of Surrey staff mailing list. Here, an advertisement approved by the University 
was sent to all staff. In all three settings, individuals who saw the advertisement and were 
interested in taking part were requested to contact the researcher to receive a questionnaire 
pack. Age was the only inclusion criteria in this study as only participants aged 50 years old
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and over were requested to complete the questionnaires as this reflects the lowest age for 
BCS participation in the U.K.
Materials
A separate advertisement was devised for each of the settings, i.e., relevant organisation 
(Appendix 19), personal contacts (Appendix 20) and University community (Appendix 21). 
Each advertisement was designed for the population it was targeting, e.g., the University 
advertisement was reduced in size for ease of sending on an e-mail. When the individuals 
contacted the researcher showing their interest in the study, they were requested to provide a 
contact address to which a questionnaire pack could be sent.
The questionnaire pack included:
• Invitation letter, explaining the aims of study (Appendix 22)
• Questionnaire one (Appendix 23)
• An envelope containing one (of five different of types) FOBt (Appendix 4 and 27) with 
instructions (Appendix 26 and 27), and questionnaire two (Appendix 24)
• Stamped addressed envelope
Each participant was invited to fill in questionnaire one before opening the enclosed 
envelope. Participants were then asked to open the envelope, look at the FOBt and 
instructions. All test kits had a clearly printed label stating that participants were only 
requested to look at the kit, not to complete it. The participants were then asked to complete 
questionnaire two, to indicate they had read the statements of consent and then return both 
questionnaires in a stamped addressed envelope provided. To clarify, participants completed 
questionnaire one before they saw the test, and questionnaire two after they had looked at the 
test.
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The test kits viewed by the participants consisted of four immunochemical tests and one 
guaiac test; as shown in Table 7.1. For the benefit of the reader, the devices were assigned 
test references by the author which were attributed by the type of device, i.e., guaiac or 
immunochemical. Pictures of these tests can be seen in Appendix 4 (GFOBt) and 27 
(IFOBt’s). The guaiac test (Hema-screen) is currently being utilised in the national BCSP, 
whereas the immunochemical tests are currently being trialled for this purpose (Halloran, 
2009). The manufacturer’s instructions for each test varied in length and style, i.e., some had 
pictures whereas others did not. Therefore, the researcher standardised the instructions for 
each test, so that the typeface matched and they appeared in text only (Appendix 26 and 27).
Table 7.1: Test characteristics
Device, type guaiac (g), 
im m unochem ical (i)
Reference Apparatus Samples Refrigeration
required?
FOB Gold tube, i IFOBt 1 Tube/probe 2 Yes
OC-Auto sampling bottle 3,i IFOBt 2 Tube/probe 2 Yes
N ew  Hemtube™, i IFOBt 3 Tube/probe 2 N o
Hema-screen™ DEVEL-A-TAB  
Sampler, i
IFOBt 4 Spatula/card 2 No
Hema-screen, g GFOBt Spatula/card 3 N o
The questions used on the questionnaires were designed to address the practical issues with a 
FOBt. Demographics, i.e., gender, age, ethnicity, work status and previous experience of BC 
were also included. Questions addressing fear, detection of the test and the practical elements 
of the test followed whereby respondents were asked to use a five point likert scale to 
indicate their response to the questionnaire items. The items used can be seen in Table 7.2. 
Most of the items were based upon those from previous research. The questions regarding 
postage and storage were based upon findings from study one and O’Sullivan and Orbell
(2004) respectively.
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Table 7.2: Barriers to screening and associated questionnaire items
Barriers Q uestionnaire item (reference) Five point Likert Scale
Fear ‘The thought ofBC makes me fe e l’ * 
(Hodgkins and Orbell, 1998)
Extremely worried - N ot worried at all
Response efficacy 7  think that BC screening is an 
effective way o f detecting BC early ’* 
(Hodgkins and Orbell, 1998)
Strongly disagree - Strongly agree
Severity ‘BC is a very serious illness ’ 
(Wurtele, 1988)
Strongly disagree - Strongly agree
Optimistic bias ‘Compared with other men and 
women my age, my chances o f  
getting BC are ’
(Weinstein, 1980)
Very low-Very high
Fatalism ‘What do you think about the 
following statement: 'It’s not worth 
having the test because ‘what will be, 
will be”
(Wardle et al., 2004)
Strongly disagree - Strongly agree
Susceptibility ‘My chances o f developing BC in the 
future are ’
(Hodgkins and Orbell, 1998)
Very low-Very high
Collection ‘The thought o f collecting 
faeces/stool samples for a bowel 
cancer screening test disgusts m e’ * 
(Hynam, Hart, Gay, Inglis, Wicks 
and Mayberry, 1995)
Strongly disagree - Strongly agree
S elf efficacy 7  would be confident in collecting 
stool samples at home, to be posted, 
and tested in a laboratory’* 
(Hodgkins and Orbell, 1998)
Strongly disagree - Strongly agree
Convenience ‘It would be difficult for me to find  
the time to do a bowel cancer 
screening test at home ’*
(Wardle et al., 2000)
Strongly disagree - Strongly agree
Posting 7  would be happy to return a bowel 
cancer screening test in the post ’*
Strongly disagree - Strongly agree
Embarrassment 7  would feel embarrassed using a 
bowel cancer screening test’ 
(ACS, 2004)*
Strongly disagree - Strongly agree
Storage 7  woidd be happy to store a used 
bowel cancer screening test before 
returning it ’*
Strongly disagree - Strongly agree
Intention 7  intend to participate in the BC 
screening programme when 
offered/becom es available ’ * 
(Hodgkins and Orbell, 1998)
Strongly disagree - Strongly agree
159
The questions marked with an asterisk also appeared on questionnaire two, so that a 
comparison could be made between before and after seeing the FOBt. However, repeated 
questions were reworded to pertain to the test participants had looked at, e.g., question 11 
became T would feel embarrassed using this test kit’. The questions were also reordered to 
reduce repetition bias. The only additional questions on questionnaire two were 7 think the 
instructions for this test kit were easy to follow ’ and 7 think this test would be awkward to 
use Participants were asked to record whether they agreed with this statement using a five 
point likert scale ranging from ‘strongly disagree’ to ‘strongly agree’. The author requested a 
colleague to assess the readability of questionnaire items, prior to implementation. It was 
agreed that both the items and the rating scales were clear and easy to understand.
Statistical analysis
Four types of data analysis were performed on the data collected from this study. To 
ascertain the differences between two groups, e.g., gender, independent t-tests were used. To 
identify differences between more than two groups, e.g., age, analyses of variance were 
utilised. Paired t-tests were conducted to explore differences within groups, e.g., the 
difference in responses before and after participants have seen the test kit. Mixed measures 
analysis of variance was used to identify differences between and within groups, e.g., the 
effect of the type of test on all questionnaire items versus seeing the FOBt. Finally, to 
ascertain which questionnaire item affects intention to be screened the most, a multiple 
regression was carried out.
Ethical considerations
Two statements were printed at the bottom of the second questionnaire which participants 
were asked to read and signify their consent by ticking the box by each statement. These 
statements incorporated consent to answers being used for research purposes, understanding 
that responses are anonymous, that all data is held and processed in confidence and that if the
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questionnaire generated any questions or concerns that they should speak to their GP. This 
study was ethically approved by the University of Surrey Ethics Committee.
Classification
A classification table was given to five independent raters who looked at each of the five 
FOBt’s and their instructions. They were asked to rate each test, using a five point likert 
scale, according to the ease/awkwardness of the test and clarity/ difficulty of the test kit 
instructions. Raters were also asked to comment on which test they thought was the best/ 
worst and why. The classification table can be seen in Appendix 25. The classification scores 
from the raters were then summed; the results of which can be seen in Figure 7.3. Here it is 
apparent that raters perceived the IFOBt 1 to have the clearest instructions, and to be the 
easiest to complete. Contrastingly, both the IFOBt 4 and the IFOBt 3 scored equally high for 
difficulty of instructions and awkwardness of test. Raters commented that they thought the 
IFOBt 1 was the best device because the instructions were straightforward and it was an easy 
test to use. However, raters commented that the IFOBt 4 instructions were confusing and the 
process of applying samples was ‘disgusting’, and the IFOBt 3 was ‘fiddly’ to use as it had 
the narrowest tubes.
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Figure 7.3: Graph to show results from classification
IFOBt 1 IFOBt 2 IFOBts IFOBt 4 ŒOBt 
Test type
■ Clear instructions □ Difficult instructions □ Simple test □ Awkward test
Results
To ensure parametric assumptions were achieved the raw data was assessed for outliers, 
missing data, normality and homogeneity of variance, prior to the analysis. Subsequently the 
values of the likert scales for some questionnaire items, on both questionnaires, required 
reverse-coding. A summary of these questions can be seen in Table 7.4.
Table 7.4: Summary of reverse-coded questionnaire items
Questionnaire Questionnaire items transformed
1 / 2
1
1/ 2
1 / 2
1/ 2
2
‘The thought ofBC makes me feel ’
‘What do you think about the following statement: 'It’s not worth having the test 
because ‘what will be, will be'’
‘The thought o f collecting faeces/stool samples for a bowel cancer screening test 
disgusts me ’
‘It would be difficult for me to find the time to do a bowel cancer screening test at 
home’
‘I  wouldfeel embarrassed using a bowel cancer screening test’
‘I  think this test would be awkward to use ’
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Two hundred and twenty questionnaire packs were sent out in total; one hundred and twenty 
one participants returned completed questionnaires equalling to a fifty five percent response 
rate. A majority of participants were female (62%), the mean age was 62 years old 
(SD=6.34). A high percentage of the population were white British (97%); with the 
remaining participants stating they were white Irish, white ‘other’. Middle Eastern and Asian 
‘other’. Finally, most of the population noted their work status as retired (45%), whereas the 
remainder reported they were full-time (36%), part-time (17%) or not employed (2%). Table 
7.5 illustrates these participant characteristics by age.
Table 7.5: Participant characteristics by age
Characteristics
50-60 61-70 71-80
Gender
Male 14 19 8
Female 38 25 6
Ethnicity
White British 51 41 13
Other
Missing
1 2 1
12
Work status
Full-time 34 6 0
Part-time 12 7 0
Not employed 1 1 0
Retired 5 30 14
The total number of participants appearing in Table 7.5 for age, gender and work status is 
n=110. This was due to eleven participants omitting age information on returning 
questionnaire one. The total number of participants stating their ethnicity was n=109, as 
twelve participants did not report their ethnic group. In addition to these demographic 
characteristics, 43% of participants stated that they knew a family member, friend or 
colleague who has been diagnosed with BC. Furthermore, 14% reported a history of large 
bowel investigation which ranged from having completed a FOBt to having had a barium 
enema or colonoscopy in the past.
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Table 7.6 illustrates the percentage of questionnaires returned by participants, by the type of 
test they were initially sent to look at.
Table 7.6: Percentage of completed questionnaires by test type
Test Percentage
IFOBt 1 12
IFOBt 2 14
IFOBt 3 24
IFOBt 4 25
GFOBt 25
The overall percentage of individuals who reported that they intended to be screened when 
invited was also calculated; the results can be seen in Table 7.7. It was found that a total of 
84.3%, before seeing the test, and 88.4% after seeing the test agreed or strongly agreed that 
they intended to participate in the screening programme when it was offered or became 
available.
Table 7.7 Responses to intention item, before and after seeing the test
Percentage
Response Before After
Strongly disagree 0.8 0.8
Disagree 0.8 0.8
Unsure 14 9.9
Agree 50.4 52.9
Strongly agree 314 35.5
Independent t-tests were carried out initially to identify differences between groups, on 
responses to each of the questionnaire items. Significant differences were found between 
male and female responses to storage of the test, as shown in Table 7.8.
Table 7.8: Means and standard deviations for differences between males and females 
for storage
Questionnaire
Item
Gender 
Mean (SD) 
Males Females t P eta squared
Storage
(Before seeing test)
3.87 (0.83) 3.50(1.01) t(108.8)=2.17 0.03 0.04
Storage
(After seeing test)
4.02 (0.78) 3.67(1.03) t( 110.7) =2.09 0.04 0.04
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Table 7.8 shows that the mean score for males was higher on both the questionnaire items 
regarding storage, which showed that men were happier to store the test before returning it. 
However, the difference in means was considered to be small, according to Cohen (1988).
Significant differences were also found, when participants who had a medical history of 
bowel investigation were compared with those who did not as shown in Table 7.9.
Table 7.9: Means and standard deviations for differences between history of bowel 
investigation and no history of bowel investigation
Questionnaire History of investigation
Item Mean (SD)
Yes No t p eta squared
Fear 3.23 (1.15) 2.58 (0.87) t(119) = 2.77 0.007 0.06
(After seeing test)
It was apparent from Table 7.9 that the mean score was higher for those who had a previous 
history of bowel investigation which meant that they were more fearful of BC than those 
who did not. According to Cohen (1988), there was a moderate effect for this variable. There 
were no differences found in fear before seeing the test, between those who had a history and 
those who did not.
Table 7.10: Comparison of mean scores for fear items
Questionnaire items
History of investigation Fear (before) Fear (after)
Mean (SD) Mean (SD)
Yes 3.00(1.21) 3.23(1.15)
No 2.65 (0.96) 2.58 (0.87)
However, the means shown in Table 7.10 demonstrate that, although not statistically 
significant, the mean scores for fear items increased from before to after seeing the test when 
there is a past history of investigation. Contrastingly, when there is no history present, fear of 
BC reduces.
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Two separate ANOVA tests were conducted to identify any differences between age groups 
or work status. It was not possible conduct a successful ANOVA on differences between 
ethnic groups due to the high majority of white British participants. No significant 
differences were found between age groups; however, differences were found between work 
status group responses to the fear items on questionnaire one, as shown in Table 7.11. There 
were only two responses from participants who reported that they were unemployed. Their 
scores were considered outliers during the data screening process, as both participants 
responded to the statement ‘The thought o f bowel cancer makes me feeV using the ^not at all 
worried" option on the likert scale provided. These were markedly different responses to the 
other participants, and therefore were excluded from the data set prior to analysis.
There was a significant difference in responses to the fear item, on questionnaire one, for the 
remaining work status groups, i.e., full-time, part-time and retired, as F (2,115) = 4.13, 
p=0.02. This was considered to be a moderate effect as partial eta squared = 0.06 (Cohen, 
1988). A Tukey HSD test was then conducted to ascertain what differences there were 
between the groups, as suggested by Field (2009). This test revealed that there was a 
significant difference between full-time and part-time, and full-time and retired participants, 
which is apparent in Table 7.11 displaying the means and standard deviation for each group.
Table 7.11: Means and standard deviations for work status groups and fear before 
seeing the test
Questionnaire item
Work status Fear (before)
Mean (SD)
Full-time 2.38 (0.85)
Part-time 3.00(1.18)
Retired 2.87 (0.96)
It is apparent from Table 7.11 that participants who are employed full-time were the least 
fearful of BC, and that fear of BC was relatively low across the three groups.
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As individuals were found to be less fearful if they were employed full-time, the relationship 
between work status and age was further examined. The participant’s characteristics in Table 
7.5, illustrated that younger individuals tended to work more than older individuals. 
Therefore, could it be that the differences found between work status groups were moderated 
by the age of the participants? To find this out, a two-way between groups ANOVA was 
conducted. The results from this test found a significant interaction between age and work 
status and their effect upon fear before seeing the test, F(2,100) = 6.33, p<0.005, partial eta 
squared = 0.11.
Paired t-tests were then carried out to identify if responses changed, from before, to after 
seeing the test kit. The only paired items to show significant differences were detection and 
storage; these are reported in Table 7.12.
Table 7.12: Means and standard deviations for significant differences between 
responses to questionnaire items, before and after seeing the test
Questionnaire
Item
Responses 
Mean (SD) 
Before After t df P eta squared
Fear 2.70(1.00) 2.65 (0.91) 1.03 119 0.30 0.09
Detection 4.28 (0.76) 3.97 (0.79) 4.40 119 <0005 0.14
Collection 3.85 (0.09) 3.96 (0.09) -1.23 119 0.22 0.11
Self efficacy 4.03 (0.83) 4.17(0.73) -1.49 117 0.17 0.09
Convenience 4.32 (0.06) 4.39 (0.06) -0.94 119 0.35 0.01
Posting 4.11 (0.85) 4.21 (0.70) -1.48 120 0.14 0.14
Embarrassment 4.12(0.86) 4.15(0.84) 0.13 120 0.90 0.13
Storage 3.65 (0.92) 3.80 (0.95) -222 118 0.03 0.04
Intention 4.16(0.75) 4.21 (0.72) -0.93 120 0.36 0.08
Table 7.12 illustrates that the mean scores for the effectiveness of the test in detecting BC 
early decreased from before to after seeing the test; and the effect size was considered large 
(Cohen, 1988). Contrastingly, the mean scores for the acceptability of storing the test
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increased from before to after seeing the test kit. The effect size here was deemed to be 
small, in accordance with Cohen (1988).
The author wanted to explore the responses to paired items further. If the responses were 
different, it was important to specify whether they altered because individuals had seen a 
screening test, i.e., a between subjects effect, whether it was the type of test that caused the 
change, i.e., a within subjects effect, or whether the change was caused by both i.e., an 
interaction effect. Therefore, separate mixed between-within subjects ANOVA’s were 
carried out for each of the paired items; as shown in Table 7.13.
Table 7.13: Main effects and interaction of time; i.e. before and after seeing the test, 
and test type from mixed between-within subjects ANOVA s
Time Test type Interaction between 
time and test type
F df P F df P F df P
Fear 0.10 115 0.98 1.4 115 0.24 0.54 115 0.71
Detection 0.34 115 0.85 15.4 115 <0.005 1.10 115 0.36
Collection 1.15 113 0.34 1.04 113 0.31 2.33 113 0.06
Self efficacy 0.63 115 0.64 2.12 115 0.14 0.63 115 0.64
Convenience 0.10 115 0.98 0.96 115 0.33 0.10 115 0.98
Posting 1.86 116 0.12 1.59 116 0.21 0.66 116 0.62
Embarrassment 0.81 116 0.52 0.09 116 0.76 0.65 116 0.63
Storage 0.44 114 0.78 2.54 114 0.11 0.71 114 0.59
Intention 5.4 116 <0.005 0.02 116 0.88 1.98 116 0.10
Significant results were found within subjects for detection items and between subjects for 
intention items. A marginally significant interaction effect was found for collection. 
Interestingly, no significant differences were found within groups for storage, as established 
in the paired t-tests. However the mean scores for the storage items, as part of these analyses, 
were considered noteworthy; as seen in Table 7.14.
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Table7.14: Means and (standard deviations) for test types, before (b) and after (a) 
seeing the test
IFOBt 1 IFOBt 2 IFOBt 3 IFOBt 4 GFOBt
b a b a b a b a b a
Fear 2.71 2.57 2.59 2.53 2.72 2.62 2.73 2.67 2.70 2.77
(0.99) (0.85) (0.87) (0.72) (1.06) (0.86) (1.08) (1.12) 0199) (0.90)
Detection 4.21 343 4.29 4.18 4.31 3.79 4.17 4.00 4.40 4.00
(1.00) (1.05) (0.81) (0.77) (0.69) (0.62) (0.79)
Collection 3.47 3.87 3 4 3 3.56 4.14 4.11 3.62 3.96 3.97 4.07
(1.19) (0.91) (1.12) (1.46) (0.52) (0.57) (1.08) (0.94) 0196) (0.91)
Self efficacy 3.80 4.13 4.23 4.23 4.00 3.93 4.00 4.21 4.10 4.37
(1.01) (0.51) (0.66) (0.75) (0.84) (0.80) (0.77) (0.92) (0.67)
Convenience 4.21 4.36 4.47 4.53 4.17 4.24 4.33 4.43 4.43 4.43
(0.58) (0.63) (1.01) 0151) (0.80) (0.51) (0.55) (0.73) (0.70) (0.68)
Posting 3jW 3.93 4.35 4.29 3.96 4.03 4.30 4.33 4.10 4.37
(1.15) 0185) (0.49) (0.47) (0.73) (0.78) (0.53) 0155) (1.12) (0.81)
Embarrassment 3.93 4.00 4.11 3^8 4.14 4.10 4.13 4.23 4.12 4.15
(1.16) (0.92) (0.99) (1.17) 0183) (0.77) (0.90) (0.82) (0.55)
Storage 3.71 3.64 3j% 3.82 3.55 3.72 3.73 4.00 3.51 3^ 0
(0.73) 0193) (0.95) (1.07) (0.87) (0.91) (0.87) (1.09) (1.06)
Intention 4.06 3.73 4.41 4.35 3.72 3.96 4.20 4.30 4.43 4.53
(0.80) (0.96) 0151) (0.49) (0.78) (0.66) 0159) (0.63)
Table 7.14 revealed that participants seemed happier to store some tests when they had seen 
what it involved e.g., IFOBt 3, IFOBt 4 and GFOBt. This was not the case for the IFOBt 1 or 
IFOBT 2. Furthermore, the mean scores for detection show that, as previously found in the 
paired t-tests, participants perceived all the tests, irrespective of test type, to be less effective 
in detecting BC early after they had seen a test. Here the type of test, plus the before and 
after effect, affected responses regarding the level of disgust in collecting samples.
A Tukey HSD test revealed that there were no significant differences between groups for the 
collection item; however it is interesting to see from Table 7.14 that the mean scores for 
disgust increased for the IFOBt 2, and decreased for IFOBt land IFOBt 4.
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A Tukey HSD test was also performed for intention, and found significant differences 
between the IFOBt 1 and GFOBt, the IFOBt 3 and IFOBt 2, and the IFOBt 3 and GFOBt. It 
is important to remember that participants had not seen the test before responding to the 
intention (before) item. Therefore, in this instance it was not the type of test that influenced 
intention; it was simply the group that participants had been allocated to. Therefore, it is not 
clear why intention differed within these groups. Contrastingly, in intention (after), it is 
apparent that the type of test could have affected intention to be screened. Here the mean 
scores suggest that intention was lowest for those who saw the IFOBt 1, and highest for 
those who saw the GFOBt.
Two further ANOVA tests were carried out to ascertain the effect of the type of test on 
questionnaire items which only appeared on questionnaire two, i.e., after participants had 
seen the test. These were two questions specifically designed to gauge responses to how easy 
participants found the instructions to understand, and how awkward they perceived the test 
would be to use. No significant differences were found between groups for either of these 
items as, overall, participants responded favourably to both items, as shown in Table 7.15.
Table 7.15: Means and standard deviations for ease of instructions and awkwardness of 
test by test type
Questionnaire items
Test Instructions Awkward
Mean (SD) Mean (SD)
IFOBt 1 4.14 (0.53) 4.00 (0.65)
IFOBt 2 4.18(0.81) 3.80(1.15)
IFOBt 3 3.72(1.03) 3.57(1.02)
IFOBt 4 4.27 (0.58) 3.77 (0.90)
GFOBt 4.03 (0.81) 4.00 (0.69)
Although there were no significant differences between groups, it is possible to see from 
these mean scores that participants considered the IFOBt 4 instructions to be the easiest, and 
the IFOBt 3 instructions the least easy to follow. The IFOBt 1 and GFOBt were considered 
the least awkward to use, whereas the IFOBt 3 was perceived to be the most awkward.
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Finally, the author wanted to examine which of the items on questionnaire one and two had 
the most effect on intention to be screened. To do this, two separate multiple regressions 
were utilised. Firstly, in relation to intention on questionnaire one, using the enter method, a 
significant model emerged, F (15, 100) = 4.30, p<0.0005. Adjusted R squared =0.30. 
Optimistic bias and embarrassment were the only significant variables found in this analysis; 
as shown in Table 7.16.
Table 7.16: Results from multiple regression - relationship between predictor variables 
and intention to be screened for BC, before seeing the test
Predictor variable Beta P Part correlation coefficient squared
Time 0.09 0.30 0.006
Susceptibility 0.07 0.35 0.005
Storage 0.14 0.13 0.01
Severity 0.14 0.14 0.01
Self efficacy 0.11 0.26 0.008
Response efficacy 0.04 0.68 0.001
Postage 0.18 0.06 0.02
Optimistic bias 0.22 p<0.0005 0.04
History -0.13 0.12 0.01
Gender 0.01 0.87 0.0001
Friend 0.10 0.23 0.009
Fear 0.29 0.74 0.001
Fatalism 0.11 0.26 0.008
Embarrassment 0.23 p<0.05 0.03
Collection -0.16 0.14 0.01
The part correlation coefficient squared for optimistic bias was 0.04, which meant that 
optimistic bias specifically accounted for four percent of the intention to be screened on 
questionnaire one, whereas embarrassment accounted for three percent (Pallant, 2005). To 
find out the direction of these relationships, the beta values were assessed (Field, 2009). It 
was apparent from these scores that lower optimistic bias and embarrassment increases 
intention to be screened.
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A second multiple regression was conducted to look at the relationships between 
questionnaire items, and intention to be screened, in questionnaire two. The enter method 
was also utilised here, resulting in a significant model, F (13, 103) = 2.54, p<0.005. Adjusted 
R squared = 0.15. Here postage of the test was the only significant variable found to predict 
intention to be screened; as shown in Table 7.17.
Table 7.17: Results from multiple regression - relationship between predictor variables 
and intention to be screened for BC, after seeing the test
Predictor variable Beta P Partial correlation coefficient squared
Time 0.08 0.50 0.003
Storage 0.004 0.97 0.000009
Self efficacy -0.07 0.63 0.002
Postage 0.31 p<0.02 0.04
Instructions -0.02 0.86 0.0002
History -0.08 0.41 0.005
Gender 0.10 0.29 0.01
Friend 0.07 0.44 0.004
Fear 0.10 0.27 0.01
Embarrassment 0.06 0.70 0.001
Detection 0.11 0.30 0.01
Collection 0.12 0.31 0.01
Awkward to use -0.10 0.44 0.004
The part correlation coefficient squared for postage was 0.04, hence postage accounted for 
four percent of the intention to be screened on questionnaire two. The beta value revealed the 
happier the participant was to return the test in the post, the higher their intention to be 
screened.
Discussion
The initial aim of this study was to explore individuals’ attitudes towards the practical 
elements of completing a FOBt. Various statistical tests established differences in attitudes
172
towards the test characteristics, i.e., test type, detection, storage, collection, and postage, and 
psychological factors i.e., fear, optimistic bias, and embarrassment. Each of these factors 
shall now be discussed in turn.
Test characteristics
The classification of the tests by independent raters concluded that the IFOBt 1 had the 
easiest instructions and was the least awkward to use, whereas the IFOBt 4 and IFOBt 3 
were scored the lowest for ease of instructions, and rated the most awkward to use. Data 
from participants in the current study agreed with these ratings to an extent. However, due to 
non significant findings, only tentative conclusions could be drawn from these means as 
follows. Participants agreed that the test which had the most difficult instructions and was 
the most awkward to carry out was the IFOBt 3, followed by the IFOBt 4. However, 
participants scored the GFOBt equally with the IFOBt 1, for the least awkward test use, 
whereas raters considered the GFOBt to be one of the more awkward tests to complete. 
Furthermore, participants perceived the IFOBt 4 to have the easiest instructions, whereas 
these were classified as the most confusing by raters. It was not apparent why participants 
scored the tests they saw, the way they did. However it is important to remember that 
participants were not comparing different test types like the raters. Therefore, their response 
may have differed if they were to compare their optimal or worst test with other test types. 
Furthermore, as commented on by O’Sullivan and Orbell (2004), participants and raters were 
not required to complete the test; therefore, responses may have differed if this was the case.
The second aim of the study was to ascertain if attitudes changed from before to after seeing 
the test, which seemed to be the case in relation to the detection and storage of the test. The 
questionnaire items relating to detection were designed to assess response efficacy, i.e., 
perceived effectiveness of the test as stipulated by Edelmann (2000). The results showed that 
perceptions about the effectiveness of the test, in detecting BC early, decreased from before
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to after seeing the test. Further exploration found that response efficacy declined from before 
to after seeing the test, regardless of the test type. These findings supported Myers et al. 
(1998) who also found that intention decreased if participants had less faith in the efficacy of 
the screening test. This was of concern to the author as it implied that if individuals had less 
confidence in the screening test they may be less likely to participate in screening as found 
by Szczepura (2003) and Weller et al. (2006). However, the factor which makes the results 
from the current study difficult to generalise to an NHS BCS population, is that the 
participants did not receive any accompanying information outlining the benefits of the 
screening test, as is the case in the screening programme. It is possible that supporting 
information may have altered their responses.
O’Sullivan and Orbell (2004) found that storage was a key concern for their participants, 
which was not supported in the current study. Here it was found that males were happier than 
females to store a FOBt during use. However, it was not evident as to why this was the case. 
Although many gender differences have been found in past research, as outlined in chapter 
two and studies within this thesis, they have focussed on gender differences in participation, 
or intention to participate in BCS, not so much the practical elements of completing a FOBt. 
However, Myers et al. (1994) did find that males had lowered self-efficacy in carrying out a 
FOBt. The results from the current study challenge these findings, as the storage of a test is 
considered to be part of carrying out the test. In this respect it could be deemed that the 
men’s self-efficacy in completing a FOBt was higher in this study.
Overall, although there were gender differences, the mean scores for storage were quite high 
indicating that individuals were quite happy about storing the test during use. Additionally, 
further exploration revealed that storage was not an issue for participants. These results 
revealed that storage of the test whilst it is being completed was considered to be more 
acceptable after participants had seen the test. This indicated that regardless of the test.
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storage was not a barrier to BCS. Although there were no significant differences within 
groups, mean scores revealed that participants were happier with storing the IFOBt 3, IFOBt 
4 and GFOBt after seeing the test, in contrast to the IFOBt land IFOBt 2. The explanation 
for this is deemed to be that, according to manufacturer guidelines, the IFOBt land IFOBt 2 
require refrigeration between uses, i.e., the initial test needs to be refrigerated whilst the 
second is performed. Therefore it is understandable why participants viewed these tests as 
less acceptable when they saw the IFOBt lor IFOBt 2 and read their instructions.
Although only approaching significance, there were differences found between and within 
groups for responses to the collection items on the questionnaires. Participant’s level of 
disgust appeared to reduce after they had seen the test, in a majority of cases. These attitudes 
seemed to be governed by the test type as found in the mean scores, in that disgust decreased 
with the IFOBt 1, GFOBt and IFOBt 4, and increased with the IFOBt 2and IFOBt 3. These 
results appear to correspond with the results found in both the classification of the tests and 
the scores for awkwardness of test and ease of instructions, as discussed previously, in that 
the IFOBt 3 seemed to incur more disgust after seeing the test whereas it reduced after 
seeing the IFOBt 1.
Although the mean scores for the IFOBt 3 show that it was the best test for collection 
overall, which contradicted the earlier findings, it was scored as less disgusting than the 
GFOBt to collect samples for. This supports the findings from the systematic review in 
chapter six, whereby faecal sampling for a GFOBt was deemed to be less acceptable to 
participants than an IFOBt (Cole et al., 2003; Hughes et al., 2005; Federici et al., 2005; Van 
Rossum et al., 2008). This was because a GFOBt was considered to be more unpleasant, 
messier, harder to use and involved taking more bowel samples; all of which could apply to 
the GFOBt in this study. However, overall, the GFOBt was considered to be one of the least 
disgusting tests, as it was scored higher than the IFOBt 1, IFOBt 2 and IFOBt 4.
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The test type also affected intention, both before and after seeing the test, which answered 
the third aim of this study; i.e., to explore the effect of test type on intention to be screened. 
It was not clear why there were differences between groups in intention before participants 
had seen a test. However, intention after seeing the test was highest for those viewing a 
GFOBt, and the lowest for those sent an IFOBt 1. This result was surprising to the author as 
it opposed implications, from the systematic review in chapter six, that an IFOBt would 
incur higher intention to be screened. For instance, it was thought from the systematic review 
that IFOBt’s in this study would be considered as less awkward because there were less 
samples to collect or the tube/probe devices would mean less faecal manipulation. This 
finding also contrasted with Ellis et al. (2007) whereby participants reported the current 
FOBt being utilised by the BCSP to be the least acceptable compared to two other FOBt’s. 
One reason for this in the current study may have been a participant awareness of the GFOBt 
being utilised in the current NHS programme, hence the familiarity of the test may have 
increased their intention to take part.
Finally, although intention to participate in the BCSP was high overall, postage was the 
strongest predictor of intention to be screened on questionnaire two. Here, the happier 
participants were to post the test back to a laboratory for analysis, the higher their intention 
to be screened. This supported the findings in study one whereby interviews revealed 
concerns about returning the test by post. This was also a significant factor found by Chappie 
et al. (2008) who found that unwillingness to post a used test, may contribute to declining 
screening participation. It was conceived by the author at this point that issues with postage 
seem to revolve around psychological cost, i.e., distaste of posting samples.
Psychologicalfactors
Fear has previously been found to be a good predictor of screening participation (Tessaro et 
al., 2006). In the current study, results found that fear about BC was higher, after seeing the
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test, in those who had a history of large bowel investigation, e.g., FOBt or colonoscopy. 
Furthermore, an examination of mean scores revealed that fear increased from before to after 
seeing the test in this group, whereas it decreased for those with no history. It is not clear 
why this was the case; perhaps participants were more fearfiil of the outcome of the test as 
found in Tessaro et al. (2006). Alternatively, these results could be likened to those found in 
study one, whereby fear stemmed from a negative past experience of bowel investigation. In 
the current study, it is possible that individuals were reminded of their previous experience 
of bowel investigation. Even if this was not a negative experience, they may have been 
reminded of their possible vulnerability to BC, hence increasing their fear after seeing the 
test.
Significant differences for fear responses between work status groups were also identified. 
This only occurred in responses to fear items on questionnaire one. The results found that 
individuals who were employed full-time were less fearful of BC than those who worked 
part-time, or were retired. Furthermore, it was found that age interacted with work status to 
produce this result; younger participants may have had less interest in BCS because they are 
occupied with work or family commitments, as found by Vernon (1997). This may interact 
with the perception that they are at a lower risk to BC because of their age, as outlined by 
Weller et al. (2006), resulting in less fear of BC. Thus, it could be conceived that older 
individuals have less of these commitments and more interest in screening, which interacts 
with a perceived vulnerability because of their age, resulting in a higher fear of BC. 
Additionally, fear did not seem to be particularly high across the three groups. This was not 
considered to be a favourable result, as lowered fear has been found to result in lowered BCS 
participation (Sun et al., 2004).
Optimistic bias is considered to be a stage in the process of contemplating BCS participation, 
as outlined by Weinstein et al. (2000). The results found optimistic bias to be one of the main
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predictors for intention to be screened on questionnaire one. This supported the findings of 
study four, whereby lowered optimistic bias was also found to predict higher intention to be 
screened. Once again it is thought that participants, who perceive their risk to BC as lower 
than others, are less likely to participate in screening as found in Klein and Helweg-Larsen 
(2002). Embarrassment has been classified in previous research as a psychological cost 
(McCaffery et al., 2001). Embarrassment was the secondary predictor of intention to be 
screened on questionnaire one. Here it was apparent that intention was higher when 
embarrassment was lower. This finding was of concern to the author as in a focus group 
study, by Beeker, Kraft, Southwell and Jorgensen (2000), embarrassment or shame of 
completing a FOBt diminished the motivation to be screened. This was supported by 
previous research outlined in chapter two, whereby embarrassment was highest in non­
participants (Janz et al., 2007). It was interesting to see how the predictors of intention 
changed from optimistic bias and embarrassment in questionnaire one, to the issue of 
postage in questionnaire two. It is as if by seeing the test that the intention is no longer 
driven by psychological factors, but by practical issues. However, overall, it seemed that 
psychological costs predicted intention.
Limitations
The limitations of this study are as follows. There may have been an element of response 
bias, in that a majority of the participants were known personally to the author and therefore 
may have responded more favourably to the questionnaire items. There was also a forty five 
percent attrition rate for the study. Therefore the results may have been subject to non­
response bias, i.e., responses from non-responders may have differed from those received. 
The sample was demographically biased in the respect that a majority of participants were 
female, white British and aged between 50-60 years old. However, it was felt that the 
percentage of males and older participants formed representative samples. It would have 
been difficult for the author to find a more ethnically diverse population because, as stated in
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chapter five, the data was collected in the county of Surrey where 93% of the population is 
white British (National Statistics Census, 2001). The age of participants ranged from 50-77 
years old. Therefore it is difficult to generalise the results from the younger participants, i.e., 
50-59 year olds, to the NHS BCSP population in England. However, it was felt that by 
excluding these cases, the response rate would be severely affected; hence all ages were 
included in the data analysis.
It was not known from the questionnaires if participants had previously taken part in the 
NHS BCSP, and whether this may have affected their responses. For instance, although there 
was a question about previous large bowel investigation, it is not known whether all 
participants would have included a previous FOBt or whether they would have thought this 
only pertained to internal bowel investigation, e.g., colonoscopy. This was deemed important 
as some participants may have responded to questionnaire items, and the test that they saw, 
based on a comparison with the test they had previously used in the national programme. 
Additionally, if this was the case with participants looking at a GFOBt, they may be aware 
that the instructions usually having diagrams and basing their responses on what they 
recalled from taking part in the national programme, rather than the instructions they were 
looking at in the study. Moreover, if participants had previously taken part in the BCSP, they 
may possess increased knowledge as they would have seen the BCSP information 
accompanying the test. Increased knowledge has previously been found to increase 
participation (Hughes et al., 2005). Therefore, responses from participants may have been 
biased.
Finally, as in chapter five, it is difficult to generalise some of the findings in this study 
relating to action or participation. As outlined by Power et al. (2008) intention and action are 
very different, and therefore just because a participant in this study intends to take part, does 
not guarantee their participation in a national screening programme. However, the results
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from this study are still considered important as they outline reasons which may decrease the 
motivation to participate in screening.
Conclusion
The significant results from this study reaffirm those found in the other studies discussed 
within this thesis to an extent. Results for fear have appeared in all of the previous studies. 
However it is not known from this study how the role of fear may affect future participation 
in the BCSP, e.g., with individuals who have a past experience of bowel investigation, would 
higher fear enhance the need to reduce the threat of BC or result in avoidance or denial of the 
disease. Alternatively, the results for optimistic bias, detection and postage supported those 
found in studies one to four. Embarrassment was the only new factor appearing within this 
study.
Each of these factors appeared to sit well within the PMT outlined in chapter three. Here it 
was thought that optimistic bias and fear were components affecting threat appraisal, 
whereas embarrassment, postage and detection were affecting individuals coping appraisal. 
Therefore, an individual who does not feel vulnerable to BC, is embarrassed about taking 
part, does not think that participating in screening will reduce their risk of BC and perceives 
posting a FOBt as an unsatisfactory method of returning a test would be less likely to intend 
to take part in BCS. This intention may be mediated by factors such as a history of bowel 
investigation which may or may not reinforce the desire to be screened.
Overall, the three aims of the study were achieved. There were different attitudes towards the 
practical elements of completing a FOBt, and attitudes did change from before to after seeing 
the test. Furthermore, the type of test also affected intention to be screened. Opinions about 
the GFOBt were more favourable than expected, which was considered beneficial for the 
current NHS BCSP.
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Chapter Eight
Discussion
Introduction
The purpose of this chapter is to provide an overview of the research findings from the five 
studies presented within this thesis. This will demonstrate how each of the studies inter­
relate, their strengths and limitations. As findings from each study have been discussed in 
depth at the end of each chapter, only the significant findings from the five studies shall be 
discussed in detail here. Once the strengths and limitations of the research have been 
outlined, the discussion will culminate with the implications of the research as a whole, its 
contribution to the field of BCS and future directions for the NHS BCSP.
Summary of findings
The aim of the three qualitative studies, in chapter four, was to explore the psychosocial 
factors and barriers affecting BCS. The author wanted to ascertain how the findings from 
these studies, specifically identifying the new NHS BCSP through personal experiences and 
expectations of the programme, related to the literature identified in chapters two and three. 
A triangulation of these studies revealed three recurrent themes, i.e., emotions, beliefs and 
issues with the FOBt. The predominant emotion, fear, was associated with the information, 
invitation and FOBt sent out by the NHS BCSP. There was also fear associated to a past 
experience of bowel investigation and cancer itself. Overall, fear was found to reduce BCS 
participation which supported previous findings (Tessaro et al., 2006). In regards to beliefs, 
there appeared to be an underlying optimistic bias in the responses relating to gender, age, 
health behaviours and predisposition to cancer. It was found here that individuals did not 
perceive themselves to be vulnerable to BC because they did not belong to a group they 
thought would be at more risk, e.g., past diagnosis of cancer. This lowered perceived 
vulnerability resulted in lower participation in the BCSP as seen in studies one and two.
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which appeared to support the findings of McCaffery et al. (2001). Issues with the FOBt in 
the qualitative studies included concerns about convenience, detection, collection, postage 
and storage of the FOBt which supported previous findings that such issues can negatively 
affect participation (Vernon, 1997; Kremers et al., 2000; ACS, 2004, O’Sullivan and Orbell, 
2004 and Chappie et al., 2008).
The aim of study four, in chapter five, was to explore individual’s attitudes towards BC and 
BCS, to see if these attitudes affected their intention to be screened in the NHS BCSP. The 
items for the questionnaire in this study were based upon the findings from the qualitative 
studies, to find out if there were any factors or barriers which affected screening participation 
more than others. Males and older adults reported higher fatalistic beliefs, which both 
supported and contradicted past research whereby females and older adults were found to be 
more fatalistic (Powe and Finnic, 2003). Males were also found to perceive the test as more 
awkward to cany out, and have lowered self and response efficacy with regards to the FOBt 
supporting Meyers et al. (1994). Older age was found to increase the perceived awkwardness 
of the test, which contrasted with previous research (Wardle et al., 2000; Ellis et al., 2007). 
Increasing age was also related to decreased intention to be screened which appeared to 
contradict findings from Jerant et al. (2004). Significant relationships were also found 
between the items tested which mostly supported previous literature and the PMT. Finally, 
there were five significant predictors of intention to be screened: detection, fear, fatalism, 
optimistic bias and practicality; the latter being the main predictor. These results supported 
previous research findings from Tessaro et al. (2006), McCaffeiy et al. (2001), Niedereppe 
and Levy (2007), Kremers et al. (2000) and Schroy (2002).
From study four, it was apparent that the practical elements of completing a FOBt may be a 
significant barrier to screening however it was not deterrhined why this was the case. 
Although practicality was discussed in chapter two, it was deemed necessary to investigate
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the practical elements of a FOBt further; hence a systematic review, in chapter six, was 
carried out. This revealed particular elements of a FOBt, including the type of device, which 
could inhibit participation. Therefore the aim of study five, in chapter seven, was to explore 
attitudes towards these practical elements, to see if attitudes changed from before to after 
seeing the test and to look at the effect of different types of FOBt upon intention. The 
findings revealed that males were happier to store the test than females, which appeared to 
contrast with study four, and past research suggesting that males had a lower self-efficacy 
and preferred other modalities of screening (Meyers et al., 1994). Differences were found in 
relation to fear whereby participants having had bowel investigation were more fearful than 
those who had not, which may have been due to a negative past experience, as seen in study 
one, or fear of a positive outcome (Tessaro et al., 2006).
Participants who were employed full-time were found to be less fearful than those who were 
part-time or retired, which may have been because they had less interest in screening 
(Vernon, 1997). Participant’s response efficacy decreased after they had seen the test which 
has been found to reduce intention to be screened (Meyers et al., 1998; Szczepura, 2003; 
Weller et al., 2006). Contrary to results from O’Sullivan and Orbell (2004) participants did 
not appear to have an issue with storage, as they perceived the storage of the test as better 
when they saw what the test involved. Psychological factors, optimistic bias and 
embarrassment, were the significant predictors of intention before seeing the test, which 
have been previously found to lower BCS participation (Wardle et al., 2000; Jorgensen, 
2000; Janz et al., 2007). After seeing the test one practical element of the FOBt, postage, was 
the main predictor of intention, which supported evidence that practical factors such as 
postage can reduce participation (Chappie et al., 2008).
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Strengths and Limitations
The deficiencies in the cuirent literature, highlighted in chapter two, included a lack of 
research specific to the national BCSP, and moreover a lack of studies which accessed 
individuals who declined screening and their reasons for doing so. These deficiencies were 
directly addressed in studies one and two whereby personal experiences of being invited for 
screening in the NHS BCSP were explored. Although studies three, four and five did not 
utilise participants from an NHS setting, hence were not directly related to the NHS BCSP, 
they each included participants to whom screening would be applicable, hence referring to 
their intention to participate in the future; which had not been done previously. Furthermore, 
study three utilised materials from the programme during the focus group and study five 
related to one FOBt which is currently being used, and four other FOBfs which may be used 
in the programme in the future. In this way, the findings are considered to make a 
contribution to this area because they are relating past literature to the current screening 
programme.
The results from these studies revealed beliefs, emotions and issues with the FOBt which 
resulted in non-participation, and interestingly, the predominant findings from these 
qualitative studies resonated throughout studies three, four and five. The findings from the 
five studies also supported previous research, outlined in chapters one and two, which 
demonstrates their external validity. The systematic review also made a valid contribution to 
the field of BCS, as the results outlined a further discrepancy in current literature; that 
although the type of test and its practical elements can affect participation, it is an under 
researched area. This discrepancy was addressed in study five.
A low response rate was the predominant limitation in study one; hence the results were not 
conceived to be a true representation of a population that have declined BCS participation. 
More participants would have improved the internal and external validity of the study. There
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were also concerns regarding the level of disclosure during interviews, which could have 
been improved by better interviewing skills. Furthennore, the author was unsatisfied with the 
responses to the fatalism question. It is thought that this could have been rectified had the 
questions been piloted prior to implementation. The sample was gender biased in each of the 
qualitative studies, i.e., more males in study one and more females in studies two and three. 
This could have been rectified by achieving a higher response rate in study one, i.e., sending 
out more invitations, inviting males to take part in the focus group, and auditing calls from 
more males contacting the helpline. The author was also concerned about the accuracy of 
responses in these studies, i.e., by the level of participant disclosure in the studies plus the 
helpline assistants taking the calls in study two. Furthermore, in study two it was not 
recorded at which point in the screening pathway the individual declined screening, i.e., after 
they had received the invitation or the test kit, which would have been useftil to compare 
with the results from study five regarding attitudes before and after seeing the test.
The results in study four may have been subject to selection bias. It was felt that this could 
have been measured had ‘approachers’ been distinguishable from ‘non-approachers’. The 
reasoning behind responses for this study were limited by the subjectivity of the author, in 
the respect that there are many reasons why individuals responded in the way that they did, 
however, these were speculated upon in relation to findings from the latter studies and the 
literature reviewed in chapters two and three. Moreover, as the items were limited, they did 
not account for mediating factors, e.g., family history. Therefore caution was exercised in the 
usefulness of these findings. The results from study five may have been subject to response 
bias, as participants were known to the author, and non-response bias as there was a 
relatively low response rate. Furthermore, there was difficulty in generalising the results as 
regards to age range, i.e., participants age started from fifty years old which is not 
characteristic of the current BCSP age range in England. These issues could have been 
avoided if a higher volume of questionnaires had been sent out initially, to a population
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unknown to the author. Finally, the questionnaire items for both studies four and five were 
limited in the respect that there was only one item to measure some multi-dimensional 
constructs. It would have been preferable to have a number of items addressing each 
construct; however, the author was constrained by the possible deterioration in response rate.
There was a predominance of female participants throughout studies three, four and five, 
which meant that males were not represented as well as hoped. There was also no ethnic 
diversity measured in any of the studies. In regards to male recruitment, the author could 
have endeavoured to balance out the genders in studies, i.e., specifically recruiting more 
males. As far as ethnicity is concerned, the author could have collected data from a wider 
geographic area, e.g., London, to gain more ethnically diverse samples.
It was difficult to attribute causal relationships in studies four and five, as the direction of the 
relationships could not be ascertained. For example, in study four, did self-efficacy influence 
the perceived awkwardness of the test, or did the awkwardness effect self-efficacy. 
Identifying the direction of these relationships would be a necessity in future research, 
particularly if these constructs were being utilised within an intervention.
Implications
The predominantly inter-relating findings from the five studies, i.e., findings which recurred 
in three or more studies, are considered to have both theoretical and practical implications 
which will now be discussed.
Demographics
Demographic characteristics were not considered in the theories and models explored in 
chapter three. However, it is possible to gauge practical implications from the results found 
in the five studies. Findings across studies one, two, three and four found that age affected
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participation and intention. Firstly, participants in studies one and three perceived older 
adults to be at more risk of BC. As discussed in chapter four, this was thought to be a belief 
which was subject to optimistic bias; i.e., individuals did not feel that they were part of a 
group prone to BC. However in study two, individuals in the upper age range felt that they 
were too old to take part. It was not certain why this was the case, i.e., due to optimistic bias, 
fatalistic beliefs or simply because individuals did not think that screening applied to them as 
they were nearing the age limit for automatic invitations. Similarly, in study four, intention 
was lowest in the seventy plus age group and it was thought that perceived awkwardness of 
the test and fatalism which increased with age may have decreased their overall intention.
Therefore, research is required to specifically address the role of age in BCS. In relation to 
factors such as optimistic bias and fatalism, qualitative research should seek to identify why 
individuals of different ages hold certain beliefs about their susceptibility to BC. From this it 
should be possible to tailor an intervention which targets specific age groups, to increase 
adherence in these groups, e.g., developing additional information for individuals over sixty 
five years old which outlines their risk to BC. Furthermore, in relation to individuals who 
consider themselves to be too old to take part in the screening programme, more publicity 
could be utilised, not only to highlight risk, but also to increase awareness that screening is 
applicable to those over sixty nine years old. For instance, the current BCS ‘The Facts’ 
leaflet (Appendix 3) only states that screening is available to over sixty nine year olds on the 
final page of the information. This may be why some individuals perceive themselves as too 
old to take part.
In relation to gender, there appeared to be some controversy within the qualitative studies as 
to who was more at risk. There also appeared to be some optimistic bias as to who was more 
susceptible, supporting evidence that individuals do not feel they belong to a group at risk. In 
study four, males appeared to respond very differently to questionnaire items, in that
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response efficacy, self-efficacy and fear were lower than females and awkwardness in 
completing a FOBt and fatalism were higher. This appeared to support the HBM in that a 
lowered perceived threat and fear seemed to be outweighed by the costs of taking part, 
resulting in the adoption of a maladaptive coping response, as specified in the PMT. 
However, men did not seem to be as concerned about the storage of the test as females, 
suggesting that their self-efficacy may not be as low as suggested in study four. The 
implications from studies one and four are that men may be in denial as to their risk of BC, 
as suggested by O’Sullivan and Orbell (2004). This may stem from a lack of awareness, 
particularly as there has been speculation of a lack of publicity for male cancers (Harris et 
al., 1998; Evans et al., 2005).
Therefore it is considered necessary to carry out further investigation into male beliefs about 
BC and BCS, to enable the development of information specifically tailored for them in the 
national programme to encourage their participation in BCS. For instance, Pignone, Harris 
and Kinsinger (2000) compiled a decision aid for BCS which included a videotape, 
containing information about susceptibility to BC, carrying out a FOBt, an explanation of 
results and footage of patient’s personal experiences of screening. After viewing the tape 
participants were asked to select one of three information booklets, depending upon whether 
they were uncertain about BCS, had further questions or were willing to be screened. Their 
health practitioner was then made aware of which booklet they had chosen. The results from 
this intervention showed an increase in intent to contact their health provider about 
screening, and overall intention to be screened. This type of intervention is considered to be 
useful on many levels. Potentially, it could increase awareness about severity and 
susceptibility to BC, increase contact between males and their GP’s and help to improve self- 
efficacy; overall improving BCS participation in males.
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Fear
According to the HBM, individuals should be motivated by fear to reduce their threat of BC 
(Becker and Rosenstock, 1984). Similarly, in the PMT, fear is part of threat appraisal 
whereby individuals seek to reduce threat by engaging in screening (Rogers, 1983). 
However, in studies one and two increased fear was found in relation to the severity of and 
susceptibility to BC. This contributed to non-participation, which may mean that the fear or 
threat of BC outweighed the benefits of screening, contrasting with earlier findings from 
O’Sullivan and Orbell (2004). This implies that fear is a barrier to screening as found in 
Tessaro et al. (2006). Therefore it was argued that, contrary to previous findings, lower fear 
may be a good predictor of screening. Contrastingly, in study four, increased fear was found 
to be a good predictor of intention in accordance with the HBM and the PMT. These findings 
suggest that increased fear is a better predictor of intention as stipulated by Milne et al. 
(2000), and lower fear is a better predictor of participation as found in Tessaro et al. (2006). 
Study five revealed that participant characteristics were an important determinant of fear 
levels. For example, individuals who had a previous experience of large bowel investigation 
were found to be more fearful than those who had not. This implies that future research 
should not only concentrate on how fear contributes to intention or participation, but also 
upon the mediating factors of perceived threat which result in higher or lower fear, hence 
participation or non-participation.
As discussed in chapters four, five and seven, there is the possibility that fear in the four 
studies was moderated by a lack of awareness, as specified by O’Sullivan and Orbell (2004). 
Research has shown that increased knowledge or awareness can redress a realistic perception 
of threat (O’Conner et al., 2006). This implies that more awareness of the programme and its 
necessity are imperative to increase participation rates. However, the type of information 
made available would also be crucial, as in studies one and two, the information received 
seemed to have a negative effect, raising concern that information may be inciting fear in
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individuals which contrasts with previous research (Wardle et ah, 1999). Once again, it 
would be useful to gain some feedback from individuals who have been invited to take part 
in screening as to the content of the information they received. An evaluation of this 
information from a public perspective, to knowledge, has not been conducted since the 
programme began.
Finally, these results highlight a limitation of health theories such as the PMT, which do not 
account for the role of socio-demographics. Therefore, it is considered important to address 
these characteristics, especially during the design of tailored interventions, e.g., increasing 
participation in individuals who do not have a history of bowel investigation.
Optimistic bias
Throughout the studies discussed within this thesis, optimistic bias has been maintained as a 
belief held by individual’s which reduces their intention, or participation in screening (Lu et 
al., 2009; Robb et al., 2008). According to the PAPM, these individuals would remain in 
Stage 2, as they appear unaware of their personal risk (Weinstein, 2000). In this way 
optimistic bias was found to be both a predictor of intention as seen in studies three, four and 
five, and a predominant barrier to screening as seen in studies one and two. These findings 
supported Lu et al. (2009) who found that optimistic bias reduces intention and Klein and 
Kunda (1994) who stipulated that optimistic bias can result in a maladaptive response, i.e., 
non-participation. Furthermore, Wardle et al. (2000) suggested that those who were 
optimistically biased were more susceptible to information relating to risk control; however, 
within the first two qualitative studies participants had difficulty with the information, which 
may also have contributed to their non-participation. In studies four and five reasons for 
optimistic bias could only be speculated upon.
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The practical implication from these findings is that individuals need to be more aware of 
their personal risk to BC. To achieve this, it is thought that more qualitative investigation 
into optimistic bias in this area is warranted, to ascertain why individuals perceived 
themselves to be at lower risk, as suggested by Clarke et al. (2000). Once these reasons have 
been established, it is thought that an intervention to increase their perceived belonging, to 
the group they consider to be more at risk, is needed as concluded by Robb et al. (2004). Lu 
et al. (2009) specified that seeking information increased intention to be screened because it 
enables individuals to understand their personal risk of cancer. If this is the case, then an 
intervention similar to that used by Pignone et al. (2000) may be useful here, i.e., 
information tailored to the individual which encourages seeking information. Futhermore, as 
suggested by Robb et al. (2004), perceived membership of a group is imperative in reducing 
optimistic bias. Therefore a film showcasing the personal experiences of ‘average’ 
individuals who have been through screenings, i.e., don’t have a family history or previous 
experience of cancer, may encourage this perceived belonging, hence improving 
participation.
Issues with FOBt
Issues with the practical elements of the FOBt were apparent throughout the five studies. In 
the qualitative studies it was ascertained that there were issues with collection, storage, 
postage, convenience and detection which affected participation; hence reflecting the 
literature in chapter two (Vernon, 1997; Kremers et al., 2000; ACS, 2004, O’Sullivan and 
Orbell, 2004; Chappie et al., 2008). Furthermore, a majqrity of the qualitative findings were 
consistent with the results found during the systematic review, where guaiac FOBt’s were 
considered to be complicated, distasteful, messy, and lacking convenience resulting in non­
participation (Cole et al., 2003; Federici et al., 2003 and Hughes et al., 2005). In study four, 
increased awkwardness with completing a test was found to lower intention to be screened. 
Therefore it was expected that the results from study five would favour immunochemical
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tests; however, this was not the case. In study five although test type was found to affect 
intention to be screened, the GFOBt was scored higher than the IFOBt’s, i.e., intention was 
higher when participants viewed a guaiac test. Possible reasons for this discrepancy were 
that participants in study five were not requested to complete the FOBt they were sent, 
whereas those invited to participant in the BCSP and participants in the systematic review 
studies were. Moreover, the studies included in the systematic review did not refer to any of 
the FOBt’s requiring refrigeration during completion; factors which may have affected 
responses in study five.
Postage was also found to predict intention to be screened in study five. This appeared to 
support findings from study one and Chappie et al. (2008), whereas this was not an issue 
discussed in the review studies. Additionally, perceptions about storage were found to 
improve after participants had seen the test in chapter five which contrasted with findings 
from O’Sullivan and Orbell (2004) who reported that participants were concerned about 
storing a FOBt during use. The implication from this result is that if attitudes changed from 
before to after seeing a FOBt in this setting, that this may also be the case in the current NHS 
BCSP. For instance, there may be individuals invited for screening who decline on the basis 
of the invitation alone, a decision which may have been different if they had seen what the 
FOBt involved.
As discussed during chapter seven, storage and postage, could be classified as psychological 
costs or factors of self-efficacy. These two areas have been found to overlap (Vernon et al., 
1997) and have both been found to be strong predictors of screening (Kremers et al., 2000; 
Janz and Becker 1984 and Harrison et al., 1992). If they are considered as costs, it could be 
that if individuals were more aware of the costs, they may be more prepared to deal with 
them, as found in Powell et al. (2008). However, as factors of self-efficacy, individuals may 
need reassurance that they can overcome storage and postage issues to successfully complete
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a FOBt. Stokamer et al. (2004) found that patient education improved participation by fifteen 
percent, and it is thought that education programmes which could help improve confidence 
in completing a FOBt would be useful here. The convenience of the test was a consistent 
issue throughout the qualitative studies. It was considered to reduce participation in studies 
one and two, and raised concerns in study three; however, this was not supported by study 
five. Perhaps this was because participants in study five were not required to complete a 
FOBt; hence convenience of the test was not deemed to be an issue.
Detection, or the ability of the FOBt to detect the early signs of BC, was considered to be 
response efficacy which has been found to affect both participation and intention (Kremers et 
al., 2000; Meyers et al. 1998). Detection was questioned in four out of the five studies within 
this thesis. In studies one and three this appeared to be the result of viewing the information 
sent by the BCSP, in study four, it was a perception of a test participants had not seen, and in 
study five the efficacy of the test was scored lower after participants had seen the test. These 
results were of concern as regardless of seeing accompanying information, or seeing the 
actual test, individuals were not convinced about the usefulness of the test. As specified 
during the discussion in chapter four, there was the possibility that participants had 
misinterpreted the information they were sent by the programme. In studies four and five, no 
accompanying information was available to participants. Therefore, it could be that there is a 
lack of knowledge and awareness about the FOBt, how it works and its usefulness as a 
screening test.
It is also thought that if the information regarding the usefulness of the test came from the 
GP, it may act as a recommendation thus increasing confidence and participation, as 
specified by Millett and Parker (2003) who found that GP support was a crucial part of 
screening adherence. Furthermore, in the decision aid used by Pignone et al. (2000), the 
videotape featured advice from health practitioners about carrying out a FOBt, which
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increased the participant’s intent to contact them after the viewing. This suggests that an 
intervention of this nature may help to overcome the issues individuals have with the FOBt 
in the NHS BCSP. Therefore, specific research regarding attitudes towards detection is 
considered vital to show how this information could be alienating part of the potential 
screening population, and how this could be presented alternatively to increase adherence 
there.
Intention
Intention to be screened in the BCSP was considered to be high in studies three, four and 
five, but as the results revealed there are many factors which àftèct intention. It was also 
understood at the commencement of these studies that increased intention may not result in 
participation (Powell et al., 2008). However, the themes in studies one and two outlining the 
reasons for non-participation revealed psychosocial factors and barriers which were 
consistent throughout the three further studies. This demonstrated that although intentions 
may not always predict behaviour, if there are reservations prior to being invited to take part 
in screening, then these may be present when the invitation arrives. Preconceived ideas about 
BC and BCS may already be embedded in the individual and therefore it is the job of the 
information they receive to provide them with the knowledge they require to make an 
informed decision. In the HAPA there is a shift between intention and actual behaviour 
(Schwarzer, 1992). Initially, there is motivation. In study three participants were asked if 
they intended to take part, to which they responded ‘yes’, but the motivation behind this was 
unknown. In studies four and five, the motivation behind screening was identified.
According to the HAPA model, motivation consists of three elements, outcome 
expectancies, appraisal of threat and self-efficacy. The main predictors of screening found in 
studies four and five appear to be distributable between these elements, i.e., detection as an 
outcome expectancy, optimistic bias, embarrassment, fear and fatalism are appraisals of
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threat and postage contributes to self-efficacy. It is understood that these predictors do not 
form a comprehensive list, as they are only responses to questions asked, i.e., there may have 
been other reasons for intention; e.g., participants may have had a family histoiy of bowel 
cancer. However, their integration into this model is encouraging. For instance, the results 
from these studies found that if detection is perceived as better, optimistic bias, fear, fatalism 
and embarrassment are lower, and issues with postage are lower, then motivation to take part 
in screening will increase. In relation to the volition stage, it is conceived that self-efficacy is 
the key to action (Schwarzer, 1992). In which case, if results are considered as a whole, 
practical issues with the FOBt may govern whether an individual is motivated and carries out 
the action, or motivated but unable to translate this into action because they lack the self- 
efficacy to do so. This carries implications that more research would be necessary to 
investigate the shift from motivation to volition and which aspects of self-efficacy affect this 
process, so that confidence can be improved hence increasing participation. To do this a 
longitudinal study could be conducted whereby intention is measured before individuals 
receive information from the BCSP, and participation is measured after they have received 
the test.
Future directions
The future directions from the research conducted here lie in the implications for the NHS 
BCSP, which shall now be outlined. The research in this thesis has found both age and 
gender to be particular factors which affect BCS; especially with regards to older adults and 
males. Therefore, it is thought the programme should look to develop specific information 
for these groups to essentially raise awareness of their risk to BC, and to target beliefs which 
may be reducing participation in screening. As regards to fear, there is concern that the 
information currently being sent out to individuals by the programme is increasing fear about 
BC rather than providing reassurance, which may be discouraging participation. There is 
also concern that individuals are not confident in the efficacy of the FOBt, which may affect
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participation when they are sent the FOBt. Therefore it would be considered useful to 
conduct an evaluation of the current information being utilised, with eligible individuals as 
specified earlier, to assess their views on the information and how it could be improved.
The programme may also benefit from providing ways to improve confidence in completing 
a test. As discussed, the use of patient experiences would be considered an adequate tool to 
do this. The results from study five demonstrated that attitudes can change from before to 
after seeing the FOBt. Therefore, it may be beneficial to conduct an intervention study to 
address the effect of sending out the FOBt at the same time as the invitation, on 
participation. Study five also revealed favourability towards the FOBt currently utilised in 
the NHS BCSP, in comparison with other FOBt’s. Therefore if a new screening test was 
implemented in the BCSP, it would be beneficial to research the psychological factors 
associated with that test specifically, as it may affect future participation in the programme.
Conclusion
The findings from the research presented within this thesis have identified five main factors 
which affect both intention to participate, and actual participation in the NHS BCSP; namely 
age, gender, fear, optimistic bias and practical issues with completing a FOBt. Furthermore, 
the research is considered to have made two unique contributions to research in the field of 
BCS. It has contributed to literature specific to the current NHS BCSP by exploring personal 
experiences of individuals who have previously declined screening, and has also highlighted 
the necessity of evaluating the psychological aspects of completing a FOBt. Overall it is felt 
that by addressing these factors affecting BCS, that future participation could be increased.
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Appendix 1: NHS Screening pathway
The screening pathway
Invitation
I  Reminder sent If I I no return within I 
I four v/aeks I
Kit dispatched
Receipt and 
de'veiopment of used
Abnormal result 
(5 or 6  positive
Unclear result 
(1-4 positive 
sampies)
Spoilt klV 
technical fail
1 repeat kit 
dispatched
Either 1 or 2 
repeat kits
FOBt offered in 
t«vo years if < 70
Offered colonoscopy 
nurse appointment
Unsuitable -  
imaging
Does not accept
Other pathologyPolypNothing
abnormal
detected
FOBt offered 
in t\’/o years if 
< 7 0
I High rl*kI > S adenomas
I OR
I > 3  adenomas of which at least 1 I is > 1 cm
Intermediate risk
3 or 4 small adenomas 
OR
t least 1 aden o m as 1 cm
Low risk
1 or 2  small (< 1 cm) adenomas
Three yearly colonoscopy 
surveillance until two negative 
examinations
FOBt in tv/o years if <: 70 Colonoscopy after 12 months.
foiiov/ed by three yearly 
colonoscopy surveillance until 
two examinations
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Appendix 2: NHS Bowel Cancer Screening invitation - Study 
One/Three
25 December 2005
Mrs A Example-Subje ct
Hemburi,  ^House
Cheitton
ShobroQke
Crediton
Devon
YY1 5TT
SI 278/7/26 NHS Ns:333 333 4444
Dear M rs Exam ple-Subject
This Is an invitation to take part in the NHS Bowel Cancer Screening Prog ramme. This 
opportunity is available to all men and women aged 60-69 who are registered with a GP in 
England. If you have received this invitation and are aged 70 or over, this is because the 
screening age range is being extended to 60-75 in your area. This is happening gradually 
across England over the next few years. Your GP knows that the NHS Bowel Cancer 
Screening Programme is being offered in his or her area. The aim of the screening programme 
is to detect bowel cancers at an early stage, when there are better chances of successful 
treatment and cure.
You will automatically be sent a test kit, including fail instructions, in about a  week's time. The 
kit is simple to use in the privacy of your own home. If you wish to take advantage of the 
screening programme, all you have to do is complete the kit and return it to us in the Freepost 
envelope that will be provided. You will receive a  result letter within two w eeks.
We do not have knowledge of your medical histoiy, and screening may not be appropriate for 
everybody. For example if you;
- have had a colonoscopy or a barium enem a plus a  sigmoidoscopy within the last 2 years;
- are on a bowel polyp surveillance programme;
- are currently being treated for bowel cancer;
- have had your large bowel removed;
- are currently being treated for ulcerative colitis or Crohn's Disease;
- are currently awaiting bowel investigations arranged by your GP.
If you fall into any of the above categories, or you do not wish to participate in the screening 
programme, please contact us to let us know. The Freephone number Is at the top of this 
letter, if you need help from family or a carer to use the kit, please call {or ask them to call) the 
Freephone number for further important information. P lease take the time to read the 
enclosed leaflet ’Sowe! Cancer Screening - The Facis\ which may help to answer any 
quesions you have. You can also call the Freephone number if you have any queries about 
whether to take part.
Yours sincerely
Stephen P Holloran FRCPath 
Hub Director
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Appendix 3: Bowel cancer Screening -  ‘The Facts’ leaflet
NHS
Cancer Screening i  ^ogi ammes
BOWEL CANCER SCREENING
The Facts
218
VVhal is I Ilf -liin of tin's Ifevllel?
This leaflet gives you information about bowel cancer” 
and the benefits and risks of bowel cancer screening, 
it aims to help you make an Informed choice about 
taking part in the NHS Bowei Cancer Screening 
Programme.
What IS llte pHipose of bowel caiicer screening?
$ Bowel cancer screening aims to detect bowel 
cancer a t an early stage (in people with no 
symptoms), when treatment is more likely to 
be effective.
e Bowel cancer screening can also detect polyps. 
These are not cancers, but may develop into 
cancers over time. They can easily be removed, 
reducing the risk of bowel cancer developing.
Is s c r e e n in g  for h w / o i  c o n r e r  in ip o r k ir n ?
#  About one in 20 people in the UK will develop 
bowel cancer during their lifetime.
# It is the third most common cancer in the UK, and 
the second leading cause of cancer deaths, with 
over 16,000 people dying from it each year (Cancer 
Research UK, 2005. Cancerstats).
Regular bowel cancer screening has been shown to 
reduce the risk of dying from bowel cancer by 16% 
(Cochrane Database of Systematic Reviews, 2006. 
ic ræ n Jflÿ  co/omcTa/ cancer tAe A e c a /
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Wliat 15 tlie NHS Bowel CaiKer Screening 
Programme?
The NHS Bowel Cancer Screening Programme 
offers screening every two years to all men and 
women aged 60 to  s i .  People in this age group will 
automatically be sent an invitation, then their 
screening kit, so they can do the test at home. Your 
GP will provide your contact details, so it is important 
that he or she has your correct name and address.
After your first screening test- you will be sent 
another Invitation and screening kit every two 
years until you reach 69. If you are agi d 70 or mrec 
you can ask for a screening kit %  calling the 
Freephone number at the end of this leaflet (page 15|.
s the bowel dor
The bowel is part of our digestive system and is 
divided into the small and large bowel The large 
bowei is made up of the colon and rectum.
2 2 0
Food passes from the stomach to the small 
After the small bowel takes nutrients Into the body 
any undigested food passes through the large bowel, 
where water is removed from the waste matter. This 
waste matter is held in the rectum (back passage) 
until it leaves the body as bowel motions (also known 
as stools or faeces).
#15 bowel ccincet?
Bowel cancer Is also known as colon, rectal or 
colorectal cancer The lining of the bowel is made of 
cells that are constantly beiiig lenewed. Sometimes 
these cells grow too quickly forming a clump of cells 
known as a bowel [mlyp (sometimes known as an 
adenoma). Polyps are not bowel cancers (they are 
usually benign), but they can change into a malignant 
cancer over a number of years. A malignant cancer is 
when cancer cells have the ability 1u spread beyond 
the original site and into other parts of the body.
D is At risk of rievelop ing .lxr/,/el cancer?
men and women are at risk of developi 
bowel cancer
# Your risk of developing bowel cancer increases with 
age. Eight out 10 people who are diagnosed with 
bowel cancer are over 60.
people with a family history of bowel cancer have 
dn increased risk of developing the disease.
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People who take little exercise^ people who are 
overwerght, and people who have a diet high 
in red meat and lew in vegetables, fruits and fil 
are all thought to have an increased risk of 
developing bowel cancer.
o w  d o e s  trie screening lest w c
e- The screening test detects tiny amounts of bio 
which you cannot normally see, in your bowel 
motions. It is called the Faecal Occult Blood 
f  occult bioodTme ans hidden blooi
ps and bowel cancers sometimes bleed, which 
is why we screen for blood in your bowel motions.
The FOB test does not diagnose bowel cancer, 
but the results will tell you whether you need an 
examination of your bowel {a colonoscopy).
dow is Ute scteeninu (FOB) test out?
You carry out the FOB test in the privacy of your own 
home. The screening kit provides a simple way for you 
to collect small samples of your bowel motions. You 
wipe the samples on a special card, which you then 
send in a hygienically sealed Freepost envelope to a 
laboralcry for testing. There are detailed instructions 
with each I it You may think that doing the test 
sounds a bit embarrassing or unpleasant, but it will 
only take a few minutes and it is an effective way to 
mwel cancer early
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Its and what do
mean?
You should receive a results letter from the 
within two weeks of sending in your sample. There are 
three types of results you could receive.
« A noirnal r e s u l t  means that blood was not found 
in your test sample. Most people (about 98 out of 
TOO) will receive a normal result. A small number 
of these people will have repeated the test due to 
an unclear result beforehand.
A normal result does not guarantee that you do 
not have or will never develop boweI cancer in 
the future, so being aware of the symptoms of bowel 
cancer (see page 10) is very important. You will be 
offered bowel cancer screening again in two years.
# An iiiri, I, I nit means there was a slight 
suggestion of blood in your FOB test sample.
This could have been caused by conditions such 
as haemorrhoids (piles) or stomach ulcers. 
Receiving an unclear result does not mean you 
have cancer; Just that you need to repeat the
If you receive an unclear result, you will be asked to 
complete the FOB test up to two more times. This is 
necessary because polyps and cancers do not bleed all 
the time and it is important to find out whether or not 
there is blood in your stools. About four people out of 
every 100 will initially receive an unclear result Most 
people who repeat the test will then receive a normal
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6 An dlnoimal lestill shows th a t blood may have 
been found in your FOB test sample -  It Is not a 
diagnosis of cancer; but It does mean tha t you 
will h i  offered a colonoscopy. The abnormal 
result may have been caused by bleeding from 
bowel polyps, rather than a bowel cancer. It may 
also have been caused by other conditions, such as 
haemorrhoids (piles).
About two in every 100 people doing the test will 
have an abnormal result. Sometimes, someone with 
an abnormal result will have repeated the test due 
to a previous unclear result. If you receive an 
abnormal result, you will be offered an appointment 
with a specialist nurse to discuss having a  more 
detailed examination of your bowel (a colonoscopy), 
to see whether or not there is a problem that may 
need treatm ent
juintririty of screening resulfs
No further tests ate needed. You 
be Invited to take part in screening 
again in two years.
ideal Repeat the FOB te s t
'Abnormal You will be offered an appointment 
to discuss colonoscopy
I N I
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Wliat is a co lon 0 sc0 |)y?
A colonoscopy is an Investigation that involves 
looking directly at the lining of p u r  targe bowel.
A thin, flexible tube with a tiny camera attached (a 
colonoscope) is passed into p u r  ba  ^I passage and 
guided around your bowel If polps are found, most 
can be removed painlessly using a wire loop passed 
down the colonoscope tube. These tissue samples will 
be checked for any abnormal cells that might be 
cancerous.
* About five in 10 people who have a colonoscopy 
will have a normal result (they do not have cancer 
or polyps).
#  About four in TO wilt be found to have a polyp, 
which if removed may prevent cancer developing.
About one in 10 people will be found to have 
cancer when they have a colonoscopy.
A colonoscopy is the most effective way to diagnose 
bowel cancer For most people, having a colonoscopy 
is a straightforward procedure. However; as with most 
medical procedures, there is the possibility of 
com p I ication s. Hie se ca n in cl ude h eavy bl eedin g 
(about a one in 150 chanc^ that needs further 
investigation or medical advice.The colonoscope can 
cause a hole (perforation) in the ivall of the bowel 
(about a one in 1,500 chance). In extremely rare 
cases, colonoscopy may result in death. Current 
evidence suggests that this may only happen in about 
one in 10,000 cases.
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For more information about colonoscopy you can read 
our leaflet 'Tlie colonoscopy investigation' (see page 
15). We will also send this leaflet to anyone who is 
offered a colonoscopy appointment: Rernember, 
most people who complete the FOB test will not
Do I liave io liove a 
abnoMTkil FOB result?
you have an abnormal result, you will be offered an 
appointment with a specialist nurse. He or she will 
fully explain the colonoscopy procedure to you and 
assess your fitness for i t  If you want to go ahead with 
the colonoscopy the nurse will book an appointment
ipliabli:" 15 bowel o iuce i screening?
Bowel cancer screening has been shown to 
reduce the risk of dying from bowel cancer:
Like all screening tests, the FOB test is not
that a cancer can be missed 
n the screening test
IS a
if it was not bleeding V 
was taken.
Bowel cancer may also start to  develop in the 
two years between screening tests.
It is important to be aware of the symptoms 
of bowel cancer in the tv,% years between 
screening tests. y
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:# are Ihe symptoms of l)owel Cctiicer?
The most common symptoms of bowel concer to look 
out for are:
# a persistent change in bowel habit, especially 
going to the toilet more often or diarrhoea for 
several weeks;
bleeding from the back passage without any 
obvious reason;
# abdominal pain, especially if it is severe; and
# a lump in your abdomen.
Please remember that these symptoms do not 
necessarily mean that you have bowel cancer; but if 
yen have one or more of these symptoms for four to 
SIX weeks, you should see your GR
i f  I i i e H i J  t i e a i m r ^ n i  f o i  b o v v N  ( o n c f ^ r ?
In the unlikely event that you are diagnosed with 
bowel cancer, a team of specialists will look after you; 
They will make sure tha t you get the best care and 
treatment at all times.
If bowel cancer is detected at the eadiest stage, there 
is over a 90% chance of suiviwiI (Cancer Research UK, 
2005.
The main treatm ent for bowel cancer is surgery.In 
some cases, chemotherapy or radiotherapy may be
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If the cancer is In a pnlyp that has been removed 
during colonoscopy regular check-ups may be all that 
Is needed.
Not ai! bowel cancers detected U  screening can be
Whal happE-ns lo my sample (mce i1 has been
tesleci /
Once the FOB test sample has been analysed, the 
result is recorded onto a database and the sample 
card is destroyed. We regularly review all screening 
records as part of our aim to offer you a good quality 
service and to help increase the expertise of specialist 
staff. This means that staff who vmrk elsewhere in the 
health service will need to see your records.
For more information on how we keep 
can contact NHS Direct on 084
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Before deciding whether or not you want to take part 
in bowel cancer screening, you may like to consider 
some of the benefits and disadvantages, and think 
about w hat is important to you.
r Bowel cancer Is the second most common cause of 
cancer deaths in the UK, Taking part in bowel 
cancer screening reduces your chances of dying 
from bowel cancer.
« Bowel cancer screening can also detect polyps that 
may develop into cancer over time. Removing 
polyps during a colonoscopy can reduce your 
chances of developing bowel cancer in the future,
#  There is a chance that a cancer can be missed if it 
wa^ not bleeding when the screening test was
An abnormal test result means that you will be 
offered a colonoscopy. Most people who have a 
colonoscopy vdll not have cancer. Although rare.
there are risks associated will 
colonoscopy
#  Not all bowel cancers detected by screening can be 
successfully treated.
c Although some people may find rnmpleting the 
FOB test unpleasant, it can be done in the privacy 
of your own home.
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was Cancer Research UK, in
association with the NHS Bowel Cancer Screening
Programme and with advice Iron 
Ca ncer Sc reen in g Pilot.
It was also developed through consuItation with the 
following charities,
# Bowel Cancer UK
# Cancerbackup
# Men's Health Forum
IK
230
vlori^  in lo r m A l io n  A ixl s u | ) p o r t
If you have any questions, or would like more 
information about screening for bowel cancer, you 
can:
#  contact your programme hub on Freephone 0800 
707 60 60;
# visit the NHS Cancer Screening Programmes 
website at www^cancersoeeninq.nlis.uk;
# visit the NHS Direct website a t 
www.nhsdirect.nh; III;
c visit the Cancerbackup website at
wwj:anceihai;ku|xo;g.ul, or call 0808 8001234;
& visit the CancerHelp website at 
ww'wcanceilHli' org.nl., or call 0800 226237;
c visit the Bowel Cancer UK website at 
wwiv.hnw':'l':an':eiul:.viq.ul, or ca
^ visit the Beating Bowel Cancer website at 
vvww^heatincilxrw'^lcancercici, or call 0208 
8925256;
visit the Men's Health Forum website at 
wwvvinenshealthioiuin.oni.ul:, or call 0207 
3884449,
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If you are 70 or over and would like a bowel cancer 
screening kit, please call Freephone 707 60 GO.
B o m t Cancer Screening ^  Tlm Cdmoscopy 
Investigatim, Available at
WWW* ill' '4 ,qe'^ iiing.nh;,xiL'l'UWrf|,y,uhli'.-itinir,'
colonoscopydnvesriqation.litrnl
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Published by the Department of Health in association with 
NHS Cancer Screening Programmes, with advice and 
support from the Cancer Research UK Primary Care 
Education Group.
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Appendix 4: NHS faecal occult blood test 
(Hcma-scrccn: GFOBt - Study Five)
(Guaiac FOBt)
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Appendix 5: NHS test Idt instructions
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Appendix 6: NHS Return envelope
}f>i
9<
3 \
\
, G < g ^
w
rt<0^
237
Appendix 7: Invitation letter - Study One
Cancer Screening Programmes 
Bowel Cancer Screening Program m e  
Southern Programme Hub 
Postgraduate Medical School 
University o f  Surrey 
Daphne Jackson Road 
Guildford 
GU2 7WG
Freephone: 0800 707 60 60
(Ref)
(Date)
Dear
In England men and women aged 60 to 69 are now being invited to have a bowel screening test 
every two years. This new testing programme is based on medical research that has shown that 
having this test performed regularly can reduce the risk of bowel cancer.
I understand that you have declined the invitation to be screen and that you do not wish to 
participate in the NHS Bowel Screening Programme. Whilst it is entirely reasonable for you not 
to choose to be tested we need to gain a better understanding of why people choose not to 
participate. By gaining this knowledge it will help us ensure that we are providing the most 
appropriate and helpful information with our invitation to be screened.
I have a University of Surrey PhD Health Psychology student, Gemma Webb, working in the 
Hub as Bowel Cancer Screening Assistant. Gemma is interested in the process of choosing and 
as part of her University of Surrey PhD she is looking at personal experiences of faecal occult 
blood testing.
This research hopes to evaluate individual’s experiences of being invited for voluntary bowel 
cancer screening and of the faecal occult blood test. Your contribution to this research would be 
greatly appreciated.
If you are interested in helping with this research, please read the information enclosed, and 
complete the consent form overleaf. Please return the consent form to me at the above address, 
using the stamped addressed envelope provided. I shall then pass the consent form on to Gemma 
Webb; who will contact you in due course.
If at any time you wish to restore your name to the screening list please contact the screening 
programme using our FreePhone number 0800 707 60 60.You may wish to keep a copy of this 
letter to refer to in the future.
Yours sincerely
Stephen Halloran FRCPath 
Programme Hub Director
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Appendix 8: Patient information sheet - Study One
Patient Information Sheet
Research Title: Evaluation of personal experiences of faecal occult blood testing 
(FOBt).
Purpose of the study: I would like to invite you to take part in a research study. Before you 
decide you need to understand why the research is being done and what it would involve for 
you. Please take time to read the following information carefully.
The purpose of the study is to find out what people think about being invited for voluntaiy 
bowel cancer screening, via faecal occult blood testing. Faecal occult blood testing is a home 
test kit used to detect traces of blood in faeces; if hidden blood is found, it may be an 
indication of bowel cancer. You have been invited as you have been asked to participate in 
faecal occult blood testing in the last two years.
It is up to you to decide whether to take part in the study or not. If you do wish to take part, 
please sign the attached consent form to show you have agreed to take part. You are free to 
withdraw at any time, without giving a reason. This would not affect the standard of care you 
receive.
The study will involve one short telephone interview, lasting approximately 30 minutes. This 
is all that is necessaiy to take part. Gemma Webb will arrange a suitable time with you to do 
the interview, and will call you, so there will be no expenses incurred by you.
If the interview itself generates any further questions or concerns, participants are asked to 
contact the Bowel Cancer Screening Free Phone Helpline: 0800 707 60 60 who will provide 
further information and details of support if required. Your participation in this study will be 
handled in the strictest confidence at all times.
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Conduct of the study:
You have the right to withdraw from the research study at any point; any data gained from 
your participation will be destroyed. If you have any concerns about any aspects of this 
study, you should ask to speak to Gemma Webb who will do her best to answer your 
questions:
Bowel Cancer Screening Free Phone Helpline: 0800 707 60 60 
Direct Line: 01483 688662
If you remain unhappy and wish to complain formally, you can do this through the NHS 
Complaints Procedure. Details can be obtained from your local NHS hospital.
The telephone interviews will be tape-recorded. The tapes will be transcribed onto paper  ^and 
the dialogue will be used in the data analysis. Parts of the dialogue may be directly used in 
the final research paper; however, no individual will be identifiable. The tapes will be 
destroyed when they have been transcribed. The paper copy of the transcribed dialogue will 
be kept securely by Gemma Webb; no other party will have access to them. The paper copy 
will be destroyed when the research paper has been written.
There are no anticipated risks to taking part in this study. However, in the instance that you 
find the content of the interview upsetting, you should contact Gemma Webb on the numbers 
detailed overleaf.
All research in the NHS is looked at by independent group of people, called a Research 
Ethics Committee to protect your safety, rights, wellbeing and dignity. This study has been 
reviewed by Surrey Research Ethics Committee which has raised no objection to it.
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Appendix 9: Consent form - Study One
Cancer Screening Programmes 
Bowel Cancer Screening Programm e 
Southern Programme Hub 
Postgraduate Medical School 
University o f  Surrey 
Daphne Jackson Road 
Guildford 
GU2 7WG
Freephone: 0800 707 60 60
C ONSENT FO RM
Title o f Project: Evaluation o f  personal experiences o f faecal occult blood testing  
N am e o f Researcher: GEMMA WEBB 
N am e o f  Participant:
1. I confirm that I have read and understand the patient information sheet dated May 2007  
(Version 2) for the research study. I have had the opportunity to consider the information, ask 
questions and have had these answered satisfactorily.
2. I understand that my participation is voluntary and that I am free to withdraw at any time 
without giving any reason, without my medical care or legal rights being affected.
3. I agree to take part in the above study.
Name o f  Participant Date Signature
Telephone Interview
1. Please circle which day o f  the week you wish to participate in the interview:
M O NDAY TUESDAY W EDNESDAY TH URSDAY FR ID AY
2. Please circle the tim e o f  day you wish to participate in the interview:
M O RNING {Between 9.30 a.m. and 12.30p.m.)
AFTERNO O N {Between 13.30p.m. and 16.00p.m.)
3. Please provide a contact telephone num ber for the purpose o f  the interview:
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Appendix 10:Semi-structured interview schedule- Study One
Interview Schedule
Introduction: Hello. My name is Gemma Webb and I am calling in response to your 
recent agreement to participate in my research study entitled evaluation of personal 
experiences of faecal occult blood testing. The interview will be completely confidential 
and no one will know how you personally answered these questions. You have the right 
to withdraw from the interview at any point. Are you happy to commence the 
interview?
Bowel cancer screening questions:
1. How did you feel when you were invited to take part in bowel cancer screening? 
(Prompt e.g. why?)
2. What do you think are the main causes of bowel cancer? (Prompt e.g. diet)
3. Who do you think is most likely to be diagnosed with bowel cancer and why? (Prompt 
e.g. older/males/females etc?)
4. What do you think about bowel cancer screening via faecal occult blood testing? 
(Prompt e.g. useful test?)
5. What do you think about the following statement? “By the time these tests find 
something, it is too late to treat it successfully.”* (Prompt e.g. why?)
6. What were your thoughts about the information you were sent regarding bowel cancer 
screening:
a. How did you feel about the information booklet? (Prompt e.g. easy to 
understand etc?)
b. How did you feel about the invitation letter? (Prompt e.g. why?)
c. How did you feel about the test kit instructions? (Prompt e.g. why?)
6. What was your reasoning behind not taking part in bowel cancer screening? (Prompt e.g. 
why?)
1. Is there anything else you would like to add to what we have just discussed?
Demographic Questions:
1. Please could you confirm your current age?
2. Please could you confirm your ethnic origin?
Thank yon and close
(* ACS, 2004)
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Appendix 11: Interview transcript
(Interviewer/ Interviewee)
H ello  
Mrs X?
It is
H ello, it’s Gemm a W ebb  
H ello
H ello, is it O .K to do the interview today?
P ardon
Is it O.K to do the interview today?
Y es, yes, I ’m all ready
Super, O.K, so first o f  all I just want to run through a sm all introduction, just to go  through what 
you  have already read basically from what w e sent to you. So to say that I am calling in response 
to your recent agreement to participate in m y research study called evaluation o f  personal 
experiences o f  faecal occult blood testing, and the interview w ill be com pletely confidential and 
no one w ill know  you have personally answered these questions, and that you  have the right to 
withdraw from the interview at any point, and are you happy to continue?
Y es, yes th a t’s fine
O.K. then. So the first question I have is when you received the first bow el cancer screening  
invitation, how  did it m ake you feel?
U m , a little  n ervou s to be h onest
Right
A nd  I thou ght, w ell I w ill do it b ut then , the actu al p rocess o f  d o ing  it, I  th ou gh t n o I ’m n ot 
go in g  to be ab le to  m anage to do this.
Right, O.K. And when you say the actual process, do you mean that you  found the actual 
com pleting o f  the test kit difficult?
Y es
Right O.K. And was that in the respect, what was it about the test kit that you didn’t want to 
really do? W as it, did you understand what you were supposed to do?
Y es, and it w as a little com p licated  ab out, you  know , the actu al p rocedu re seem ed  a little  
com p licated .
Right, right.
243
Remembering to do it all in the right order and things, I thought no this is too fiddly and, 
and the whole process was messy shall we say, and I thought. I’m disabled so my hands 
don’t work terribly well and I thought this was all going to be very difficult to do.
Right. Right O.K, and do you think that there should be more information given  to help  
individuals, m aybe in your position, was, is there anything you think could helped that
Yes, I think it could be a lot easier to be able to do, to be honest.
Right
The wording was quite complicated, it, remembering to do which bit where, and how to do 
it, um, I think it should be simplified.
Right, O.K. So when you first got the invitation and you thought about doing it, w as it, w as that 
quite a strong response, w as that because it was all a bit too com plicated?
Yes
Fine, right, O.K. And, going onto a question about bow el cancer itself, do you know , or what do 
you  think are the main causes o f  bow el cancer, is there anything that com es to mind?
Not really no
N o? U m , or sym ptom s, or anything like that?
Not really no
O.K., no problem, and also do you, is there anybody in a population you  think w ould be more 
likely to be diagnosed with, you know  people w ho m ight do the test kit and be more likely to be 
found to have bow el cancer than som ebody else?
No I don’t think so, I think it’s a general thing like most cancers really, it can affect anyone.
And that information, is that som ething w hich you  have heard or som ething you have kind o f  
assum e or, or, um, where w ould you know  that from?
Well, I mean just from general information sort of television, newspapers, that sort of 
thing, hospitals when I’ve been, sitting in hospitals with all signs up saying it affects 
everyone really.
Right, right O.K. A nds the test kit itself, I know  you said it w as quite com plicated, but how  do 
you feel about the test kit being able to pick up on bowel cancer, do you think i f  s a useful test, 
do you think i f  s som ething w hich you know would, w ell yes w e know  is only a screening test 
only, but is it som ething you feel w ould be useful in picking up signs o f  bow el cancer?
Oh yes definitely, I mean its like breast screening, I think it should be a thing, but I don’t 
know about doing these at home, I don’t think that’s a very safe option to be honest.
O.K, and w hy’s that?
Well, I think if it was done under sterilised conditions, you’d get a truer reading and like, 
breast screening, if there was a unit that came round where you could actually do it, um 
have the screening done, at a specific place, um I think you’d get a truer reading. When it’s
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done in the home, you don’t know what other germs have contaminated the sample, or 
under what conditions they’re done.
O.k., so say for exam ple, they were saying that they were running this screening at your local 
hospital; you  w ould pop in and take a sam ple, or som ething o f  that kind o f  nature, so it w ould be 
in a sterile setting?
Yes
That kind o f  thing?
Yes. Yes, I think that would be much more advisable.
Right, and how do you feel, if um, the letter itself as you know came from our screening 
director, how would you have felt, would you have felt any differently if that letter had 
come from your G.P?
No
N o, O.K, it w ould have been exactly the same, you know  you would have felt the sam e about you  
k n ow ...
Yes, I just think the wording wasn’t that good to be honest.
And the wording, w as the wording, is it just in the like the screening instructions or w as it in the 
letter as w ell?
Well, to be honest, I think most people would sort of read half of it and get terribly 
complicated and bored by the time they got halfway through, you probably wouldn’t read it 
completely
Right
I mean, I had to read it through twice to really understand what it was all about, and I 
thought it was a bit too....
Too much was it?
Too much, yes
Right, right, O.K, and that w as all o f  the information, not just say the letter or the instructions, 
b u t....
No, I think all of it really, I think it was too much information to take in, in one go, I think 
it, you know if you’re just asking for screening it should just state, you know, we’ re doing 
this screening test because and just that, and would you like to take part, if so, then send 
the other details but I think it was too much information to take in, in one go.
Right, right, O.K, so som ething a bit more sim plified would be 
Yes
W ould be useful, um O.K. So m oving on, there’s a statement that’s been made, um, in recent 
research from an individual w ho said, by the tim e these tests, and by these tests they m ean this 
faecal occult blood test, by the time these tests find som ething, it’s too late to treat it successfu lly . 
H ow  do you feel about som eone saying that?
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Well, I think it makes people think well it seems pointless doing the test if its going to be too 
late by the time you’ve done all this complicated test and what have you, and the result 
comes through, it’s too late then anyway and what’s the point.
Mmm, and what, do you think, you know  I’m not saying that you w ould hold that v iew  at all, but 
do you think that, you know, som eone m ight think that the test, that you know, its useless 
because w ell it doesn’t matter because o f  by the tim e they’ve got that, they’ve probably got 
bow el cancer i f  they find blood and there is no point in doing it, do you  think that’s som ething  
people m ight think or ...
Yes, yes I do think, you know, an awful lot of people are going to say well this is wasting an 
awful lot of tax payers money doing the tests that are absolutely useless.
Mmm, and do you think it’s a useful test to be doing?
I think if it, if it can serve some purposes to diagnose um people who are likely to get it, 
then yes it’s a good thing. If like you say, the test is going to come back and its too late to do 
anything about anything, then yes it is a waste of taxpayers money.
M m m , so going back to what you just said, i f  people w ho were more likely to get bow el cancer 
should do the test, um, do you know  w ho would be more likely, do you  think there is any reason  
w hy they might be more likely than som ebody else?
Well I think you know, anyone that might, sort of, like myself, had a hysterectomy because 
they thought I had cancer.
Right
And, a, and so therefore you’re more, you feel you might be more prone to getting cancers, 
so you go for your regular breast screening and all the other things because you’ve already 
had one type of cancer
Right, so people w ho m ight have had an experience o f  cancer or thought cancer in the past 
Yes
Should do, O.K. Um , do you think there’s anything about gender, do you think there’s any 
chance o f  m en or fem ales being diagnosed more than the other, is there any
No, I don’t actually. I mean its like breast cancer, my daughter in law had her breasts 
removed from breast cancer, and whilst she was in hospital we went to you know, visit her, 
and that, and there seemed to be a lot of men in there with breast cancer, I was quite 
surprised. But since that, I mean, that was tivo years ago now, um, I understand that 
(proves) hospital treatments and that, that I’ve been and seen that men are just as likely to 
get it, as women and it doesn’t seem to matter on your age or whether you’ve had children, 
or no had children, there’s no particular reason
Right, yes, yes, I see what you mean
Bit like the common cold really, anyone can get it
Y es, yes absolutely. Y es you  are right, that’s true. Um , so um, som e o f  these questions I’ve  
already been through, um, because I was going to ask you what your thoughts were about the 
information you were sent, so the information booklet, the invitation and the test kit instructions, 
and I know  you said that there was, they could be sim plified, um is there anything, else that you
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could add to that? Anything that you think w e could do to make the process better? To improve 
it?
Well, as say, I think it would be better done in a sterilised environment. I, I, can quite see 
things are going to get contaminated and I don’t see that you’d have a really cross 
reference with people because you, you don’t know what conditions there were done under.
Y es, right, right. Indeed, and, so um, just as a kind o f  a conclusion really that the reason you  
didn’t want to do this was because o f  those two main reasons, because it w as a little bit to 
com plicated and you w ould have preferred to be in a sterile environment? W as there anything 
else you didn’t like about it or, personally you  thought I don’t want to do that, um because o f  a 
reason?
No, I think it was generally because one, it was a little complicated and two because I’m 
disabled, I was worried about sort of my hands and stuff like that, and ways of doing it, and 
how it was being done, and felt it would be better if it was like in a hospital where you could 
perhaps do it in, not necessarily a toilet but a bed pan, or something you know?
Mmm
It would be easier to get at you know?
Y es, no, absolutely, yes no I do understand that. Mmm, so m y final question is that is there 
anything else you ’d like to add to what w e ’ve talked about in the recent minutes?
Well, I mean that, I think we’ve covered most (laughs) my thoughts on the subject.
W ell that’s great, and I really do appreciate all o f  your com m ents and w e are alw ays seeking to 
improve the service and um you know  evaluate how  people are getting on with it, so that’s been  
really important, so thank you very much for answering those questions. U m , just for m y  
research criteria, could you just confirm your current age please?
I’m 61
And also your ethnic origin?
Oh, definitely British.
That’s super, I thought it was but I needed to write it down
I was born and bred in Devonshire my dear, for about the ninth generation (Laughs)
Ah, w ell Mrs X , thank you very much for talking to m e
That’s alright, you’re welcome. I hope it helps you in the future
It w ill do, it absolutely w ill do, so thank you very much for your time
Thanks very much
O.K then 
Bye, Bye
B ye B ye
(End o f  interview)
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Appendix 12: Advertisement- Study Three
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Appendix 13: Invitation letter- Stndy Three
UNIVERSITY OF
SURREY
Faculty of
Arts & Human Sciences
Psychology Department
Room 18AC04
Guildford, Surrey GU2 7XH UK
Gemma Webb 
BSc, MSc
PhD/MPbil Health Psychology 
Student
M A TER IA L REDACTED A T REQUEST OF UNIVERSITY
(Date)
Dear
By December 2009, men and women aged 60 to 70 in Surrey will be invited to have a bowel 
screening test every two years. This new testing programme is based on medical research that 
has shown that having this test performed regularly can reduce the risk of bowel cancer.
I am a University of Surrey PhD Health Psychology student, currently working in the Southern 
Hub as a Bowel Cancer Screening Assistant. As part of my University of Surrey PhD, I am 
looking at individual’s understanding of faecal occult blood testing. Your contribution to this 
research would be greatly appreciated.
If you are interested in helping with this research, please read the information enclosed, and 
complete the consent form overleaf. Please return the consent form to me at the above address, 
using the stamped addressed envelope provided.
Yours sincerely
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Appendix 14: Information sheet -  Study three 
Information Sheet
Title: Expectations of faecal occult blood testing in an older population - a focus 
group study.
Purpose of the study: I would like to invite you to take part in a research study. 
Before you decide you need to understand why the research is being done and what it 
would involve for you. Please take time to read the following information carefully.
The purpose of the study is to find out what you think about voluntary bowel cancer 
screening, via faecal occult blood testing. Faecal occult blood testing is a home test 
kit used to detect traces of blood in faeces; if  hidden blood is found, it may be an 
indication o f bowel cancer. You have been invited as you are currently within an age 
criteria o f 60- 69 years old.
The study will involve participation in a group discussion. This is all that is 
necessary to take part. Gemma Webb will contact you to participate in the group 
discussion.
It is up to you to decide whether to take part in the study or not. If you do wish to 
take part, please sign the attached consent form to show you have agreed to take part. 
You are free to withdraw at any time, without giving a reason. This would not affect 
the standard o f care you receive.
If the discussion itself generates any further questions or concerns, participants are 
asked to contact the Bowel Cancer Screening Programme (details overleaf) who will 
provide further information and details o f support if  required. Your participation in 
this study will be handled in the strictest confidence at all times.
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Conduct of the study:
You have the right to withdraw from the research study at any point; any data gained 
from your participation will be destroyed. If you have any concerns about any 
aspects of this study, you should ask to speak to Gemma Webb (details overleaf) who 
will do her best to answer your questions. If you remain unhappy and wish to discuss 
a matter further, please contact Dr. Victoria Senior -Academic Supervisor (details 
overleaf).
The discussion will be tape-recorded. The tapes will be transcribed onto paper, and 
the dialogue will be used in the data analysis. Parts o f the dialogue may be directly 
used in the final research paper; however, no individual will be identifiable. The 
tapes will be destroyed when they have been transcribed.
The paper copy o f the transcribed dialogue will be kept securely by Gemma Webb; 
no other party will have access to them. The paper copy will be destroyed when the 
research paper has been written.
There are no anticipated risks to taking part in this study. However, in the instance 
that you find the content of the discussion upsetting, you should contact Gemma 
Webb on the numbers detailed below.
This study has been reviewed by the University of Surrey Ethics Committee which 
has raised no objection to it.
Contact details:
1. Bowel Cancer Sereening Free Phone Helpline: MATERIAL REDACTED
2. Gemma Webb: AT REQUEST
OF UNIVERSITY
3. Dr. Vietoria Senior:
251
Appendix 15: Consent form - Study Three
UNIVERSITY OF
SURREY
Consent Form
I the undersigned voluntarily agree to take part in the study on ‘Expectations of faecal 
occult blood testing in an older population -  a focus group study.’
I have read and understood the Information Sheet provided. I have been given a full 
explanation by the investigators of the nature, purpose, location and likely duration of 
the study, and of what I will be expected to do. I have been advised about any 
discomfort and possible ill-effects on my health and well-being which may result. I have 
been given the opportunity to ask questions on all aspects of the study and have 
understood the advice and information given as a result.
I consent to my personal data, as outlined in the accompanying information sheet, being 
used for the research project detailed in the information sheet, and agree that data 
collected may be shared with other researchers or interested parties. I understand that all 
personal data relating to volunteers is held and processed in the strictest confidence, and 
in accordance with the Data Protection Act (1998).
I understand that I am free to withdraw from the study at any time without needing to 
justify my decision and without prejudice.
I understand that in the event of my suffering a significant and enduring injury 
(including illness or disease) as a direct result of my participation in the study, 
compensation will be paid to me by the University (or sponsor where a clinical trial is 
sponsored by a pharmaceutical company), subject to certain provisos and limitations. 
The amount of compensation will be appropriate to the nature, severity and persistence 
of the injury and will, in general terms, be consistent with the amount of damages 
commonly awarded for similar injury by an English court in cases where the liability has 
been admitted
I confirm that I have read and understood the above and freely consent to participating in 
this study. I have been given adequate time to consider my participation and agree to 
comply with the instructions and restrictions of the study.
Name of volunteer (BLOCK CAPITALS) .......................................................
Signed .......................................................
Date................................................................... .......................................................
Name of researcher taking consent (BLOCK CAPITALS)
Signed
Date
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Appendix 16; Focus group discussion schedule -  Study three 
Focus Group Schedule
Introduction:
Welcome everyone and thank you for coming today. My name is Gemma Webb and I will be 
running this group discussion today, with Sarah Brown. Over the next hour or so we’re 
going to ask a few open ended questions, about your understanding of voluntary bowel 
cancer screening via faecal occult blood testing. We would like you to respond and discuss 
each of these questions freely. We also want to hear everything you want to tell us, but we 
need to ensure that everyone gets a chance to talk today. Therefore, for the purpose of the 
recording, please try to speak one at a time. Finally, we also want to ensure that we ask all of 
our questions, so please don’t be offended if we have to move onto the next question.
Bowel Cancer Screening questions:
1. What do you know about bowel cancer screening? (Prompt e.g. have you  heard about 
Bowel Cancer Questions:
2. What do you understand by the term bowel cancer?
3. What do you think are the main causes of bowel cancer? (Prompt e.g. diet)
4. Who do you think is most likely to be diagnosed with bowel cancer and why? (Prompt 
e.g. o lder/m ales/fem ales etc?)
5. Do you think you, yourselves, are at risk of developing bowel cancer? (Prompt e.g. what 
level o f  risk, i.e. high/ medium/ low and why?)
We are going to hand around some information about bowel cancer screening. These will 
include some exerts from the information about bowel cancer, bowel cancer screening and 
the faecal occult blood test currently being used in the screening programme.
Material 1: ‘Bowel Cancer Screening -  The Facts’ leaflet.
Please take a moment to read the information we have distributed (p2, 3, 4 only)
6. What are your first impressions about this information? (Prompt e.g. confused)
Material 2: ‘Test-kit instructions’ leaflet.
Please take a moment to read the information we have distributed.
7. What are your first impressions about this information? (Prompt e.g. confused)
Material 3: Faecal Occult Blood Test Kit (Includes test card/ cardboard sticlcs/ return 
envelope)
Please take a moment to look at the test kit we have distributed.
8. What are your first impressions about the test kit? (Prompt e.g. confused)
9. What do you think about bowel cancer screening via faecal occult blood testing? 
(Prompt e.g. useful test?)
10. How confident do you think you would you be carrying out this test kit at home?
11. Do you think that if you received an abnormal faecal occult blood test result, that bowel 
cancer was still preventable? (Prompt e.g. bowel cancer is at an early stage /curable or 
late stage/ too late?)
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Participation Questions:
12. In light of this discussion, are you worried or fearful about being invited to participate in 
the bowel cancer screening programme? (Prompt e.g. why?)
13. Do you intend to participate in the bowel cancer screening programme when offered? 
(Prompt e.g. why?)
Closing Question:
14. Is there anything further anyone would like to add to what we have discussed today? 
Thank yon and close
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Appendix 17: Questionnaire- Study Four
Cancer Screening Programmes 
Bowel Cancer Screening Program m e
We would appreciate your view  on the introduction o f  the National Bowel Cancer Screening 
Programme and invite you to participate in the collation o f  valuable viewpoints from the public on 
this new service.
Please READ each o f  the following statem ents and CIRCLE the relevant answer:
Gender: Age:
Female Male Under 60 60-64 65-69 70+
M y  chances o f  developing bowel cancer in the future are:
Very low___________ Low_____________ Unsure____________ High______________ Very High
The thought o f  bowel cancer makes me feel:
Extremely worried Very worried_______ Worried_______Slightly worried Not at all worried
1 think that bowel cancer screening is an effective w ay o f detecting bowel cancer early:
Strongly disagree Disagree__________ Unsure____________ Agree Strongly agree
I would feel awkward collecting stool samples at home, to be posted, and tested in a laboratory:
Strongly disagree Disagree__________ Unsure____________ Agree Strongly agree
Bowel cancer is a very serious illness:
Strongly disagree Disagree__________ Unsure____________ Agree Strongly agree
I would be confident in collecting stool sam ples at home, to be posted, and tested in a 
laboratory:
Strongly disagree Disagree__________ Unsure____________ Agree Strongly agree
Compared with other men and women my age, my cliances of getting bowel cancer are:
Very low___________ Low_____________ Unsure__________ High______________ Very high
W hat do you think about the following statement:
____________ IP s not worth having the test because ‘what will be, will be'
Strongly disagree Disagree__________ Unsure  Agree Strongly agree
I intend to participate in the bowel cancer screening program m e when offered/ becom es 
available:
Strongly disagree Disagree__________ Unsure____________ Agree Strongly agree
I consent to my answers being used for research purposes and agree that data collected may be shared 
with other researchers or interested parties. 1 understand that all data is anonymous, held and 
processed in the strictest confidence; and in accordance with the Data Protection Act (1998). I 
understand that if  this questionnaire generates any further questions or concerns that T should contact
my G.P. (Please tick box) □___________________________________________________
Thank you for the tim e you have taken to m ake your contribution. W e value your opinion.
This research is being conducted by Gemma Webb- Research Student at
&SURREY
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Appendix 18: Correlations for questionnaire items -  Study Four
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Appendix 19: Advertisement One -  Study Five
Are you interested in the new Bowel Cancer 
Screening Programme?
We are currently researching what people think 
about bowel cancer screening.
To And ont more please come and Gemma in the 
foyer today.
(This stndy has been reviewed by the University 
of Surrey Ethics Committee and has been given 
a favourable ethical opinion.)
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Appendix 20: Advertisement Two -  Study Five
Are you interested in the new Bowel Cancer 
Screening Programme?
We are currently researching what people thinlc 
about bowel cancer screening.
To find out more please contact Gemma Webb:
MATERIAL REDACTED AT REQUEST OF UNIVERSITY
(This study has been reviewed by the University of Surrey 
Ethics Committee and has been given a favourable ethical 
opinion.)
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Appendix 21: Advertisement Three- Stndy Five
Subject: Are you aged 55 years old or over?
Are you aged 55 years old or over?
Volunteers required for a study investigating what people think about cancer
screening tests.
Helping with this research only involves completing two short forms.
If you are interested, please e-mail: REDACTED
Gemma Webb, FAHS, University of Surrey
This study has been reviewed and given a favourable ethical opinion by the 
University o f  Surrey Ethics Committee.
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Appendix 22: Invitation letter -  Study Five
if  UNIVERSITY OF
#  SURREY
Faculty of Arts & Human Sciences 
Psychology Department
Room 18 AC 04 
Guildford, Surrey 
GU2 7XH
Gemma Webb 
BSc, MSc
PhD Health Psychology 
Student
MATERIAL REDACTED AT REQUEST OF UNIVERSITY
Dear Sir/Madam,
By December 2009, men and women aged 60 to 69 in the UK will be invited to have a bowel 
cancer screening test every two years. People over 70 can request a screening kit by calling a 
free phone helpline when the programme reaches their area. This screening programme is based 
on medical research that has shown that having this test performed regularly can reduce the risk 
of bowel cancer. If you would like to find out more information about this bowel cancer 
screening programme, please call Freephone; 0800 707 60 60.
I am a PhD Health Psychology student at the University of Surrey. The aim of my current 
research is to find out what people think about bowel cancer screening test kits. Helping with this 
research only involves completing the two short forms enclosed. This is all that is 
necessary to take part.
If you are interested in taking part nlease read and complete Form 1 overleaf BEFORE opening 
the enclosed envelope.
Please return Forms 1 and 2 to me using the stamped addressed envelope provided, within two 
weeks. If these forms should generate any further questions, please contact your G.P.
Yours sincerely,
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Appendix 23: Form One- Study Five
FORM 1- Please complete this form BEFORE opening the envelope enclosed. 
Please READ each of the following statements and CIRCLE/ PRINT the relevant answer:
Gender: Male _________Female_____________________ Age;
I  know a family member/friend/colleagne who has been diagnosed with bowel cancer:
I Yes No
I have a medical history of large bowel investigation:_______________________________
Yes (please specify type)__________________________________  No
The thought of bowel cancer makes me feel:
Extremely worried Very worried Worried Slightly worried Not at all worried
I think that bowel cancer screening is an effective way of detecting bowel cancer early;_________________
I Strongly disagree Disagree Unsure Agree Strongly agree
Bowel cancer is a very serious illness:________________________________________________________________
I Strongly disagree Disagree Neutral Agree Strongly agree
Compared with other men and women my age, my chances of getting bowel cancer are:________________
I Very low Low Same High Very high
W hat do you think about the statement 'It's not worth haviitf^ the test because ‘what will be, will be '?______
I Strongly disagree Disagree Unsure Agree Strongly agree
My chances of developing bowel cancer in the future are:_____________________________________________
I Very low Low Moderate High Very High
The thought of collecting faeces/stool samples for a bowel cancer screening test disgusts me:____________
I Strongly disagree Disagree Unsure Agree Strongly agree
I would be confident in collecting faeces/stool samples for a bowel cancer screening test:__________________
I Strongly disagree Disagree Unsure Agree Strongly agree |
It would be difficult for me to find the time to do a bowel cancer screening test at home:________________
I Strongly disagree Disagree Unsure Agree Strongly agree
I would be happy to return a bowel cancer screening test in the post:__________________________________
I Strongly disagree Disagree Unsure Agree Strongly agree
I would feel embarrassed using a bowel cancer screening test:
Strongly disagree Disagree____________Unsure______________ Agree_____________ Strongly agree
T ivduld be happy to store a used bow el cancer screening test before returning it:_____________________
I Strongly disagree Disagree Unsure Agree Strongly agree
It is likely I will participate in the bowel cancer screening programme in the future:_________________
I Strongly disagree Disagree Unsure Agree Strongly agree
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Appendix 24: Form Two- Study Five
kit. Please READ each o f the following statements and CIRCLE the relevant answer:
I think the instructions for this test kit were easy to follow:
1 Strongly disagree Disagree Unsure Agree Strongly agree I
I think this test kit would be awkward to use:
1 Strongly disagree Disagree Unsure Agree Strongly agree I
I would be happy to return this completed test kit in the post:
1 Strongly disagree Disagree Unsure Agree Strongly agree |
The thought o f collecting faeces/stool samples for this test kit disgusts me:
Strongly disagree Disagree Unsure Agree Strongly agree
I would be confident in completing this test kit at home:
Strongly disagree Disagree Unsure Agree Strongly agree
I would feel embarrassed using this test kit:
Strongly disagree Disagree Unsure Agree Strongly agree
I would be happy to store the used test kit before returning it:
Strongly disagree Disagree Unsure Agree Strongly agree
It would be difficult for me to find the time to do this test kit:
Strongly disagree Disagree Unsure Agree Strongly agree
I think that this test kit is an effective way of detecting bowel cancer early:
Strongly disagree Disagree Unsure Agree Strongly agree
The thought of bowel cancer makes me feel:
Extremely worried Very worried Worried Slightly worried Not at all worried
It is likely I will participate in the bowel cancer screening programme in the future:
I Strongly disagree Disagree Unsure Agree Strongly agree
Ethnic Group:
White British Irish Other
Mixed White and Black Caribbean White and Black African 
White and Asian Other
Asian or Asian British Indian Pakistani Bangladeshi Other
Black or Black British Caribbean African Other
Chinese Other Ethnic Group {please print)
Current work status:
Full-time Part-time Not employed Retired
I consent to my personal data, as outlined in the accompanying letter, being used for the research project 0 
detailed in the letter, and agree that data collected may be shared with other researchers or interested 
parties. I understand that all personal data relating to volunteers is held and processed in the strictest 
confidence, and in accordance with the Data Protection Act (1998).
I understand that if  these forms generate any further questions/ concerns that I should contact my G.P. □
Thank you for the time you have taken to make your contribution.
Please return Form 1 and 2 ONLY in the stamned addressed envelope provided.
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Appendix 25: Classification table- Study Five
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Appendix 26: Instructions for guaiac FOBt -Study Five
Hema-screen: GFOBt
1. Peel back flap 1.
2. Use a cardboard stick to apply a smear o f bowel motion on rectangle I,
3. Use a fresh stick to take another sample form a different area of the bowel 
motion. Spread this on rectangle II.
4. Close the flap by tucking under the orange tab.
5. Peel back flap 2.
6. Repeat steps 2 to 4
7. Peel back flap 3.
8. Repeat steps 2 to 4
Note: Your samples do not need to be taken from three bowel motions in a row, 
but they must be from three separate motions.
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Appendix 27: Immunochemical FOBt s -  Study Five
FOB Gold tube: IFOBt 1
Instructions
1. Loosen and remove the purple cap from the bottle with the internal probe 
attached.
2. Insert the purple probe into 5 or 6 different sites o f the bowel motion.
3. Insert the probe back into the bottle and tighten the cap.
4. Shake the bottle up and down several times.
5. Store in a refrigerator until returning.
6. Repeat steps 1 to 5 for the next bowel movement.
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OC-Auto sampling bottle 3: IFOBt 2
Instructions
1. Store in a refrigerator before use, allow to return to room temperature before 
use.
2. Twist the green cap on the bottle 180 degrees and pull to open.
3. Use green probe attached to the lid to scrape some stool/faeces from the 
surface of the bowel motion.
4. Insert the probe back into the bottle and snap shut.
5. Shake the bottle up and down several times.
6. Store in a refrigerator until returning.
7. Repeat steps 1 to 6 for the next bowel movement.
Precautions:
• Do not pour any fluid or water in the sampling bottle or add water to it.
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New Hemtube TM: IFOBt 3
Instructions
1. Insert the pointed tip of the sampling stick into 5 or 6 different sites of the 
bowel motion and then scrape the surface of the specimen several times 
horizontally.
2. Insert the sampling stick all the way into the sampling tube printed in 
BLACK ink* completely, until you hear the click. Ensure the stick clicks into 
place, fits tightly and does not leak.
3. Place in plastic bag.
4. Repeat steps 1-3 for another bowel movement, on a different day using the 
sampling tube printed in RED ink*.
('^One tube is printed in black ink, the other in red ink)
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Hema-screen TM DEVEL-A-TAB: IFOBt 4
-----
\0aW:OfBÜ1K::
5: ct: O' *bsz:a: f..
Opei(2p4vadd3Klma(yiKeRelM;W|*y$'dan*l3bmlonf
Sample « 1 
DATE:___
■■Mi
mAiMi
F O R  IN  V IT R O  D I A G N O S T I C  U S E
1 2
fO R  I N  VITRO DIAGNOSTIC U S E
Instructions
1. Before you use the toilet, flush the toilet to clear the bowl.
2. Place tissue provided onto water in bowl.
3. Lift front flap on the test card.
4. After defecating into the bowl, using applicator stick, stab stool/faeces in 4 
different sites o f the bowel movement and apply to circle number 1.
5. Close the flap.
6. Discard the applicator in a rubbish bin NOT the toilet.
7. Repeat steps 1 to 6 for the next bowel movement and apply to circle 2.
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